Plotkin, Scott
eCommons Login: SRP5
first name: Scott
last name: Plotkin
coauthor of: Merker, Vanessa
coauthor of: Vranceanu, Ana-Maria
coauthor of: Batchelor, Tracy
coauthor of: Stemmer-Rachamimov, Anat
coauthor of: Barker, Frederick
full name: Scott Randall Plotkin, M.D.,Ph.D.
has faculty rank: Full Professor
has network: selected publications
has network: research areas
has network: coauthor of
has network: similar to
latitude: 42.36241700000000
longitude: -71.06893700000000
photo: https://connects.catalyst.harvard.edu/Profiles/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx
Person ID: 57533
person in primary position: Giovanni Armenise - Harvard Professor of Neurology
physical neighbor: Arrillaga-Romany, Isabel
physical neighbor: Dietrich, Jorg
physical neighbor: Gerstner, Elizabeth
physical neighbor: Jones, Robin
physical neighbor: Musolino, Patricia
similar to: Vranceanu, Ana-Maria
similar to: Merker, Vanessa
similar to: Stemmer-Rachamimov, Anat
similar to: Welling, D.
similar to: Ullrich, Nicole
type: Agent
type: Person
selected publications: Authorship 1779047
selected publications: Authorship 1834614
selected publications: Authorship 1852673
selected publications: Authorship 1833941
selected publications: Authorship 1832015
selected publications: Authorship 1819508
selected publications: Authorship 1814479
selected publications: Authorship 1833424
selected publications: Authorship 1783577
selected publications: Authorship 1849145
selected publications: Authorship 1827414
selected publications: Authorship 1810743
selected publications: Authorship 1844452
selected publications: Authorship 1752181
selected publications: Authorship 1741282
selected publications: Authorship 1747996
selected publications: Authorship 1750732
selected publications: Authorship 1831312
selected publications: Authorship 1831313
selected publications: Authorship 1820144
selected publications: Authorship 1716666
selected publications: Authorship 1701342
selected publications: Authorship 1684033
selected publications: Authorship 1660316
selected publications: Authorship 1663208
selected publications: Authorship 1649772
selected publications: Authorship 1652897
selected publications: Authorship 1648934
selected publications: Authorship 1640812
selected publications: Authorship 1637451
selected publications: Authorship 1602490
selected publications: Authorship 1666782
selected publications: Authorship 1615282
selected publications: Authorship 1567819
selected publications: Authorship 1605328
selected publications: Authorship 1597104
selected publications: Authorship 1586209
selected publications: Authorship 1586403
selected publications: Authorship 1524574
selected publications: Authorship 1560984
selected publications: Authorship 1583754
selected publications: Authorship 1552849
selected publications: Authorship 1573040
selected publications: Authorship 1566172
selected publications: Authorship 1557987
selected publications: Authorship 1526646
selected publications: Authorship 1503052
selected publications: Authorship 1512575

eCommons Login
tag name: catalyst:eCommonsLogin
type: DatatypeProperty

coauthor of
tag name: prns:coAuthorOf
type: ObjectProperty

end date
tag name: prns:endDate
type: DatatypeProperty

Faculty Rank
type: Class

full name
tag name: prns:fullName
type: DatatypeProperty

author list
tag name: prns:hasAuthorList
type: DatatypeProperty

has faculty rank
tag name: prns:hasFacultyRank
type: ObjectProperty

has network
tag name: prns:hasNetwork
type: ObjectProperty

published in
tag name: prns:hasPublicationVenue
type: DatatypeProperty

information resource reference
tag name: prns:informationResourceReference
type: DatatypeProperty

is primary position
tag name: prns:isPrimaryPosition
type: DatatypeProperty

latitude
tag name: prns:latitude
type: DatatypeProperty

longitude
tag name: prns:longitude
type: DatatypeProperty

photo
tag name: prns:mainImage
type: ObjectProperty

maximum weight
tag name: prns:maxWeight
type: DatatypeProperty

journal title abbreviation
tag name: prns:medlineTA
type: DatatypeProperty

MeSH DescriptorUI
tag name: prns:meshDescriptorUI
type: DatatypeProperty

MeSH semantic group name
tag name: prns:meshSemanticGroupName
type: DatatypeProperty

minimum weight
tag name: prns:minWeight
type: DatatypeProperty

number of authors
tag name: prns:numberOfAuthors
type: DatatypeProperty

number of connections
tag name: prns:numberOfConnections
type: DatatypeProperty

number of publications
tag name: prns:numberOfPublications
type: DatatypeProperty

Person ID
tag name: prns:personId
type: DatatypeProperty

person in primary position
tag name: prns:personInPrimaryPosition
type: ObjectProperty

physical neighbor
tag name: prns:physicalNeighborOf
type: ObjectProperty

position in department
tag name: prns:positionInDepartment
type: ObjectProperty

position in division
tag name: prns:positionInDivision
type: ObjectProperty

predicate node
tag name: prns:predicateNode
type: ObjectProperty

principal investigator name
tag name: prns:principalInvestigatorName
type: DatatypeProperty

publication date
tag name: prns:publicationDate
type: DatatypeProperty

similar to
tag name: prns:similarTo
type: ObjectProperty

sort order
tag name: prns:sortOrder
type: DatatypeProperty

start date
tag name: prns:startDate
type: DatatypeProperty

educational organization
tag name: prns:trainingAtOrganization
type: DatatypeProperty

training location
tag name: prns:trainingLocation
type: DatatypeProperty

uniqueness weight
tag name: prns:uniquenessWeight
type: DatatypeProperty

year
tag name: prns:year
type: DatatypeProperty

Academic Article
type: Class

Article
type: Class

Document
type: Class

PubMed Identifier
tag name: bibo:pmid
type: DatatypeProperty

Address
type: Class

address line 1
tag name: vivo:address1
type: DatatypeProperty

address line 2
tag name: vivo:address2
type: DatatypeProperty

address line 3
tag name: vivo:address3
type: DatatypeProperty

city
tag name: vivo:addressCity
type: DatatypeProperty
type: FunctionalProperty

postal code
tag name: vivo:addressPostalCode
type: DatatypeProperty
type: FunctionalProperty

state or province
tag name: vivo:addressState
type: DatatypeProperty
type: FunctionalProperty

selected publications
tag name: vivo:authorInAuthorship
type: ObjectProperty

author rank in publication
tag name: vivo:authorRank
type: DatatypeProperty
type: FunctionalProperty

Authorship
type: Class

degree earned
tag name: vivo:degreeEarned
type: ObjectProperty

Department
type: Class

Division
type: Class

education and training
tag name: vivo:educationalTraining
type: Class
type: ObjectProperty
label: Educational Training

Grant
type: Class

research areas
tag name: vivo:hasResearchArea
type: ObjectProperty

research activities
tag name: vivo:hasResearcherRole
type: ObjectProperty

HR job title
tag name: vivo:hrJobTitle
type: DatatypeProperty

Information Resource
type: Class

linked author
tag name: vivo:linkedAuthor
type: ObjectProperty

linked information resource
tag name: vivo:linkedInformationResource
type: ObjectProperty

mailing address
tag name: vivo:mailingAddress
type: ObjectProperty

major field of degree
tag name: vivo:majorField
type: DatatypeProperty

middle name or initial
tag name: vivo:middleName
type: DatatypeProperty
type: FunctionalProperty

ORCID id
tag name: vivo:orcidId
type: DatatypeProperty

positions
tag name: vivo:personInPosition
type: ObjectProperty

phone
tag name: vivo:phoneNumber
type: DatatypeProperty

Position
type: Class

position in organization
tag name: vivo:positionInOrganization
type: ObjectProperty

preferred title
tag name: vivo:preferredTitle
type: DatatypeProperty
type: FunctionalProperty

Researcher Role
type: Class

researcher role of
tag name: vivo:researcherRoleOf
type: ObjectProperty

contributes to
tag name: vivo:roleContributesTo
type: ObjectProperty

sponsor award id
tag name: vivo:sponsorAwardId
type: DatatypeProperty
type: FunctionalProperty

predicate
tag name: rdf:predicate
type: ObjectProperty

type
tag name: rdf:type
type: ObjectProperty

label
tag name: rdfs:label
type: DatatypeProperty

Concept
type: Class

Agent
type: Class

first name
tag name: foaf:firstName
type: DatatypeProperty
type: FunctionalProperty

last name
tag name: foaf:lastName
type: DatatypeProperty
type: FunctionalProperty

Organization
type: Class

Person
type: Class

Authorship 1046664
type: Authorship
author rank in publication: 16
linked author: Plotkin, Scott
linked information resource: Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models.

Authorship 1051793
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Neurofibromatosis and Schwannomatosis.

Neurofibromatosis and Schwannomatosis.
PubMed Identifier: 29548054
author list: Plotkin SR, Wick A
published in: Seminars in neurology
information resource reference: Neurofibromatosis and Schwannomatosis. Semin Neurol. 2018 02; 38(1):73-85.
journal title abbreviation: Semin Neurol
publication date: 2018-03-16T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 110696
type: Authorship
author rank in publication: 7
linked author: Plotkin, Scott
linked information resource: Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome.

Permeability of the blood-brain barrier to soluble cytokine receptors.
PubMed Identifier: 8646566
author list: Banks WA, Plotkin SR, Kastin AJ
published in: Neuroimmunomodulation
information resource reference: Permeability of the blood-brain barrier to soluble cytokine receptors. Neuroimmunomodulation. 1995 May-Jun; 2(3):161-5.
journal title abbreviation: Neuroimmunomodulation
publication date: 1995-05-01T00:00:00
year: 1995
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1058274
type: Authorship
author rank in publication: 8
linked author: Plotkin, Scott
linked information resource: Improvement in Patient-reported Hearing After Treatment With Bevacizumab in People With Neurofibromatosis Type 2.

Improvement in Patient-reported Hearing After Treatment With Bevacizumab in People With Neurofibromatosis Type 2.
PubMed Identifier: 29649040
author list: Huang V, Bergner AL, Halpin C, Merker VL, Sheridan MR, Widemann BC, Blakeley JO, Plotkin SR
published in: Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
information resource reference: Improvement in Patient-reported Hearing After Treatment With Bevacizumab in People With Neurofibromatosis Type 2. Otol Neurotol. 2018 06; 39(5):632-638.
journal title abbreviation: Otol Neurotol
publication date: 2018-06-01T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Erlotinib for progressive vestibular schwannoma in neurofibromatosis 2 patients.
PubMed Identifier: 20736812
author list: Plotkin SR, Halpin C, McKenna MJ, Loeffler JS, Batchelor TT, Barker FG
published in: Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
information resource reference: Erlotinib for progressive vestibular schwannoma in neurofibromatosis 2 patients. Otol Neurotol. 2010 Sep; 31(7):1135-43.
journal title abbreviation: Otol Neurotol
publication date: 2010-09-01T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource

Case records of the Massachusetts General Hospital. Case 11-2007. A 59-year-old man with neck pain, weakness in the arms, and cranial-nerve palsies.
PubMed Identifier: 17429088
author list: Greer DM, Schaefer PW, Plotkin SR, Hasserjian RP, Steere AC
published in: The New England journal of medicine
information resource reference: Case records of the Massachusetts General Hospital. Case 11-2007. A 59-year-old man with neck pain, weakness in the arms, and cranial-nerve palsies. N Engl J Med. 2007 Apr 12; 356(15):1561-70.
journal title abbreviation: N Engl J Med
publication date: 2007-04-12T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2.
PubMed Identifier: 22140088
author list: Blakeley JO, Evans DG, Adler J, Brackmann D, Chen R, Ferner RE, Hanemann CO, Harris G, Huson SM, Jacob A, Kalamarides M, Karajannis MA, Korf BR, Mautner VF, McClatchey AI, Miao H, Plotkin SR, Slattery W, Stemmer-Rachamimov AO, Welling DB, Wen PY, Widemann B, Hunter-Schaedle K, Giovannini M
published in: American journal of medical genetics. Part A
information resource reference: Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2. Am J Med Genet A. 2012 Jan; 158A(1):24-41.
journal title abbreviation: Am J Med Genet A
publication date: 2011-12-02T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Clinical features of schwannomatosis: a retrospective analysis of 87 patients.
PubMed Identifier: 22927469
author list: Merker VL, Esparza S, Smith MJ, Stemmer-Rachamimov A, Plotkin SR
published in: The oncologist
information resource reference: Clinical features of schwannomatosis: a retrospective analysis of 87 patients. Oncologist. 2012; 17(10):1317-22.
journal title abbreviation: Oncologist
publication date: 2012-08-27T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Role of resection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis type 1.
PubMed Identifier: 23101443
author list: Dunn GP, Spiliopoulos K, Plotkin SR, Hornicek FJ, Harmon DC, Delaney TF, Williams Z
published in: Journal of neurosurgery
information resource reference: Role of resection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis type 1. J Neurosurg. 2013 Jan; 118(1):142-8.
journal title abbreviation: J Neurosurg
publication date: 2012-10-26T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1070876
type: Authorship
author rank in publication: 14
linked author: Plotkin, Scott
linked information resource: Resolving the phylogenetic origin of glioblastoma via multifocal genomic analysis of pre-treatment and treatment-resistant autopsy specimens.

Resolving the phylogenetic origin of glioblastoma via multifocal genomic analysis of pre-treatment and treatment-resistant autopsy specimens.
PubMed Identifier: 29872714
author list: Brastianos PK, Nayyar N, Rosebrock D, Leshchiner I, Gill CM, Livitz D, Bertalan MS, D'Andrea M, Hoang K, Aquilanti E, Chukwueke UN, Kaneb A, Chi A, Plotkin S, Gerstner ER, Frosch MP, Suva ML, Cahill DP, Getz G, Batchelor TT
published in: NPJ precision oncology
information resource reference: Resolving the phylogenetic origin of glioblastoma via multifocal genomic analysis of pre-treatment and treatment-resistant autopsy specimens. NPJ Precis Oncol. 2017; 1(1):33.
journal title abbreviation: NPJ Precis Oncol
publication date: 2017-09-18T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Differential transport of rat and human interleukin-1alpha across the blood-brain barrier and blood-testis barrier in rats.
PubMed Identifier: 11033093
author list: Plotkin SR, Banks WA, Maness LM, Kastin AJ
published in: Brain research
information resource reference: Differential transport of rat and human interleukin-1alpha across the blood-brain barrier and blood-testis barrier in rats. Brain Res. 2000 Oct 20; 881(1):57-61.
journal title abbreviation: Brain Res
publication date: 2000-10-20T00:00:00
year: 2000
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1074573
type: Authorship
author rank in publication: 22
linked author: Plotkin, Scott
linked information resource: Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2.

Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2.
PubMed Identifier: 29897904
author list: Allaway R, Angus SP, Beauchamp RL, Blakeley JO, Bott M, Burns SS, Carlstedt A, Chang LS, Chen X, Clapp DW, Desouza PA, Erdin S, Fernandez-Valle C, Guinney J, Gusella JF, Haggarty SJ, Johnson GL, La Rosa S, Morrison H, Petrilli AM, Plotkin SR, Pratap A, Ramesh V, Sciaky N, Stemmer-Rachamimov A, Stuhlmiller TJ, Talkowski ME, Welling DB, Yates CW, Zawistowski JS, Zhao WN
published in: PloS one
information resource reference: Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2. PLoS One. 2018; 13(6):e0197350.
journal title abbreviation: PLoS One
publication date: 2018-06-13T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Anti-vascular endothelial growth factor therapies as a novel therapeutic approach to treating neurofibromatosis-related tumors.
PubMed Identifier: 20406973
author list: Wong HK, Lahdenranta J, Kamoun WS, Chan AW, McClatchey AI, Plotkin SR, Jain RK, di Tomaso E
published in: Cancer research
information resource reference: Anti-vascular endothelial growth factor therapies as a novel therapeutic approach to treating neurofibromatosis-related tumors. Cancer Res. 2010 May 01; 70(9):3483-93.
journal title abbreviation: Cancer Res
publication date: 2010-04-20T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource

Case records of the Massachusetts General Hospital. Case 29-2012. A 49-year-old man with pain and cranial-nerve palsies after treatment of oral cancer.
PubMed Identifier: 22992078
author list: Wirth LJ, Plotkin SR, Emerick KS, Cunnane ME, Faquin WC
published in: The New England journal of medicine
information resource reference: Case records of the Massachusetts General Hospital. Case 29-2012. A 49-year-old man with pain and cranial-nerve palsies after treatment of oral cancer. N Engl J Med. 2012 Sep 20; 367(12):1136-47.
journal title abbreviation: N Engl J Med
publication date: 2012-09-20T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Metastatic brain tumors
author list: Fitzsimmons AL and Plotkin SR
published in: In: Longo D, Chabner B, and Lynch T, editors. Harrison's Handbook of Oncology
information resource reference: Metastatic brain tumors. In: Longo D, Chabner B, and Lynch T, editors. Harrison's Handbook of Oncology. 2007.
publication date: 2007-01-01T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Expression of SMARCB1 (INI1) mutations in familial schwannomatosis.
PubMed Identifier: 22949514
author list: Smith MJ, Walker JA, Shen Y, Stemmer-Rachamimov A, Gusella JF, Plotkin SR
published in: Human molecular genetics
information resource reference: Expression of SMARCB1 (INI1) mutations in familial schwannomatosis. Hum Mol Genet. 2012 Dec 15; 21(24):5239-45.
journal title abbreviation: Hum Mol Genet
publication date: 2012-09-04T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.
PubMed Identifier: 17222792
author list: Batchelor TT, Sorensen AG, di Tomaso E, Zhang WT, Duda DG, Cohen KS, Kozak KR, Cahill DP, Chen PJ, Zhu M, Ancukiewicz M, Mrugala MM, Plotkin S, Drappatz J, Louis DN, Ivy P, Scadden DT, Benner T, Loeffler JS, Wen PY, Jain RK
published in: Cancer cell
information resource reference: AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell. 2007 Jan; 11(1):83-95.
journal title abbreviation: Cancer Cell
publication date: 2007-01-01T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Brain metastases.
PubMed Identifier: 18579017
author list: Eichler AF, Plotkin SR
published in: Current treatment options in neurology
information resource reference: Brain metastases. Curr Treat Options Neurol. 2008 Jul; 10(4):308-14.
journal title abbreviation: Curr Treat Options Neurol
publication date: 2008-07-01T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma.
PubMed Identifier: 19430883
author list: Plotkin SR, Halpin C, Blakeley JO, Slattery WH, Welling DB, Chang SM, Loeffler JS, Harris GJ, Sorensen AG, McKenna MJ, Barker FG
published in: Journal of neuro-oncology
information resource reference: Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma. J Neurooncol. 2009 May; 93(1):61-77.
journal title abbreviation: J Neurooncol
publication date: 2009-05-09T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth.
PubMed Identifier: 19451225
author list: James MF, Han S, Polizzano C, Plotkin SR, Manning BD, Stemmer-Rachamimov AO, Gusella JF, Ramesh V
published in: Molecular and cellular biology
information resource reference: NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth. Mol Cell Biol. 2009 Aug; 29(15):4250-61.
journal title abbreviation: Mol Cell Biol
publication date: 2009-05-18T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1078878
type: Authorship
author rank in publication: 12
linked author: Plotkin, Scott
linked information resource: EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma.

Authorship 1080409
type: Authorship
author rank in publication: 3
linked author: Plotkin, Scott
linked information resource: Considerations for development of therapies for cutaneous neurofibroma.

Authorship 1080926
type: Authorship
author rank in publication: 5
linked author: Plotkin, Scott
linked information resource: Cutaneous neurofibromas: Current clinical and pathologic issues.

EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma.
PubMed Identifier: 29982664
author list: Angus SP, Oblinger JL, Stuhlmiller TJ, DeSouza PA, Beauchamp RL, Witt L, Chen X, Jordan JT, Gilbert TSK, Stemmer-Rachamimov A, Gusella JF, Plotkin SR, Haggarty SJ, Chang LS, Johnson GL, Ramesh V
published in: Neuro-oncology
information resource reference: EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma. Neuro Oncol. 2018 08 02; 20(9):1185-1196.
journal title abbreviation: Neuro Oncol
publication date: 2018-08-02T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Considerations for development of therapies for cutaneous neurofibroma.
PubMed Identifier: 29987132
author list: Verma SK, Riccardi VM, Plotkin SR, Weinberg H, Anderson RR, Blakeley JO, Jarnagin K, Lee J
published in: Neurology
information resource reference: Considerations for development of therapies for cutaneous neurofibroma. Neurology. 2018 07 10; 91(2 Suppl 1):S21-S30.
journal title abbreviation: Neurology
publication date: 2018-07-10T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Cutaneous neurofibromas: Current clinical and pathologic issues.
PubMed Identifier: 29987130
author list: Ortonne N, Wolkenstein P, Blakeley JO, Korf B, Plotkin SR, Riccardi VM, Miller DC, Huson S, Peltonen J, Rosenberg A, Carroll SL, Verma SK, Mautner V, Upadhyaya M, Stemmer-Rachamimov A
published in: Neurology
information resource reference: Cutaneous neurofibromas: Current clinical and pathologic issues. Neurology. 2018 07 10; 91(2 Suppl 1):S5-S13.
journal title abbreviation: Neurology
publication date: 2018-07-10T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Understanding relationships between autism, intelligence, and epilepsy: a cross-disorder approach.
PubMed Identifier: 23205844
author list: van Eeghen AM, Pulsifer MB, Merker VL, Neumeyer AM, van Eeghen EE, Thibert RL, Cole AJ, Leigh FA, Plotkin SR, Thiele EA
published in: Developmental medicine and child neurology
information resource reference: Understanding relationships between autism, intelligence, and epilepsy: a cross-disorder approach. Dev Med Child Neurol. 2013 Feb; 55(2):146-153.
journal title abbreviation: Dev Med Child Neurol
publication date: 2012-12-04T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1085767
type: Authorship
author rank in publication: 2
linked author: Plotkin, Scott
linked information resource: Benign Intracranial Tumors.

Benign Intracranial Tumors.
PubMed Identifier: 30072068
author list: Jordan JT, Plotkin SR
published in: Neurologic clinics
information resource reference: Benign Intracranial Tumors. Neurol Clin. 2018 08; 36(3):501-516.
journal title abbreviation: Neurol Clin
publication date: 2018-08-01T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Determination of Tumor Burden in NF1, NF2, and Schwannomatosis on Whole Body MR Images
author list: Cai W, Kassarjian A, Bredella MA, Harris GJ, Yoshida H, Mautner VF, Wenzel R, and Plotkin SR
published in: Radiology
information resource reference: Determination of Tumor Burden in NF1, NF2, and Schwannomatosis on Whole Body MR Images. Radiology. 2009; 250(3):665-73.
publication date: 2009-03-10T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis.
PubMed Identifier: 18647326
author list: Boyd C, Smith MJ, Kluwe L, Balogh A, Maccollin M, Plotkin SR
published in: Clinical genetics
information resource reference: Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis. Clin Genet. 2008 Oct; 74(4):358-66.
journal title abbreviation: Clin Genet
publication date: 2008-07-21T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escape.
PubMed Identifier: 21199795
author list: di Tomaso E, Snuderl M, Kamoun WS, Duda DG, Auluck PK, Fazlollahi L, Andronesi OC, Frosch MP, Wen PY, Plotkin SR, Hedley-Whyte ET, Sorensen AG, Batchelor TT, Jain RK
published in: Cancer research
information resource reference: Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escape. Cancer Res. 2011 Jan 01; 71(1):19-28.
journal title abbreviation: Cancer Res
publication date: 2011-01-01T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1090122
type: Authorship
author rank in publication: 6
linked author: Plotkin, Scott
linked information resource: Increasing access to specialty care for rare diseases: a case study using a foundation sponsored clinic network for patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis.

Increasing access to specialty care for rare diseases: a case study using a foundation sponsored clinic network for patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis.
PubMed Identifier: 30157837
author list: Merker VL, Dai A, Radtke HB, Knight P, Jordan JT, Plotkin SR
published in: BMC health services research
information resource reference: Increasing access to specialty care for rare diseases: a case study using a foundation sponsored clinic network for patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis. BMC Health Serv Res. 2018 Aug 29; 18(1):668.
journal title abbreviation: BMC Health Serv Res
publication date: 2018-08-29T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Whole-body MRI in neurofibromatosis: incidental findings and prevalence of scoliosis.
PubMed Identifier: 22146869
author list: Jaremko JL, MacMahon PJ, Torriani M, Merker VL, Mautner VF, Plotkin SR, Bredella MA
published in: Skeletal radiology
information resource reference: Whole-body MRI in neurofibromatosis: incidental findings and prevalence of scoliosis. Skeletal Radiol. 2012 Aug; 41(8):917-23.
journal title abbreviation: Skeletal Radiol
publication date: 2011-12-07T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Outcomes of hospitalization in pregnant women with CNS neoplasms: a population-based study.
PubMed Identifier: 22513749
author list: Terry AR, Barker FG, Leffert L, Bateman BT, Souter I, Plotkin SR
published in: Neuro-oncology
information resource reference: Outcomes of hospitalization in pregnant women with CNS neoplasms: a population-based study. Neuro Oncol. 2012 Jun; 14(6):768-76.
journal title abbreviation: Neuro Oncol
publication date: 2012-04-18T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Neurologic complications of cancer therapy
author list: Plotkin SR, Wen PY
published in: In: Wen PY, Glanz MJ, editors. Neurologic Clinics: Neurologic Complications of Cancer
information resource reference: Neurologic complications of cancer therapy. In: Wen PY, Glanz MJ, editors. Neurologic Clinics: Neurologic Complications of Cancer. 2003; 21(1):279-318.
publication date: 2003-02-01T00:00:00
year: 2003
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 105164
type: Authorship
author rank in publication: 2
linked author: Plotkin, Scott
linked information resource: The Neurofibromatoses. Part 1: NF1.

Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.
PubMed Identifier: 1988830
author list: Whitley R, Arvin A, Prober C, Corey L, Burchett S, Plotkin S, Starr S, Jacobs R, Powell D, Nahmias A
published in: The New England journal of medicine
information resource reference: Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med. 1991 Feb 14; 324(7):450-4.
journal title abbreviation: N Engl J Med
publication date: 1991-02-14T00:00:00
year: 1991
type: Academic Article
type: Article
type: Document
type: Information Resource

Activity of Cilengitide, an Integrin-Targeting RGD Peptide, Among Adults with Recurrent Glioblastoma Multiforme: Results of a Randomized Phase 2 Study
author list: David Reardon, Karen Fink, Tom Mikkelsen, Timothy Cloughesy, Alison O'Neill, Scott Plotkin, Michael Glantz, Paula Ravin, Jeffrey Raizer, Keith Rich, David Schiff, William Shapiro, Susan Burdette-Radoux, Edward Dropcho, Sabine Wittemer, Johannes Nippgen, Martin Picard, Louis Nabors
published in: J Clin Oncol
information resource reference: Activity of Cilengitide, an Integrin-Targeting RGD Peptide, Among Adults with Recurrent Glioblastoma Multiforme: Results of a Randomized Phase 2 Study. J Clin Oncol. 2008; 26(34):5610-5617.
publication date: 2008-11-16T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Neurofibromatosis type 2 and related disorders
author list: Scott Randall Plotkin
published in: Ruggieri M, Pascual-Castroviejo I, and DiRocco C, editors. Neurocutaneous Disorders: Phakomatoses and Hamartoneoplastic Sydnromes
information resource reference: Neurofibromatosis type 2 and related disorders. Ruggieri M, Pascual-Castroviejo I, and DiRocco C, editors. Neurocutaneous Disorders: Phakomatoses and Hamartoneoplastic Sydnromes. 2008; 153-180.
publication date: 2008-02-01T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Comparison of saturable transport and extracellular pathways in the passage of interleukin-1 alpha across the blood-brain barrier.
PubMed Identifier: 8707929
author list: Plotkin SR, Banks WA, Kastin AJ
published in: Journal of neuroimmunology
information resource reference: Comparison of saturable transport and extracellular pathways in the passage of interleukin-1 alpha across the blood-brain barrier. J Neuroimmunol. 1996 Jun; 67(1):41-7.
journal title abbreviation: J Neuroimmunol
publication date: 1996-06-01T00:00:00
year: 1996
type: Academic Article
type: Article
type: Document
type: Information Resource

The Neurofibromatoses. Part 1: NF1.
PubMed Identifier: 19587630
author list: Lu-Emerson C, Plotkin SR
published in: Reviews in neurological diseases
information resource reference: The Neurofibromatoses. Part 1: NF1. Rev Neurol Dis. 2009; 6(2):E47-53.
journal title abbreviation: Rev Neurol Dis
publication date: 2009-01-01T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1108051
type: Authorship
author rank in publication: 9
linked author: Plotkin, Scott
linked information resource: Mind-Body Treatment for International English-Speaking Adults With Neurofibromatosis via Live Videoconferencing: Protocol for a Single-Blind Randomized Controlled Trial.

Mind-Body Treatment for International English-Speaking Adults With Neurofibromatosis via Live Videoconferencing: Protocol for a Single-Blind Randomized Controlled Trial.
PubMed Identifier: 30355560
author list: Vranceanu AM, Zale EL, Funes CJ, Macklin EA, McCurley J, Park ER, Jordan JT, Lin A, Plotkin SR
published in: JMIR research protocols
information resource reference: Mind-Body Treatment for International English-Speaking Adults With Neurofibromatosis via Live Videoconferencing: Protocol for a Single-Blind Randomized Controlled Trial. JMIR Res Protoc. 2018 Oct 23; 7(10):e11008.
journal title abbreviation: JMIR Res Protoc
publication date: 2018-10-23T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Bevacizumab treatment for meningiomas in NF2: a retrospective analysis of 15 patients.
PubMed Identifier: 23555840
author list: Nunes FP, Merker VL, Jennings D, Caruso PA, di Tomaso E, Muzikansky A, Barker FG, Stemmer-Rachamimov A, Plotkin SR
published in: PloS one
information resource reference: Bevacizumab treatment for meningiomas in NF2: a retrospective analysis of 15 patients. PLoS One. 2013; 8(3):e59941.
journal title abbreviation: PLoS One
publication date: 2013-03-21T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Brain metastases
author list: Plotkin SR, Wen PY
published in: Office Practice of Neurology
information resource reference: Brain metastases. Office Practice of Neurology. 2002.
publication date: 2002-01-02T00:00:00
year: 2002
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1112228
type: Authorship
author rank in publication: 11
linked author: Plotkin, Scott
linked information resource: Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI.

Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI.
PubMed Identifier: 30459364
author list: Ly KI, Vakulenko-Lagun B, Emblem KE, Ou Y, Da X, Betensky RA, Kalpathy-Cramer J, Duda DG, Jain RK, Chi AS, Plotkin SR, Batchelor TT, Sorensen G, Rosen BR, Gerstner ER
published in: Scientific reports
information resource reference: Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI. Sci Rep. 2018 11 20; 8(1):17062.
journal title abbreviation: Sci Rep
publication date: 2018-11-20T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome.
PubMed Identifier: 22878510
author list: Wang DL, Smith KB, Esparza S, Leigh FA, Muzikansky A, Park ER, Plotkin SR
published in: Genetics in medicine : official journal of the American College of Medical Genetics
information resource reference: Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome. Genet Med. 2012 Dec; 14(12):977-82.
journal title abbreviation: Genet Med
publication date: 2012-08-09T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria.
PubMed Identifier: 23401320
author list: Plotkin SR, Blakeley JO, Evans DG, Hanemann CO, Hulsebos TJ, Hunter-Schaedle K, Kalpana GV, Korf B, Messiaen L, Papi L, Ratner N, Sherman LS, Smith MJ, Stemmer-Rachamimov AO, Vitte J, Giovannini M
published in: American journal of medical genetics. Part A
information resource reference: Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria. Am J Med Genet A. 2013 Mar; 161A(3):405-16.
journal title abbreviation: Am J Med Genet A
publication date: 2013-02-07T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Increased intracranial pressure and extradural compression syndromes
author list: Plotkin SR and Grier JT
published in: In: Baehring JM and Piepmeier JM, editors. Brain tumors: practical guide to diagnosis and treatment
information resource reference: Increased intracranial pressure and extradural compression syndromes. In: Baehring JM and Piepmeier JM, editors. Brain tumors: practical guide to diagnosis and treatment. 2007; 89:427-446.
publication date: 2007-03-01T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Designing clinical trials for cutaneous neurofibromas, an unmet medical need for patients with neurofibromatosis 1
end date: 2020-11-30
principal investigator name: PLOTKIN, SCOTT R
start date: 2018-12-01
type: Grant
sponsor award id: R13CA236402

Principal Investigator
type: Researcher Role
researcher role of: Plotkin, Scott
contributes to: Designing clinical trials for cutaneous neurofibromas, an unmet medical need for patients with neurofibromatosis 1

Authorship 120762
type: Authorship
author rank in publication: 3
linked author: Plotkin, Scott
linked information resource: Peripheral and cranial nerve sheath tumors.

Authorship 1126220
type: Authorship
author rank in publication: 16
linked author: Plotkin, Scott
linked information resource: A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma.

A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma.
PubMed Identifier: 30617350
author list: Chen J, Landegger LD, Sun Y, Ren J, Maimon N, Wu L, Ng MR, Chen JW, Zhang N, Zhao Y, Gao X, Fujita T, Roberge S, Huang P, Jain RK, Plotkin SR, Stankovic KM, Xu L
published in: Nature protocols
information resource reference: A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma. Nat Protoc. 2019 02; 14(2):541-555.
journal title abbreviation: Nat Protoc
publication date: 2019-02-01T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

The neurofibromatoses. Part 2: NF2 and schwannomatosis.
PubMed Identifier: 19898272
author list: Lu-Emerson C, Plotkin SR
published in: Reviews in neurological diseases
information resource reference: The neurofibromatoses. Part 2: NF2 and schwannomatosis. Rev Neurol Dis. 2009; 6(3):E81-6.
journal title abbreviation: Rev Neurol Dis
publication date: 2009-01-01T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

The Phakomatoses
author list: Chu-Shore C and Plotkin SR
published in: Rosenberg RN, DiMauro S, Paulson H, Ptacek L, Nestler E, editors. The molecular and genetic basis of neurological and psychiatric disease
information resource reference: The Phakomatoses. Rosenberg RN, DiMauro S, Paulson H, Ptacek L, Nestler E, editors. The molecular and genetic basis of neurological and psychiatric disease. 2007.
publication date: 2007-10-01T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Otolaryngology Head and Neck Surgery
type: Department
type: Organization

Neurilemmoma
MeSH DescriptorUI: D009442
MeSH semantic group name: Disorders
number of authors: 217
number of publications: 539
uniqueness weight: 0.662512
type: Concept

Neurofibromatosis 1
MeSH DescriptorUI: D009456
MeSH semantic group name: Disorders
number of authors: 235
number of publications: 556
uniqueness weight: 0.686581
type: Concept

Authorship 124202
type: Authorship
author rank in publication: 4
linked author: Plotkin, Scott
linked information resource: Patient and physician attitudes regarding clinical trials in neurofibromatosis 1.

Neuroma, Acoustic
MeSH DescriptorUI: D009464
MeSH semantic group name: Disorders
number of authors: 151
number of publications: 443
uniqueness weight: 0.739532
type: Concept

Neurofibromatosis 2
MeSH DescriptorUI: D016518
MeSH semantic group name: Disorders
number of authors: 99
number of publications: 389
uniqueness weight: 0.747053
type: Concept

Authorship 1142464
type: Authorship
author rank in publication: 9
linked author: Plotkin, Scott
linked information resource: From process to progress-2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis.

Authorship 1141973
type: Authorship
author rank in publication: 24
linked author: Plotkin, Scott
linked information resource: First International Conference on RASopathies and Neurofibromatoses in Asia: Identification and advances of new therapeutics.

From process to progress-2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis.
PubMed Identifier: 30908866
author list: Ferner RE, Bakker A, Elgersma Y, Evans DGR, Giovannini M, Legius E, Lloyd A, Messiaen LM, Plotkin S, Reilly KM, Schindeler A, Smith MJ, Ullrich NJ, Widemann B, Sherman LS
published in: American journal of medical genetics. Part A
information resource reference: From process to progress-2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis. Am J Med Genet A. 2019 06; 179(6):1098-1106.
journal title abbreviation: Am J Med Genet A
publication date: 2019-03-25T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

First International Conference on RASopathies and Neurofibromatoses in Asia: Identification and advances of new therapeutics.
PubMed Identifier: 30908877
author list: Rauen KA, Alsaegh A, Ben-Shachar S, Berman Y, Blakeley J, Cordeiro I, Elgersma Y, Evans DG, Fisher MJ, Frayling IM, George J, Huson SM, Kerr B, Khire U, Korf B, Legius E, Messiaen L, van Minkelen R, Nampoothiri S, Ngeow J, Parada LF, Phadke S, Pillai A, Plotkin SR, Puri R, Raji A, Ramesh V, Ratner N, Shankar SP, Sharda S, Tambe A, Vikkula M, Widemann BC, Wolkenstein P, Upadhyaya M
published in: American journal of medical genetics. Part A
information resource reference: First International Conference on RASopathies and Neurofibromatoses in Asia: Identification and advances of new therapeutics. Am J Med Genet A. 2019 06; 179(6):1091-1097.
journal title abbreviation: Am J Med Genet A
publication date: 2019-03-25T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1149693
type: Authorship
author rank in publication: 4
linked author: Plotkin, Scott
linked information resource: First report of quality of life in adults with neurofibromatosis 2 who are deafened or have significant hearing loss: results of a live-video randomized control trial.

First report of quality of life in adults with neurofibromatosis 2 who are deafened or have significant hearing loss: results of a live-video randomized control trial.
PubMed Identifier: 31049826
author list: Funes CJ, Mace RA, Macklin EA, Plotkin SR, Jordan JT, Vranceanu AM
published in: Journal of neuro-oncology
information resource reference: First report of quality of life in adults with neurofibromatosis 2 who are deafened or have significant hearing loss: results of a live-video randomized control trial. J Neurooncol. 2019 Jul; 143(3):505-513.
journal title abbreviation: J Neurooncol
publication date: 2019-05-02T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Neurofibromatoses
MeSH DescriptorUI: D017253
MeSH semantic group name: Disorders
number of authors: 96
number of publications: 301
uniqueness weight: 0.737844
type: Concept

Neurology
type: Department
type: Organization

Pathology
type: Department
type: Organization

Psychiatry
type: Department
type: Organization

Oncology
type: Division
type: Organization

Brigham and Women's Hospital
type: Organization

Boston Children's Hospital
type: Organization

Massachusetts Eye and Ear Infirmary
type: Organization

Massachusetts General Hospital
type: Organization

Dietrich, Jorg
eCommons Login: JD61
first name: Jorg
last name: Dietrich
full name: Jorg Dietrich, M.D.,Ph.D.
has faculty rank: Associate Professor
latitude: 42.36241700000000
longitude: -71.06893700000000
Person ID: 41197
person in primary position: Associate Professor of Neurology
type: Agent
type: Person
preferred title: Associate Professor of Neurology

Ullrich, Nicole
eCommons Login: NU1
first name: Nicole
last name: Ullrich
full name: Nicole J Ullrich, M.D., Ph.D.
has faculty rank: Full Professor
latitude: 42.33743600000000
longitude: -71.10544700000000
Person ID: 15549
person in primary position: Professor of Neurology
type: Agent
type: Person
preferred title: Professor of Neurology

Arrillaga-Romany, Isabel
eCommons Login: ICA4
first name: Isabel
last name: Arrillaga-Romany
full name: Isabel Arrillaga-Romany, M.D.
has faculty rank: Assistant Professor
latitude: 42.36241700000000
longitude: -71.06893700000000
Person ID: 999
person in primary position: Assistant Professor of Neurology
type: Agent
type: Person
preferred title: Assistant Professor of Neurology

Stemmer-Rachamimov, Anat
eCommons Login: AS15
first name: Anat
last name: Stemmer-Rachamimov
full name: Anat Stemmer-Rachamimov, M.D.
has faculty rank: Associate Professor
latitude: 42.36241700000000
longitude: -71.06893700000000
Person ID: 5208
person in primary position: Associate Professor of Pathology
type: Agent
type: Person
preferred title: Associate Professor of Pathology

Vranceanu, Ana-Maria
eCommons Login: AV58
first name: Ana-Maria
last name: Vranceanu
full name: Ana-Maria Vranceanu, Ph.D.
has faculty rank: Full Professor
latitude: 42.36168300000000
longitude: -71.06231700000000
photo: https://connects.catalyst.harvard.edu/Profiles/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx
Person ID: 12341
person in primary position: Professor of Psychology in the Department of Psychiatry
type: Agent
type: Person
preferred title: Professor of Psychology in the Department of Psychiatry

Jones, Robin
eCommons Login: RMJ3
first name: Robin
last name: Jones
full name: Robin Moira Jones, M.D.
has faculty rank: Other Faculty
latitude: 42.36241700000000
longitude: -71.06893700000000
Person ID: 64789
person in primary position: Corresponding Member of the Faculty of Neurology
type: Agent
type: Person
preferred title: Corresponding Member of the Faculty of Neurology

Publisher Correction: Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI.
PubMed Identifier: 31197238
author list: Ly KI, Vakulenko-Lagun B, Emblem KE, Ou Y, Da X, Betensky RA, Kalpathy-Cramer J, Duda DG, Jain RK, Chi AS, Plotkin SR, Batchelor TT, Sorensen G, Rosen BR, Gerstner ER
published in: Scientific reports
information resource reference: Publisher Correction: Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI. Sci Rep. 2019 Jun 14; 9(1):8721.
journal title abbreviation: Sci Rep
publication date: 2019-06-14T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Batchelor, Tracy
eCommons Login: TTB1
first name: Tracy
last name: Batchelor
full name: Tracy Todd Batchelor, M.D.
has faculty rank: Full Professor
latitude: 42.36241700000000
longitude: -71.06893700000000
Person ID: 23665
person in primary position: Martin A. Samuels Professor of Neurology
type: Agent
type: Person
preferred title: Martin A. Samuels Professor of Neurology

Barker, Frederick
eCommons Login: FGB2
first name: Frederick
last name: Barker
full name: Frederick George Barker, II, M.D.
has faculty rank: Full Professor
latitude: 42.36241700000000
longitude: -71.06893700000000
Person ID: 29178
person in primary position: William and Elizabeth Sweet Professor of Neurosurgery
type: Agent
type: Person
preferred title: William and Elizabeth Sweet Professor of Neurosurgery

Authorship 1160599
type: Authorship
author rank in publication: 11
linked author: Plotkin, Scott
linked information resource: Publisher Correction: Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI.

Gerstner, Elizabeth
eCommons Login: ERG7
first name: Elizabeth
last name: Gerstner
full name: Elizabeth Robins Gerstner, M.D.
has faculty rank: Associate Professor
latitude: 42.36241700000000
longitude: -71.06893700000000
Person ID: 38556
person in primary position: Associate Professor of Neurology
type: Agent
type: Person
preferred title: Associate Professor of Neurology

selected publications
maximum weight: 1
minimum weight: 1
number of connections: 265
predicate node: https://connects.catalyst.harvard.edu/Profiles/profile/113
predicate: selected publications
type: Network

research areas
maximum weight: 15.5041
minimum weight: 0.000334815
number of connections: 737
predicate node: https://connects.catalyst.harvard.edu/Profiles/profile/217
predicate: research areas
type: Network

coauthor of
maximum weight: 8.00956
minimum weight: 0.0108136
number of connections: 180
predicate node: https://connects.catalyst.harvard.edu/Profiles/profile/363
predicate: coauthor of
type: Network

similar to
maximum weight: 356.118
minimum weight: 25.8801
number of connections: 60
predicate node: https://connects.catalyst.harvard.edu/Profiles/profile/494
predicate: similar to
type: Network

Musolino, Patricia
eCommons Login: PLM8
first name: Patricia
last name: Musolino
full name: Patricia Leonor Musolino, M.D., Ph.D.
has faculty rank: Associate Professor
latitude: 42.36241700000000
longitude: -71.06893700000000
Person ID: 83134
person in primary position: Associate Professor of Neurology
type: Agent
type: Person
preferred title: Associate Professor of Neurology

Authorship 150382
type: Authorship
author rank in publication: 8
linked author: Plotkin, Scott
linked information resource: Clinical presentation, immunohistochemistry and electron microscopy indicate neurofibromatosis type 2-associated gliomas to be spinal ependymomas.

Authorship 1192444
type: Authorship
author rank in publication: 8
linked author: Plotkin, Scott
linked information resource: Bevacizumab Reduces Permeability and Concurrent Temozolomide Delivery in a Subset of Patients with Recurrent Glioblastoma.

Bevacizumab Reduces Permeability and Concurrent Temozolomide Delivery in a Subset of Patients with Recurrent Glioblastoma.
PubMed Identifier: 31558474
author list: Gerstner ER, Emblem KE, Chang K, Vakulenko-Lagun B, Yen YF, Beers AL, Dietrich J, Plotkin SR, Catana C, Hooker JM, Duda DG, Rosen B, Kalpathy-Cramer J, Jain RK, Batchelor T
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Bevacizumab Reduces Permeability and Concurrent Temozolomide Delivery in a Subset of Patients with Recurrent Glioblastoma. Clin Cancer Res. 2020 01 01; 26(1):206-212.
journal title abbreviation: Clin Cancer Res
publication date: 2019-09-26T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1197460
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma.

Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma.
PubMed Identifier: 31626572
author list: Plotkin SR, Duda DG, Muzikansky A, Allen J, Blakeley J, Rosser T, Campian JL, Clapp DW, Fisher MJ, Tonsgard J, Ullrich N, Thomas C, Cutter G, Korf B, Packer R, Karajannis MA
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma. J Clin Oncol. 2019 12 10; 37(35):3446-3454.
journal title abbreviation: J Clin Oncol
publication date: 2019-10-18T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 119391
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Enkephalin, PPE mRNA, and PTS-1 in alcohol withdrawal seizure-prone and -resistant mice.

Authorship 1200198
type: Authorship
author rank in publication: 6
linked author: Plotkin, Scott
linked information resource: Cultivating resiliency in patients with neurofibromatosis 2 who are deafened or have severe hearing loss: a live-video randomized control trial.

Cultivating resiliency in patients with neurofibromatosis 2 who are deafened or have severe hearing loss: a live-video randomized control trial.
PubMed Identifier: 31677033
author list: Greenberg J, Carter S, Lester E, Funes CJ, Macklin EA, Plotkin S, Vranceanu AM
published in: Journal of neuro-oncology
information resource reference: Cultivating resiliency in patients with neurofibromatosis 2 who are deafened or have severe hearing loss: a live-video randomized control trial. J Neurooncol. 2019 Dec; 145(3):561-569.
journal title abbreviation: J Neurooncol
publication date: 2019-11-01T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Associate Professor of Pathology
is primary position: true
position in department: Pathology
position in division: https://connects.catalyst.harvard.edu/Profiles/profile/1229413
sort order: 1
type: Position
HR job title: Associate Professor of Pathology
position in organization: Massachusetts General Hospital

Authorship 1212314
type: Authorship
author rank in publication: 5
linked author: Plotkin, Scott
linked information resource: Virtual mind-body treatment for geographically diverse youth with neurofibromatosis: A pilot randomized controlled trial.

Virtual mind-body treatment for geographically diverse youth with neurofibromatosis: A pilot randomized controlled trial.
PubMed Identifier: 31841875
author list: Lester E, DiStefano S, Mace R, Macklin E, Plotkin S, Vranceanu AM
published in: General hospital psychiatry
information resource reference: Virtual mind-body treatment for geographically diverse youth with neurofibromatosis: A pilot randomized controlled trial. Gen Hosp Psychiatry. 2020 Jan - Feb; 62:72-78.
journal title abbreviation: Gen Hosp Psychiatry
publication date: 2019-12-06T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 170611
type: Authorship
author rank in publication: 9
linked author: Plotkin, Scott
linked information resource: Bevacizumab treatment for meningiomas in NF2: a retrospective analysis of 15 patients.

Authorship 166249
type: Authorship
author rank in publication: 6
linked author: Plotkin, Scott
linked information resource: Whole-body MRI in neurofibromatosis: incidental findings and prevalence of scoliosis.

Authorship 1226567
type: Authorship
author rank in publication: 3
linked author: Plotkin, Scott
linked information resource: Improvement in resiliency factors among adolescents with neurofibromatosis who participate in a virtual mind-body group program.

Improvement in resiliency factors among adolescents with neurofibromatosis who participate in a virtual mind-body group program.
PubMed Identifier: 32078086
author list: Lester EG, Macklin EA, Plotkin S, Vranceanu AM
published in: Journal of neuro-oncology
information resource reference: Improvement in resiliency factors among adolescents with neurofibromatosis who participate in a virtual mind-body group program. J Neurooncol. 2020 Apr; 147(2):451-457.
journal title abbreviation: J Neurooncol
publication date: 2020-02-20T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1238864
type: Authorship
author rank in publication: 9
linked author: Plotkin, Scott
linked information resource: The Use of MEK Inhibitors in Neurofibromatosis Type 1-Associated Tumors and Management of Toxicities.

The Use of MEK Inhibitors in Neurofibromatosis Type 1-Associated Tumors and Management of Toxicities.
PubMed Identifier: 32272491
author list: Klesse LJ, Jordan JT, Radtke HB, Rosser T, Schorry E, Ullrich N, Viskochil D, Knight P, Plotkin SR, Yohay K
published in: The oncologist
information resource reference: The Use of MEK Inhibitors in Neurofibromatosis Type 1-Associated Tumors and Management of Toxicities. Oncologist. 2020 07; 25(7):e1109-e1116.
journal title abbreviation: Oncologist
publication date: 2020-04-22T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1243157
type: Authorship
author rank in publication: 8
linked author: Plotkin, Scott
linked information resource: Correlation between NF1 genotype and imaging phenotype on whole-body MRI: NF1 radiogenomics.

Correlation between NF1 genotype and imaging phenotype on whole-body MRI: NF1 radiogenomics.
PubMed Identifier: 32345730
author list: Liu Y, Jordan JT, Bredella MA, Erdin S, Walker JA, Vangel M, Harris GJ, Plotkin SR, Cai W
published in: Neurology
information resource reference: Correlation between NF1 genotype and imaging phenotype on whole-body MRI: NF1 radiogenomics. Neurology. 2020 06 16; 94(24):e2521-e2531.
journal title abbreviation: Neurology
publication date: 2020-04-28T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Giovanni Armenise - Harvard Professor of Neurology
is primary position: true
position in department: Neurology
position in division: https://connects.catalyst.harvard.edu/Profiles/profile/1229413
sort order: 1
type: Position
HR job title: Giovanni Armenise - Harvard Professor of Neurology
position in organization: Massachusetts General Hospital

Harvard College, Chemistry
end date: 06/1991
educational organization: Harvard College
training location: Cambridge
type: EducationalTraining
degree earned: B.A.
major field of degree: Chemistry

Authorship 204555
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Audiologic and radiographic response of NF2-related vestibular schwannoma to erlotinib therapy.

Authorship 143310
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients.

Authorship 165498
type: Authorship
author rank in publication: 3
linked author: Plotkin, Scott
linked information resource: Clinical reasoning: a case of multiple intracerebral hemorrhages.

Authorship 1280609
type: Authorship
author rank in publication: 9
linked author: Plotkin, Scott
linked information resource: Are Some Randomized Clinical Trials Impossible?

Are Some Randomized Clinical Trials Impossible?
PubMed Identifier: 32852366
author list: Rios JJ, Richards BS, Stevenson DA, Oberlander B, Viskochil D, Gross AM, Dombi E, Widemann BC, Plotkin SR, May CJ, Ullrich NJ, Goldstein RY, Jain V, Schorry EK
published in: Journal of pediatric orthopedics
information resource reference: Are Some Randomized Clinical Trials Impossible? J Pediatr Orthop. 2021 Jan; 41(1):e90-e93.
journal title abbreviation: J Pediatr Orthop
publication date: 2021-01-01T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1284612
type: Authorship
author rank in publication: 10
linked author: Plotkin, Scott
linked information resource: Exploring Predictors of Response to Dacomitinib in EGFR-Amplified Recurrent Glioblastoma.

Exploring Predictors of Response to Dacomitinib in EGFR-Amplified Recurrent Glioblastoma.
PubMed Identifier: 32923886
author list: Chi AS, Cahill DP, Reardon DA, Wen PY, Mikkelsen T, Peereboom DM, Wong ET, Gerstner ER, Dietrich J, Plotkin SR, Norden AD, Lee EQ, Nayak L, Tanaka S, Wakimoto H, Lelic N, Koerner MV, Klofas LK, Bertalan MS, Arrillaga-Romany IC, Betensky RA, Curry WT, Borger DR, Balaj L, Kitchen RR, Chakrabortty SK, Valentino MD, Skog J, Breakefield XO, Iafrate AJ, Batchelor TT
published in: JCO precision oncology
information resource reference: Exploring Predictors of Response to Dacomitinib in EGFR-Amplified Recurrent Glioblastoma. JCO Precis Oncol. 2020; 4.
journal title abbreviation: JCO Precis Oncol
publication date: 2020-06-08T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1293255
type: Authorship
author rank in publication: 18
linked author: Plotkin, Scott
linked information resource: Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.

Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.
PubMed Identifier: 33025139
author list: Mansouri S, Suppiah S, Mamatjan Y, Paganini I, Liu JC, Karimi S, Patil V, Nassiri F, Singh O, Sundaravadanam Y, Rath P, Sestini R, Gensini F, Agnihotri S, Blakeley J, Ostrow K, Largaespada D, Plotkin SR, Stemmer-Rachamimov A, Ferrer MM, Pugh TJ, Aldape KD, Papi L, Zadeh G
published in: Acta neuropathologica
information resource reference: Epigenomic, genomic, and transcriptomic landscape of schwannomatosis. Acta Neuropathol. 2021 01; 141(1):101-116.
journal title abbreviation: Acta Neuropathol
publication date: 2020-10-06T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1297608
type: Authorship
author rank in publication: 2
linked author: Plotkin, Scott
linked information resource: Effective provider-patient communication of a rare disease diagnosis: A qualitative study of people diagnosed with schwannomatosis.

Effective provider-patient communication of a rare disease diagnosis: A qualitative study of people diagnosed with schwannomatosis.
PubMed Identifier: 33051127
author list: Merker VL, Plotkin SR, Charns MP, Meterko M, Jordan JT, Elwy AR
published in: Patient education and counseling
information resource reference: Effective provider-patient communication of a rare disease diagnosis: A qualitative study of people diagnosed with schwannomatosis. Patient Educ Couns. 2021 04; 104(4):808-814.
journal title abbreviation: Patient Educ Couns
publication date: 2020-09-28T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1300015
type: Authorship
author rank in publication: 18
linked author: Plotkin, Scott
linked information resource: Correction to: Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.

Correction to: Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.
PubMed Identifier: 33112994
author list: Mansouri S, Suppiah S, Mamatjan Y, Paganini I, Liu JC, Karimi S, Patil V, Nassiri F, Singh O, Sundaravadanam Y, Rath P, Sestini R, Gensini F, Agnihotri S, Blakeley J, Ostrow K, Largaespada D, Plotkin SR, Stemmer-Rachamimov A, Ferrer MM, Pugh TJ, Aldape KD, Papi L, Zadeh G
published in: Acta neuropathologica
information resource reference: Correction to: Epigenomic, genomic, and transcriptomic landscape of schwannomatosis. Acta Neuropathol. 2021 Jan; 141(1):117.
journal title abbreviation: Acta Neuropathol
publication date: 2021-01-01T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1308265
type: Authorship
author rank in publication: 5
linked author: Plotkin, Scott
linked information resource: mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.

Authorship 1308615
type: Authorship
author rank in publication: 2
linked author: Plotkin, Scott
linked information resource: Familial Nervous System Tumor Syndromes.

mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.
PubMed Identifier: 33273014
author list: Beauchamp RL, Erdin S, Witt L, Jordan JT, Plotkin SR, Gusella JF, Ramesh V
published in: The Journal of biological chemistry
information resource reference: mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition. J Biol Chem. 2021 Jan-Jun; 296:100157.
journal title abbreviation: J Biol Chem
publication date: 2020-12-09T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Familial Nervous System Tumor Syndromes.
PubMed Identifier: 33273171
author list: Strowd RE, Plotkin SR
published in: Continuum (Minneapolis, Minn.)
information resource reference: Familial Nervous System Tumor Syndromes. Continuum (Minneap Minn). 2020 12; 26(6):1523-1552.
journal title abbreviation: Continuum (Minneap Minn)
publication date: 2020-12-01T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1322980
type: Authorship
author rank in publication: 5
linked author: Plotkin, Scott
linked information resource: mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.

Authorship 1320301
type: Authorship
author rank in publication: 15
linked author: Plotkin, Scott
linked information resource: Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.

Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.
PubMed Identifier: 33442015
author list: Fisher MJ, Shih CS, Rhodes SD, Armstrong AE, Wolters PL, Dombi E, Zhang C, Angus SP, Johnson GL, Packer RJ, Allen JC, Ullrich NJ, Goldman S, Gutmann DH, Plotkin SR, Rosser T, Robertson KA, Widemann BC, Smith AE, Bessler WK, He Y, Park SJ, Mund JA, Jiang L, Bijangi-Vishehsaraei K, Robinson CT, Cutter GR, Korf BR, Blakeley JO, Clapp DW
published in: Nature medicine
information resource reference: Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial. Nat Med. 2021 01; 27(1):165-173.
journal title abbreviation: Nat Med
publication date: 2021-01-13T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.
PubMed Identifier: 33461953
author list: Beauchamp RL, Erdin S, Witt L, Jordan JT, Plotkin SR, Gusella JF, Ramesh V
published in: The Journal of biological chemistry
information resource reference: mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition. J Biol Chem. 2020 Dec 09; 296:100157.
journal title abbreviation: J Biol Chem
publication date: 2020-12-09T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1324508
type: Authorship
author rank in publication: 3
linked author: Plotkin, Scott
linked information resource: NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.

NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.
PubMed Identifier: 33507822
author list: Weiss BD, Wolters PL, Plotkin SR, Widemann BC, Tonsgard JH, Blakeley J, Allen JC, Schorry E, Korf B, Robison NJ, Goldman S, Vinks AA, Emoto C, Fukuda T, Robinson CT, Cutter G, Edwards L, Dombi E, Ratner N, Packer R, Fisher MJ
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas. J Clin Oncol. 2021 03 01; 39(7):797-806.
journal title abbreviation: J Clin Oncol
publication date: 2021-01-28T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Co-Principal Investigator
type: Researcher Role
researcher role of: Plotkin, Scott
contributes to: Training Program in Nervous System Tumors

Authorship 1326148
type: Authorship
author rank in publication: 8
linked author: Plotkin, Scott
linked information resource: The impact of the COVID-19 pandemic on neurofibromatosis clinical care and research.

The impact of the COVID-19 pandemic on neurofibromatosis clinical care and research.
PubMed Identifier: 33522938
author list: Radtke HB, Klein-Tasman BP, Merker VL, Knight P, Ullrich NJ, Jordan JT, Korf B, Plotkin SR
published in: Orphanet journal of rare diseases
information resource reference: The impact of the COVID-19 pandemic on neurofibromatosis clinical care and research. Orphanet J Rare Dis. 2021 02 01; 16(1):61.
journal title abbreviation: Orphanet J Rare Dis
publication date: 2021-02-01T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 224656
type: Authorship
author rank in publication: 3
linked author: Plotkin, Scott
linked information resource: Facial reanimation of patients with neurofibromatosis type 2.

Authorship 1350893
type: Authorship
author rank in publication: 8
linked author: Plotkin, Scott
linked information resource: Identifying challenges in neurofibromatosis: a modified Delphi procedure.

Identifying challenges in neurofibromatosis: a modified Delphi procedure.
PubMed Identifier: 33903738
author list: Dhaenens BAE, Ferner RE, Bakker A, Nievo M, Evans DG, Wolkenstein P, Potratz C, Plotkin SR, Heimann G, Legius E, Oostenbrink R
published in: European journal of human genetics : EJHG
information resource reference: Identifying challenges in neurofibromatosis: a modified Delphi procedure. Eur J Hum Genet. 2021 11; 29(11):1625-1633.
journal title abbreviation: Eur J Hum Genet
publication date: 2021-04-26T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Merker, Vanessa
eCommons Login: vlm888
first name: Vanessa
last name: Merker
full name: Vanessa Leigh Merker, Ph.D.
has faculty rank: Assistant Professor
photo: https://connects.catalyst.harvard.edu/Profiles/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx
Person ID: 197761
person in primary position: Assistant Professor of Neurology
type: Agent
type: Person
preferred title: Assistant Professor of Neurology

Authorship 1356406
type: Authorship
author rank in publication: 31
linked author: Plotkin, Scott
linked information resource: Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation.

Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation.
PubMed Identifier: 34012067
author list: Legius E, Messiaen L, Wolkenstein P, Pancza P, Avery RA, Berman Y, Blakeley J, Babovic-Vuksanovic D, Cunha KS, Ferner R, Fisher MJ, Friedman JM, Gutmann DH, Kehrer-Sawatzki H, Korf BR, Mautner VF, Peltonen S, Rauen KA, Riccardi V, Schorry E, Stemmer-Rachamimov A, Stevenson DA, Tadini G, Ullrich NJ, Viskochil D, Wimmer K, Yohay K, Huson SM, Evans DG, Plotkin SR
published in: Genetics in medicine : official journal of the American College of Medical Genetics
information resource reference: Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation. Genet Med. 2021 08; 23(8):1506-1513.
journal title abbreviation: Genet Med
publication date: 2021-05-19T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Transcriptomic signature of painful human neurofibromatosis type 2 schwannomas.
PubMed Identifier: 34053190
author list: Kukutla P, Ahmed SG, DuBreuil DM, Abdelnabi A, Cetinbas M, Fulci G, Aldikacti B, Stemmer-Rachamimov A, Plotkin SR, Wainger B, Sadreyev RI, Brenner GJ
published in: Annals of clinical and translational neurology
information resource reference: Transcriptomic signature of painful human neurofibromatosis type 2 schwannomas. Ann Clin Transl Neurol. 2021 07; 8(7):1508-1514.
journal title abbreviation: Ann Clin Transl Neurol
publication date: 2021-05-30T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1360729
type: Authorship
author rank in publication: 9
linked author: Plotkin, Scott
linked information resource: Transcriptomic signature of painful human neurofibromatosis type 2 schwannomas.

Authorship 1363477
type: Authorship
author rank in publication: 8
linked author: Plotkin, Scott
linked information resource: DINs: Deep Interactive Networks for Neurofibroma Segmentation in Neurofibromatosis Type 1 on Whole-Body MRI.

DINs: Deep Interactive Networks for Neurofibroma Segmentation in Neurofibromatosis Type 1 on Whole-Body MRI.
PubMed Identifier: 34106871
author list: Zhang JW, Chen W, Ly KI, Zhang X, Yan F, Jordan J, Harris G, Plotkin S, Hao P, Cai W
published in: IEEE journal of biomedical and health informatics
information resource reference: DINs: Deep Interactive Networks for Neurofibroma Segmentation in Neurofibromatosis Type 1 on Whole-Body MRI. IEEE J Biomed Health Inform. 2022 02; 26(2):786-797.
journal title abbreviation: IEEE J Biomed Health Inform
publication date: 2022-02-04T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1370682
type: Authorship
author rank in publication: 17
linked author: Plotkin, Scott
linked information resource: Reliability of Handheld Dynamometry to Measure Focal Muscle Weakness in Neurofibromatosis Types 1 and 2.

Authorship 1372485
type: Authorship
author rank in publication: 11
linked author: Plotkin, Scott
linked information resource: Enhancing Neurofibromatosis Clinical Trial Outcome Measures Through Patient Engagement: Lessons From REiNS.

Authorship 1372484
type: Authorship
author rank in publication: 2
linked author: Plotkin, Scott
linked information resource: Neurofibromatosis Clinical Trials-REiNS Collaboration 2020 Recommendations: Looking Back and Moving Ahead.

Authorship 1373458
type: Authorship
author rank in publication: 5
linked author: Plotkin, Scott
linked information resource: Measuring the Effect of Cutaneous Neurofibromas on Quality of Life in Neurofibromatosis Type 1.

Authorship 1372915
type: Authorship
author rank in publication: 15
linked author: Plotkin, Scott
linked information resource: Validating Techniques for Measurement of Cutaneous Neurofibromas: Recommendations for Clinical Trials.

Authorship 1372545
type: Authorship
author rank in publication: 13
linked author: Plotkin, Scott
linked information resource: Perspective of Adults With Neurofibromatosis 1 and Cutaneous Neurofibromas: Implications for Clinical Trials.

Authorship 1372448
type: Authorship
author rank in publication: 6
linked author: Plotkin, Scott
linked information resource: Phase 0 Clinical Trial of Everolimus in Patients with Vestibular Schwannoma or Meningioma.

Authorship 1372544
type: Authorship
author rank in publication: 12
linked author: Plotkin, Scott
linked information resource: Imaging Evaluation of Plexiform Neurofibromas in Neurofibromatosis Type 1: A Survey-Based Assessment.

Phase 0 Clinical Trial of Everolimus in Patients with Vestibular Schwannoma or Meningioma.
PubMed Identifier: 34224367
author list: Karajannis MA, Mauguen A, Maloku E, Xu Q, Dunbar EM, Plotkin SR, Yaffee A, Wang S, Roland JT, Sen C, Placantonakis DG, Golfinos JG, Allen JC, Vitanza NA, Chiriboga LA, Schneider RJ, Deng J, Neubert TA, Goldberg JD, Zagzag D, Giancotti FG, Blakeley JO
published in: Molecular cancer therapeutics
information resource reference: Phase 0 Clinical Trial of Everolimus in Patients with Vestibular Schwannoma or Meningioma. Mol Cancer Ther. 2021 09; 20(9):1584-1591.
journal title abbreviation: Mol Cancer Ther
publication date: 2021-06-17T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Neurofibromatosis Clinical Trials-REiNS Collaboration 2020 Recommendations: Looking Back and Moving Ahead.
PubMed Identifier: 34230201
author list: Gross AM, Plotkin SR, Widemann BC
published in: Neurology
information resource reference: Neurofibromatosis Clinical Trials-REiNS Collaboration 2020 Recommendations: Looking Back and Moving Ahead. Neurology. 2021 Aug 16; 97(7 Supplement 1):S1-S3.
journal title abbreviation: Neurology
publication date: 2021-08-16T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Perspective of Adults With Neurofibromatosis 1 and Cutaneous Neurofibromas: Implications for Clinical Trials.
PubMed Identifier: 34230202
author list: Cannon A, Pichard DC, Wolters PL, Adsit S, Erickson G, Lessing AJ, Li P, Narmore W, Röhl C, Rosser T, Widemann BC, Blakeley JO, Plotkin SR
published in: Neurology
information resource reference: Perspective of Adults With Neurofibromatosis 1 and Cutaneous Neurofibromas: Implications for Clinical Trials. Neurology. 2021 08 17; 97(7 Suppl 1):S15-S24.
journal title abbreviation: Neurology
publication date: 2021-07-06T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Enhancing Neurofibromatosis Clinical Trial Outcome Measures Through Patient Engagement: Lessons From REiNS.
PubMed Identifier: 34230208
author list: Merker VL, Lessing AJ, Moss I, Hussey M, Oberlander B, Rose T, Thalheimer R, Wirtanen T, Wolters PL, Gross AM, Plotkin SR
published in: Neurology
information resource reference: Enhancing Neurofibromatosis Clinical Trial Outcome Measures Through Patient Engagement: Lessons From REiNS. Neurology. 2021 08 17; 97(7 Suppl 1):S4-S14.
journal title abbreviation: Neurology
publication date: 2021-07-06T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Validating Techniques for Measurement of Cutaneous Neurofibromas: Recommendations for Clinical Trials.
PubMed Identifier: 34230197
author list: Thalheimer RD, Merker VL, Ly KI, Champlain A, Sawaya J, Askenazi NL, Herr HP, Da JLW, Jordan JT, Muzikansky A, Pearce EM, Sakamoto FH, Blakeley JO, Anderson RR, Plotkin SR
published in: Neurology
information resource reference: Validating Techniques for Measurement of Cutaneous Neurofibromas: Recommendations for Clinical Trials. Neurology. 2021 08 17; 97(7 Suppl 1):S32-S41.
journal title abbreviation: Neurology
publication date: 2021-07-06T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Measuring the Effect of Cutaneous Neurofibromas on Quality of Life in Neurofibromatosis Type 1.
PubMed Identifier: 34230204
author list: Maguiness S, Berman Y, Rubin N, Dodds M, Plotkin SR, Wong C, Moertel C
published in: Neurology
information resource reference: Measuring the Effect of Cutaneous Neurofibromas on Quality of Life in Neurofibromatosis Type 1. Neurology. 2021 08 17; 97(7 Suppl 1):S25-S31.
journal title abbreviation: Neurology
publication date: 2021-07-06T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Reliability of Handheld Dynamometry to Measure Focal Muscle Weakness in Neurofibromatosis Types 1 and 2.
PubMed Identifier: 34230196
author list: Akshintala S, Khalil N, Yohay K, Muzikansky A, Allen J, Yaffe A, Gross AM, Fisher MJ, Blakeley JO, Oberlander B, Pudel M, Engelson C, Obletz J, Mitchell C, Widemann BC, Stevenson DA, Plotkin SR
published in: Neurology
information resource reference: Reliability of Handheld Dynamometry to Measure Focal Muscle Weakness in Neurofibromatosis Types 1 and 2. Neurology. 2021 08 17; 97(7 Suppl 1):S99-S110.
journal title abbreviation: Neurology
publication date: 2021-07-06T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Imaging Evaluation of Plexiform Neurofibromas in Neurofibromatosis Type 1: A Survey-Based Assessment.
PubMed Identifier: 34230200
author list: Ahlawat S, Ly KI, Fayad LM, Fisher MJ, Lessing AJ, Berg DJ, Salamon JM, Mautner VF, Babovic-Vuksanovic D, Dombi E, Harris G, Plotkin SR, Blakeley J
published in: Neurology
information resource reference: Imaging Evaluation of Plexiform Neurofibromas in Neurofibromatosis Type 1: A Survey-Based Assessment. Neurology. 2021 08 17; 97(7 Suppl 1):S111-S119.
journal title abbreviation: Neurology
publication date: 2021-07-06T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1374359
type: Authorship
author rank in publication: 21
linked author: Plotkin, Scott
linked information resource: Losartan prevents tumor-induced hearing loss and augments radiation efficacy in NF2 schwannoma rodent models.

Authorship 1375907
type: Authorship
author rank in publication: 32
linked author: Plotkin, Scott
linked information resource: Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK.

Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK.
PubMed Identifier: 34264955
author list: Chang LS, Oblinger JL, Smith AE, Ferrer M, Angus SP, Hawley E, Petrilli AM, Beauchamp RL, Riecken LB, Erdin S, Poi M, Huang J, Bessler WK, Zhang X, Guha R, Thomas C, Burns SS, Gilbert TSK, Jiang L, Li X, Lu Q, Yuan J, He Y, Dixon SAH, Masters A, Jones DR, Yates CW, Haggarty SJ, La Rosa S, Welling DB, Stemmer-Rachamimov AO, Plotkin SR, Gusella JF, Guinney J, Morrison H, Ramesh V, Fernandez-Valle C, Johnson GL, Blakeley JO, Clapp DW
published in: PloS one
information resource reference: Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK. PLoS One. 2021; 16(7):e0252048.
journal title abbreviation: PLoS One
publication date: 2021-07-15T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Losartan prevents tumor-induced hearing loss and augments radiation efficacy in NF2 schwannoma rodent models.
PubMed Identifier: 34261799
author list: Wu L, Vasilijic S, Sun Y, Chen J, Landegger LD, Zhang Y, Zhou W, Ren J, Early S, Yin Z, Ho WW, Zhang N, Gao X, Lee GY, Datta M, Sagers JE, Brown A, Muzikansky A, Stemmer-Rachamimov A, Zhang L, Plotkin SR, Jain RK, Stankovic KM, Xu L
published in: Science translational medicine
information resource reference: Losartan prevents tumor-induced hearing loss and augments radiation efficacy in NF2 schwannoma rodent models. Sci Transl Med. 2021 07 14; 13(602).
journal title abbreviation: Sci Transl Med
publication date: 2021-07-14T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1410709
type: Authorship
author rank in publication: 4
linked author: Plotkin, Scott
linked information resource: A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma.

Authorship 1410671
type: Authorship
author rank in publication: 4
linked author: Plotkin, Scott
linked information resource: Pseudoprogression of Malignant Peripheral Nerve Sheath Tumor in Patient with Neurofibromatosis Type 1, a Case Report.

Authorship 1413900
type: Authorship
author rank in publication: 3
linked author: Plotkin, Scott
linked information resource: A practical guide to neuro-oncology fellowship.

Authorship 1413180
type: Authorship
author rank in publication: 2
linked author: Plotkin, Scott
linked information resource: Neurofibromatoses.

Pseudoprogression of Malignant Peripheral Nerve Sheath Tumor in Patient with Neurofibromatosis Type 1, a Case Report.
PubMed Identifier: 34720939
author list: Lessing AJ, Cote GM, DeLaney TF, Plotkin SR, Raskin KA, Lessing JN
published in: Case reports in oncology
information resource reference: Pseudoprogression of Malignant Peripheral Nerve Sheath Tumor in Patient with Neurofibromatosis Type 1, a Case Report. Case Rep Oncol. 2021 Sep-Dec; 14(3):1342-1346.
journal title abbreviation: Case Rep Oncol
publication date: 2021-09-20T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Neurofibromatoses.
PubMed Identifier: 34756486
author list: Jordan JT, Plotkin SR
published in: Hematology/oncology clinics of North America
information resource reference: Neurofibromatoses. Hematol Oncol Clin North Am. 2022 02; 36(1):253-267.
journal title abbreviation: Hematol Oncol Clin North Am
publication date: 2021-10-27T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma.
PubMed Identifier: 34728525
author list: Lassman AB, Wen PY, van den Bent MJ, Plotkin SR, Walenkamp AME, Green AL, Li K, Walker CJ, Chang H, Tamir S, Henegar L, Shen Y, Alvarez MJ, Califano A, Landesman Y, Kauffman MG, Shacham S, Mau-Sørensen M
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma. Clin Cancer Res. 2022 02 01; 28(3):452-460.
journal title abbreviation: Clin Cancer Res
publication date: 2021-11-02T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

A practical guide to neuro-oncology fellowship.
PubMed Identifier: 34855097
author list: Gonzalez Castro LN, Forst DA, Plotkin SR, Lee EQ
published in: Journal of neuro-oncology
information resource reference: A practical guide to neuro-oncology fellowship. J Neurooncol. 2022 Jan; 156(1):73-79.
journal title abbreviation: J Neurooncol
publication date: 2021-12-02T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1430484
type: Authorship
author rank in publication: 6
linked author: Plotkin, Scott
linked information resource: Awareness and agreement with neurofibromatosis care guidelines among U.S. neurofibromatosis specialists.

Awareness and agreement with neurofibromatosis care guidelines among U.S. neurofibromatosis specialists.
PubMed Identifier: 35144646
author list: Merker VL, Knight P, Radtke HB, Yohay K, Ullrich NJ, Plotkin SR, Jordan JT
published in: Orphanet journal of rare diseases
information resource reference: Awareness and agreement with neurofibromatosis care guidelines among U.S. neurofibromatosis specialists. Orphanet J Rare Dis. 2022 02 10; 17(1):44.
journal title abbreviation: Orphanet J Rare Dis
publication date: 2022-02-10T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial.
PubMed Identifier: 35167655
author list: Frigault MJ, Dietrich J, Gallagher K, Roschewski M, Jordan JT, Forst D, Plotkin SR, Cook D, Casey KS, Lindell KA, Depinho GD, Katsis K, Elder EL, Leick MB, Choi B, Horick N, Preffer F, Saylor M, McAfee S, O'Donnell PV, Spitzer TR, Dey B, DeFilipp Z, El-Jawahri A, Batchelor TT, Maus MV, Chen YB
published in: Blood
information resource reference: Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial. Blood. 2022 04 14; 139(15):2306-2315.
journal title abbreviation: Blood
publication date: 2022-04-14T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1434131
type: Authorship
author rank in publication: 7
linked author: Plotkin, Scott
linked information resource: Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial.

Authorship 1438879
type: Authorship
author rank in publication: 11
linked author: Plotkin, Scott
linked information resource: Fractionated Proton Radiation Therapy and Hearing Preservation for Vestibular Schwannoma: Preliminary Analysis of a Prospective Phase 2 Clinical Trial.

Fractionated Proton Radiation Therapy and Hearing Preservation for Vestibular Schwannoma: Preliminary Analysis of a Prospective Phase 2 Clinical Trial.
PubMed Identifier: 35229827
author list: Saraf A, Pike LRG, Franck KH, Horick NK, Yeap BY, Fullerton BC, Wang IS, Abazeed ME, McKenna MJ, Mehan WA, Plotkin SR, Loeffler JS, Shih HA
published in: Neurosurgery
information resource reference: Fractionated Proton Radiation Therapy and Hearing Preservation for Vestibular Schwannoma: Preliminary Analysis of a Prospective Phase 2 Clinical Trial. Neurosurgery. 2022 05 01; 90(5):506-514.
journal title abbreviation: Neurosurgery
publication date: 2022-05-01T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1447232
type: Authorship
author rank in publication: 6
linked author: Plotkin, Scott
linked information resource: Developing a Virtual Equity Hub: Adapting the Tumor Board Model for Equity in Cancer Care.

Developing a Virtual Equity Hub: Adapting the Tumor Board Model for Equity in Cancer Care.
PubMed Identifier: 35443045
author list: Irwin KE, Ko N, Walsh EP, Decker V, Arrillaga-Romany I, Plotkin SR, Franas J, Gorton E, Moy B
published in: The oncologist
information resource reference: Developing a Virtual Equity Hub: Adapting the Tumor Board Model for Equity in Cancer Care. Oncologist. 2022 07 05; 27(7):518-524.
journal title abbreviation: Oncologist
publication date: 2022-07-05T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Understanding barriers to diagnosis in a rare, genetic disease: Delays and errors in diagnosing schwannomatosis.
PubMed Identifier: 35678462
author list: Merker VL, Slobogean B, Jordan JT, Langmead S, Meterko M, Charns MP, Elwy AR, Blakeley JO, Plotkin SR
published in: American journal of medical genetics. Part A
information resource reference: Understanding barriers to diagnosis in a rare, genetic disease: Delays and errors in diagnosing schwannomatosis. Am J Med Genet A. 2022 09; 188(9):2672-2683.
journal title abbreviation: Am J Med Genet A
publication date: 2022-06-09T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation.
PubMed Identifier: 35674741
author list: Plotkin SR, Messiaen L, Legius E, Pancza P, Avery RA, Blakeley JO, Babovic-Vuksanovic D, Ferner R, Fisher MJ, Friedman JM, Giovannini M, Gutmann DH, Hanemann CO, Kalamarides M, Kehrer-Sawatzki H, Korf BR, Mautner VF, MacCollin M, Papi L, Rauen KA, Riccardi V, Schorry E, Smith MJ, Stemmer-Rachamimov A, Stevenson DA, Ullrich NJ, Viskochil D, Wimmer K, Yohay K, Huson SM, Wolkenstein P, Evans DG
published in: Genetics in medicine : official journal of the American College of Medical Genetics
information resource reference: Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation. Genet Med. 2022 09; 24(9):1967-1977.
journal title abbreviation: Genet Med
publication date: 2022-06-09T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1453972
type: Authorship
author rank in publication: 9
linked author: Plotkin, Scott
linked information resource: Understanding barriers to diagnosis in a rare, genetic disease: Delays and errors in diagnosing schwannomatosis.

Authorship 1454075
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation.

Genetic testing to gain diagnostic clarity in neurofibromatosis type 2 and schwannomatosis.
PubMed Identifier: 35638454
author list: Burns R, Niendorf K, Steinberg K, Mueller A, Ly I, Jordan JT, Plotkin SR, Hicks SR
published in: American journal of medical genetics. Part A
information resource reference: Genetic testing to gain diagnostic clarity in neurofibromatosis type 2 and schwannomatosis. Am J Med Genet A. 2022 08; 188(8):2413-2420.
journal title abbreviation: Am J Med Genet A
publication date: 2022-05-31T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 356219
type: Authorship
author rank in publication: 3
linked author: Plotkin, Scott
linked information resource: Role of resection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis type 1.

Neurofibromatosis type 1 and pregnancy complications: a population-based study.
PubMed Identifier: 23535241
author list: Terry AR, Barker FG, Leffert L, Bateman BT, Souter I, Plotkin SR
published in: American journal of obstetrics and gynecology
information resource reference: Neurofibromatosis type 1 and pregnancy complications: a population-based study. Am J Obstet Gynecol. 2013 Jul; 209(1):46.e1-8.
journal title abbreviation: Am J Obstet Gynecol
publication date: 2013-03-25T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Design of a randomized, placebo-controlled, phase 2 study evaluating the safety and efficacy of tanezumab for treatment of schwannomatosis-related pain.
PubMed Identifier: 36038003
author list: Da JLW, Merker VL, Jordan JT, Ly KI, Muzikansky A, Parsons M, Wolters PL, Xu L, Styren S, Brown MT, Plotkin SR
published in: Contemporary clinical trials
information resource reference: Design of a randomized, placebo-controlled, phase 2 study evaluating the safety and efficacy of tanezumab for treatment of schwannomatosis-related pain. Contemp Clin Trials. 2022 10; 121:106900.
journal title abbreviation: Contemp Clin Trials
publication date: 2022-08-26T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1462332
type: Authorship
author rank in publication: 7
linked author: Plotkin, Scott
linked information resource: Genetic testing to gain diagnostic clarity in neurofibromatosis type 2 and schwannomatosis.

Authorship 1465506
type: Authorship
author rank in publication: 13
linked author: Plotkin, Scott
linked information resource: Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2.

Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2.
PubMed Identifier: 35846573
author list: Prabhakar S, Beauchamp RL, Cheah PS, Yoshinaga A, Haidar EA, Lule S, Mani G, Maalouf K, Stemmer-Rachamimov A, Jung DH, Welling DB, Giovannini M, Plotkin SR, Maguire CA, Ramesh V, Breakefield XO
published in: Molecular therapy. Methods & clinical development
information resource reference: Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2. Mol Ther Methods Clin Dev. 2022 Sep 08; 26:169-180.
journal title abbreviation: Mol Ther Methods Clin Dev
publication date: 2022-06-22T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1503052
type: Authorship
author rank in publication: 13
linked author: Plotkin, Scott
linked information resource: Ten-Year Follow-up of Internal Neurofibroma Growth Behavior in Adult Patients With Neurofibromatosis Type 1 Using Whole-Body MRI.

Authorship 1498044
type: Authorship
author rank in publication: 11
linked author: Plotkin, Scott
linked information resource: Design of a randomized, placebo-controlled, phase 2 study evaluating the safety and efficacy of tanezumab for treatment of schwannomatosis-related pain.

Ten-Year Follow-up of Internal Neurofibroma Growth Behavior in Adult Patients With Neurofibromatosis Type 1 Using Whole-Body MRI.
PubMed Identifier: 36332985
author list: Ly KI, Merker VL, Cai W, Bredella MA, Muzikansky A, Thalheimer RD, Da JL, Orr CC, Herr HP, Morris ME, Chang CY, Harris GJ, Plotkin SR, Jordan JT
published in: Neurology
information resource reference: Ten-Year Follow-up of Internal Neurofibroma Growth Behavior in Adult Patients With Neurofibromatosis Type 1 Using Whole-Body MRI. Neurology. 2023 02 14; 100(7):e661-e670.
journal title abbreviation: Neurology
publication date: 2022-11-04T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1512575
type: Authorship
author rank in publication: 6
linked author: Plotkin, Scott
linked information resource: COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis.

COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis.
PubMed Identifier: 36565307
author list: Banerjee J, Friedman JM, Klesse LJ, Yohay KH, Jordan JT, Plotkin SR, Allaway RJ, Blakeley JO
published in: Genetics in medicine : official journal of the American College of Medical Genetics
information resource reference: COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis. Genet Med. 2023 02; 25(2):100324.
journal title abbreviation: Genet Med
publication date: 2022-10-19T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1524574
type: Authorship
author rank in publication: 10
linked author: Plotkin, Scott
linked information resource: Proteasomal pathway inhibition as a potential therapy for NF2-associated meningioma and schwannoma.

Authorship 1525894
type: Authorship
author rank in publication: 6
linked author: Plotkin, Scott
linked information resource: Isolated gA/gB glycoprotein complex of human cytomegalovirus envelope induces humoral and cellular immune-responses in human volunteers.

Authorship 1526646
type: Authorship
author rank in publication: 19
linked author: Plotkin, Scott
linked information resource: Co-Targeting IL-6 and EGFR signaling for the treatment of schwannomatosis and associated pain.

Isolated gA/gB glycoprotein complex of human cytomegalovirus envelope induces humoral and cellular immune-responses in human volunteers.
PubMed Identifier: 2159679
author list: Gonczol E, Ianacone J, Ho WZ, Starr S, Meignier B, Plotkin S
published in: Vaccine
information resource reference: Isolated gA/gB glycoprotein complex of human cytomegalovirus envelope induces humoral and cellular immune-responses in human volunteers. Vaccine. 1990 Apr; 8(2):130-6.
journal title abbreviation: Vaccine
publication date: 1990-04-01T00:00:00
year: 1990
type: Academic Article
type: Article
type: Document
type: Information Resource

Co-Targeting IL-6 and EGFR signaling for the treatment of schwannomatosis and associated pain.
PubMed Identifier: 36798353
author list: Yin Z, Wu L, Zhang Y, Sun Y, Chen JW, Subudhi S, Ho W, Lee GY, Wang A, Gao X, Ren J, Zhu C, Zhang N, Ferraro GB, Muzikansky A, Zhang L, Stemmer-Rachamimov A, Mao J, Plotkin SR, Xu L
published in: bioRxiv : the preprint server for biology
information resource reference: Co-Targeting IL-6 and EGFR signaling for the treatment of schwannomatosis and associated pain. bioRxiv. 2023 Feb 06.
journal title abbreviation: bioRxiv
publication date: 2023-02-06T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Proteasomal pathway inhibition as a potential therapy for NF2-associated meningioma and schwannoma.
PubMed Identifier: 36806881
author list: Bhattacharyya S, Oblinger JL, Beauchamp RL, Yin Z, Erdin S, Koundinya P, Ware AD, Ferrer M, Jordan JT, Plotkin SR, Xu L, Chang LS, Ramesh V
published in: Neuro-oncology
information resource reference: Proteasomal pathway inhibition as a potential therapy for NF2-associated meningioma and schwannoma. Neuro Oncol. 2023 09 05; 25(9):1617-1630.
journal title abbreviation: Neuro Oncol
publication date: 2023-09-05T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1528454
type: Authorship
author rank in publication: 5
linked author: Plotkin, Scott
linked information resource: Characterization of multiple molecular interactions between human cytomegalovirus (HCMV) and human immunodeficiency virus type 1 (HIV-1).

Characterization of multiple molecular interactions between human cytomegalovirus (HCMV) and human immunodeficiency virus type 1 (HIV-1).
PubMed Identifier: 2158700
author list: Rando RF, Srinivasan A, Feingold J, Gonczol E, Plotkin S
published in: Virology
information resource reference: Characterization of multiple molecular interactions between human cytomegalovirus (HCMV) and human immunodeficiency virus type 1 (HIV-1). Virology. 1990 May; 176(1):87-97.
journal title abbreviation: Virology
publication date: 1990-05-01T00:00:00
year: 1990
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1560984
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma.

Authorship 1543840
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Clinical comparison of preinjection anesthetics.

Authorship 1566172
type: Authorship
author rank in publication: 13
linked author: Plotkin, Scott
linked information resource: Prospective phase II trial of the dual mTORC1/2 inhibitor vistusertib for progressive or symptomatic meningiomas in persons with neurofibromatosis 2.

Authorship 1557987
type: Authorship
author rank in publication: 4
linked author: Plotkin, Scott
linked information resource: Proton Radiotherapy for Vestibular Schwannomas in Patients with NF2-Related Schwannomatosis: A Case Series.

Authorship 1552849
type: Authorship
author rank in publication: 13
linked author: Plotkin, Scott
linked information resource: Perspectives of adolescents with neurofibromatosis 1 and cutaneous neurofibromas: Implications for clinical trials.

Authorship 1567819
type: Authorship
author rank in publication: 8
linked author: Plotkin, Scott
linked information resource: Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cells.

Authorship 1573040
type: Authorship
author rank in publication: 7
linked author: Plotkin, Scott
linked information resource: Effect of Mind-Body Skills Training on Quality of Life for Geographically Diverse Adults With Neurofibromatosis: A Fully Remote Randomized Clinical Trial.

Perspectives of adolescents with neurofibromatosis 1 and cutaneous neurofibromas: Implications for clinical trials.
PubMed Identifier: 37269078
author list: Cannon A, Sarin KY, Petersen AK, Pichard DC, Wolters PL, Erickson G, Lessing AJ, Li P, Röhl C, Rosser T, Widemann BC, Blakeley JO, Plotkin SR
published in: Clinical trials (London, England)
information resource reference: Perspectives of adolescents with neurofibromatosis 1 and cutaneous neurofibromas: Implications for clinical trials. Clin Trials. 2024 02; 21(1):67-72.
journal title abbreviation: Clin Trials
publication date: 2023-06-02T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Prospective phase II trial of the dual mTORC1/2 inhibitor vistusertib for progressive or symptomatic meningiomas in persons with neurofibromatosis 2.
PubMed Identifier: 37215956
author list: Jordan JT, Orr CC, Thalheimer RD, Cambillo JV, Beauchamp RL, Shaikh G, Muzikansky A, Stemmer-Rachamimov A, Giovannini M, Kalamarides M, Barker FG, Ramesh V, Plotkin SR
published in: Neuro-oncology advances
information resource reference: Prospective phase II trial of the dual mTORC1/2 inhibitor vistusertib for progressive or symptomatic meningiomas in persons with neurofibromatosis 2. Neurooncol Adv. 2023 Jan-Dec; 5(1):vdad041.
journal title abbreviation: Neurooncol Adv
publication date: 2023-04-17T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Effect of Mind-Body Skills Training on Quality of Life for Geographically Diverse Adults With Neurofibromatosis: A Fully Remote Randomized Clinical Trial.
PubMed Identifier: 37378983
author list: Vranceanu AM, Manglani HR, Choukas NR, Kanaya MR, Lester E, Zale EL, Plotkin SR, Jordan J, Macklin E, Bakhshaie J
published in: JAMA network open
information resource reference: Effect of Mind-Body Skills Training on Quality of Life for Geographically Diverse Adults With Neurofibromatosis: A Fully Remote Randomized Clinical Trial. JAMA Netw Open. 2023 06 01; 6(6):e2320599.
journal title abbreviation: JAMA Netw Open
publication date: 2023-06-01T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Proton Radiotherapy for Vestibular Schwannomas in Patients with NF2-Related Schwannomatosis: A Case Series.
PubMed Identifier: 36975476
author list: Douwes JPJ, Koetsier KS, van Dam VS, Plotkin SR, Barker FG, Welling DB, Jansen JC, Hensen EF, Shih HA
published in: Current oncology (Toronto, Ont.)
information resource reference: Proton Radiotherapy for Vestibular Schwannomas in Patients with NF2-Related Schwannomatosis: A Case Series. Curr Oncol. 2023 03 20; 30(3):3473-3483.
journal title abbreviation: Curr Oncol
publication date: 2023-03-20T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Clinical comparison of preinjection anesthetics.
PubMed Identifier: 9503770
author list: Plotkin S
published in: Journal of the American Podiatric Medical Association
information resource reference: Clinical comparison of preinjection anesthetics. J Am Podiatr Med Assoc. 1998 Feb; 88(2):73-9.
journal title abbreviation: J Am Podiatr Med Assoc
publication date: 1998-02-01T00:00:00
year: 1998
type: Academic Article
type: Article
type: Document
type: Information Resource

Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cells.
PubMed Identifier: 37402650
author list: Karschnia P, Arrillaga-Romany IC, Eichler A, Forst DA, Gerstner E, Jordan JT, Ly I, Plotkin SR, Wang N, Martinez-Lage M, Winter SF, Tonn JC, Rejeski K, von Baumgarten L, Cahill DP, Nahed BV, Shankar GM, Abramson JS, Barnes JA, El-Jawahri A, Hochberg EP, Johnson PC, Soumerai JD, Takvorian RW, Chen YB, Frigault MJ, Dietrich J
published in: Neuro-oncology
information resource reference: Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cells. Neuro Oncol. 2023 12 08; 25(12):2239-2249.
journal title abbreviation: Neuro Oncol
publication date: 2023-12-08T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma.
PubMed Identifier: 37010875
author list: Plotkin SR, Allen J, Dhall G, Campian JL, Clapp DW, Fisher MJ, Jain RK, Tonsgard J, Ullrich NJ, Thomas C, Edwards LJ, Korf B, Packer R, Karajannis MA, Blakeley JO
published in: Neuro-oncology
information resource reference: Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma. Neuro Oncol. 2023 08 03; 25(8):1498-1506.
journal title abbreviation: Neuro Oncol
publication date: 2023-08-03T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1583754
type: Authorship
author rank in publication: 11
linked author: Plotkin, Scott
linked information resource: Association of MTHFR Polymorphisms With Leukoencephalopathy Risk in Patients With Primary CNS Lymphoma Treated With Methotrexate-Based Regimens.

Authorship 1586209
type: Authorship
author rank in publication: 2
linked author: Plotkin, Scott
linked information resource: Potential endpoints for assessment of bone health in persons with neurofibromatosis type 1.

Authorship 1586403
type: Authorship
author rank in publication: 4
linked author: Plotkin, Scott
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/220735162

Potential endpoints for assessment of bone health in persons with neurofibromatosis type 1.
PubMed Identifier: 37772407
author list: Gross AM, Plotkin SR, Watts NB, Fisher MJ, Klesse LJ, Lessing AJ, McManus ML, Larson AN, Oberlander B, Rios JJ, Sarnoff H, Simpson BN, Ullrich NJ, Stevenson DA
published in: Clinical trials (London, England)
information resource reference: Potential endpoints for assessment of bone health in persons with neurofibromatosis type 1. Clin Trials. 2024 02; 21(1):29-39.
journal title abbreviation: Clin Trials
publication date: 2023-09-29T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Association of MTHFR Polymorphisms With Leukoencephalopathy Risk in Patients With Primary CNS Lymphoma Treated With Methotrexate-Based Regimens.
PubMed Identifier: 37527941
author list: Karschnia P, Kurz SC, Brastianos PK, Winter SF, Gordon A, Jones S, Pisapia M, Nayyar N, Tonn JC, Batchelor TT, Plotkin SR, Dietrich J
published in: Neurology
information resource reference: Association of MTHFR Polymorphisms With Leukoencephalopathy Risk in Patients With Primary CNS Lymphoma Treated With Methotrexate-Based Regimens. Neurology. 2023 10 24; 101(17):e1741-e1746.
journal title abbreviation: Neurology
publication date: 2023-08-01T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/220735162
PubMed Identifier: 37776044
author list: Merker VL, Gross AM, Widemann BC, Plotkin SR
published in: Clinical trials (London, England)
information resource reference: Advancing neurofibromatosis and schwannomatosis clinical trial design: Consensus recommendations from the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration. Clin Trials. 2024 02; 21(1):3-5.
journal title abbreviation: Clin Trials
publication date: 2023-09-29T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Advancing neurofibromatosis and schwannomatosis clinical trial design: Consensus recommendations from the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration.

Authorship 1597104
type: Authorship
author rank in publication: 13
linked author: Plotkin, Scott
linked information resource: Development of a MEK inhibitor, NFX-179, as a chemoprevention agent for squamous cell carcinoma.

Development of a MEK inhibitor, NFX-179, as a chemoprevention agent for squamous cell carcinoma.
PubMed Identifier: 37820007
author list: Sarin KY, Kincaid J, Sell B, Shahryari J, Duncton MAJ, Morefield E, Sun W, Prieto K, Chavez-Chiang O, de Moran Segura C, Nguyen J, Bronson RT, Plotkin SR, Kochendoerfer GG, Fenn P, Wootton MA, Powala C, de Souza MP, Tsai KY
published in: Science translational medicine
information resource reference: Development of a MEK inhibitor, NFX-179, as a chemoprevention agent for squamous cell carcinoma. Sci Transl Med. 2023 10 11; 15(717):eade1844.
journal title abbreviation: Sci Transl Med
publication date: 2023-10-11T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Associate Professor of Neurology
is primary position: true
position in department: Neurology
position in division: https://connects.catalyst.harvard.edu/Profiles/profile/1229413
sort order: 1
type: Position
HR job title: Associate Professor of Neurology
position in organization: Massachusetts General Hospital

Authorship 434806
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Hearing improvement after bevacizumab in patients with neurofibromatosis type 2.

Authorship 442859
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Primary nervous system lymphoma.

Authorship 1602490
type: Authorship
author rank in publication: 4
linked author: Plotkin, Scott
linked information resource: A core outcome domain set to assess cutaneous neurofibromas related to neurofibromatosis type 1 in clinical trials.

A core outcome domain set to assess cutaneous neurofibromas related to neurofibromatosis type 1 in clinical trials.
PubMed Identifier: 37877514
author list: Fertitta L, Bergqvist C, Sarin KY, Plotkin SR, Moertel C, Petersen AK, Cannon A, Berman Y, Pichard DC, Röhl C, Lessing A, Brizion B, Peiffer B, Ravaud P, Tran VT, Armand ML, Moryousef S, Ferkal S, Jannic A, Ezzedine K, Wolkenstein P
published in: The British journal of dermatology
information resource reference: A core outcome domain set to assess cutaneous neurofibromas related to neurofibromatosis type 1 in clinical trials. Br J Dermatol. 2024 01 23; 190(2):216-225.
journal title abbreviation: Br J Dermatol
publication date: 2024-01-23T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1605328
type: Authorship
author rank in publication: 14
linked author: Plotkin, Scott
linked information resource: Gene-targeted therapy for neurofibromatosis and schwannomatosis: The path to clinical trials.

Gene-targeted therapy for neurofibromatosis and schwannomatosis: The path to clinical trials.
PubMed Identifier: 37937606
author list: Staedtke V, Anstett K, Bedwell D, Giovannini M, Keeling K, Kesterson R, Kim Y, Korf B, Leier A, McManus ML, Sarnoff H, Vitte J, Walker JA, Plotkin SR, Wallis D
published in: Clinical trials (London, England)
information resource reference: Gene-targeted therapy for neurofibromatosis and schwannomatosis: The path to clinical trials. Clin Trials. 2024 02; 21(1):51-66.
journal title abbreviation: Clin Trials
publication date: 2023-11-08T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1615282
type: Authorship
author rank in publication: 4
linked author: Plotkin, Scott
linked information resource: Noninvasive treatment of cutaneous neurofibromas (cNFs): Results of a randomized prospective, direct comparison of four methods.

Noninvasive treatment of cutaneous neurofibromas (cNFs): Results of a randomized prospective, direct comparison of four methods.
PubMed Identifier: 38086517
author list: Richey P, Funk M, Sakamoto F, Plotkin S, Ly I, Jordan J, Muzikansky A, Roberts J, Farinelli W, Levin Y, Garibyan L, Blakeley JO, Anderson RR
published in: Journal of the American Academy of Dermatology
information resource reference: Noninvasive treatment of cutaneous neurofibromas (cNFs): Results of a randomized prospective, direct comparison of four methods. J Am Acad Dermatol. 2024 04; 90(4):767-774.
journal title abbreviation: J Am Acad Dermatol
publication date: 2023-12-10T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 518660
type: Authorship
author rank in publication: 6
linked author: Plotkin, Scott
linked information resource: Outcomes of hospitalization in pregnant women with CNS neoplasms: a population-based study.

Authorship 1629248
type: Authorship
author rank in publication: 7
linked author: Plotkin, Scott
linked information resource: Effects of L-dopa in autism.

Effects of L-dopa in autism.
PubMed Identifier: 4335857
author list: Ritvo ER, Yuwiler A, Geller E, Kales A, Rashkis S, Schicor A, Plotkin S, Axelrod R, Howard C
published in: Journal of autism and childhood schizophrenia
information resource reference: Effects of L-dopa in autism. J Autism Child Schizophr. 1971 Apr-Jun; 1(2):190-205.
journal title abbreviation: J Autism Child Schizophr
publication date: 1971-04-01T00:00:00
year: 1971
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 521236
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Primary nervous-system lymphoma.

Authorship 1637451
type: Authorship
author rank in publication: 6
linked author: Plotkin, Scott
linked information resource: Preclinical evaluation of the third-generation, bi-steric mechanistic target of rapamycin complex 1-selective inhibitor RMC-6272 in NF2-deficient models.

Preclinical evaluation of the third-generation, bi-steric mechanistic target of rapamycin complex 1-selective inhibitor RMC-6272 in NF2-deficient models.
PubMed Identifier: 38476930
author list: Bhattacharyya S, Oblinger JL, Beauchamp RL, Kosa L, Robert F, Plotkin SR, Chang LS, Ramesh V
published in: Neuro-oncology advances
information resource reference: Preclinical evaluation of the third-generation, bi-steric mechanistic target of rapamycin complex 1-selective inhibitor RMC-6272 in NF2-deficient models. Neurooncol Adv. 2024 Jan-Dec; 6(1):vdae024.
journal title abbreviation: Neurooncol Adv
publication date: 2024-02-16T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1640812
type: Authorship
author rank in publication: 3
linked author: Plotkin, Scott
linked information resource: Histologic correlates of "Choroidal abnormalities" in Neurofibromatosis type 1 (NF1).

Histologic correlates of "Choroidal abnormalities" in Neurofibromatosis type 1 (NF1).
PubMed Identifier: 38607446
author list: Stemmer-Rachamimov AO, Kozanno L, Plotkin SR, Jordan JT, Rd Rizzo JF
published in: Acta neuropathologica
information resource reference: Histologic correlates of "Choroidal abnormalities" in Neurofibromatosis type 1 (NF1). Acta Neuropathol. 2024 04 12; 147(1):71.
journal title abbreviation: Acta Neuropathol
publication date: 2024-04-12T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Neurofibromatosis and Schwannomatosis Genes Variant Curation Expert Panel (VCEP)
end date: 2027-05-31
principal investigator name: PLOTKIN, SCOTT R
start date: 2024-06-01
type: Grant
sponsor award id: U24NS131158

Principal Investigator
type: Researcher Role
researcher role of: Plotkin, Scott
contributes to: Neurofibromatosis and Schwannomatosis Genes Variant Curation Expert Panel (VCEP)

Authorship 1648934
type: Authorship
author rank in publication: 15
linked author: Plotkin, Scott
linked information resource: Effect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1.

Authorship 1649772
type: Authorship
author rank in publication: 5
linked author: Plotkin, Scott
linked information resource: Evolving concepts in meningioma management in the era of genomics.

Authorship 1652897
type: Authorship
author rank in publication: 13
linked author: Plotkin, Scott
linked information resource: Erratum: Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2.

Effect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1.
PubMed Identifier: 38691597
author list: Sarin KY, Bradshaw M, O'Mara C, Shahryari J, Kincaid J, Kempers S, Tu JH, Dhawan S, DuBois J, Wilson D, Horwath P, de Souza MP, Powala C, Kochendoerfer GG, Plotkin SR, Webster GF, Le LQ
published in: Science advances
information resource reference: Effect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1. Sci Adv. 2024 05 03; 10(18):eadk4946.
journal title abbreviation: Sci Adv
publication date: 2024-05-01T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Erratum: Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2.
PubMed Identifier: 38745896
author list: Prabhakar S, Beauchamp RL, Cheah PS, Yoshinaga A, Abou Haidar E, Lule S, Mani G, Maalouf K, Stemmer-Rachamimov A, Jung DH, Welling DB, Giovannini M, Plotkin SR, Maguire CA, Ramesh V, Breakefield XO
published in: Molecular therapy. Methods & clinical development
information resource reference: Erratum: Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2. Mol Ther Methods Clin Dev. 2024 Jun 13; 32(2):101262.
journal title abbreviation: Mol Ther Methods Clin Dev
publication date: 2024-05-08T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Evolving concepts in meningioma management in the era of genomics.
PubMed Identifier: 38753473
author list: Hsieh AL, Bi WL, Ramesh V, Brastianos PK, Plotkin SR
published in: Cancer
information resource reference: Evolving concepts in meningioma management in the era of genomics. Cancer. 2024 Aug 01; 130(15):2586-2600.
journal title abbreviation: Cancer
publication date: 2024-05-16T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1660316
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Brigatinib in NF2-Related Schwannomatosis with Progressive Tumors.

Authorship 1663208
type: Authorship
author rank in publication: 9
linked author: Plotkin, Scott
linked information resource: Integrating Ataxia Evaluation into Tumor-Induced Hearing Loss Model to Comprehensively Study NF2-Related Schwannomatosis.

Integrating Ataxia Evaluation into Tumor-Induced Hearing Loss Model to Comprehensively Study NF2-Related Schwannomatosis.
PubMed Identifier: 38893082
author list: Lu S, Yin Z, Chen J, Wu L, Sun Y, Gao X, Huang P, Jordan JT, Plotkin SR, Xu L
published in: Cancers
information resource reference: Integrating Ataxia Evaluation into Tumor-Induced Hearing Loss Model to Comprehensively Study NF2-Related Schwannomatosis. Cancers (Basel). 2024 May 22; 16(11).
journal title abbreviation: Cancers (Basel)
publication date: 2024-05-22T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Brigatinib in NF2-Related Schwannomatosis with Progressive Tumors.
PubMed Identifier: 38904277
author list: Plotkin SR, Yohay KH, Nghiemphu PL, Dinh CT, Babovic-Vuksanovic D, Merker VL, Bakker A, Fell G, Trippa L, Blakeley JO
published in: The New England journal of medicine
information resource reference: Brigatinib in NF2-Related Schwannomatosis with Progressive Tumors. N Engl J Med. 2024 06 27; 390(24):2284-2294.
journal title abbreviation: N Engl J Med
publication date: 2024-06-21T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Associate Professor of Neurology
is primary position: true
position in department: Neurology
position in division: https://connects.catalyst.harvard.edu/Profiles/profile/1229413
sort order: 1
type: Position
HR job title: Associate Professor of Neurology
position in organization: Massachusetts General Hospital

Authorship 1666782
type: Authorship
author rank in publication: 14
linked author: Plotkin, Scott
linked information resource: Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseases.

Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseases.
PubMed Identifier: 39006526
author list: Dhaenens BAE, Heimann G, Bakker A, Nievo M, Ferner RE, Evans DG, Wolkenstein P, Leubner J, Potratz C, Carton C, Iloeje U, Kirk G, Blakeley JO, Plotkin S, Fisher MJ, Kim A, Driever PH, Azizi AA, Widemann BC, Gross A, Parke T, Legius E, Oostenbrink R
published in: Neuro-oncology practice
information resource reference: Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseases. Neurooncol Pract. 2024 Aug; 11(4):395-403.
journal title abbreviation: Neurooncol Pract
publication date: 2024-01-04T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Walter Augustus Lecompte Distinguished Professor of Otology and Laryngology
is primary position: true
position in department: Otolaryngology Head and Neck Surgery
position in division: https://connects.catalyst.harvard.edu/Profiles/profile/1229413
sort order: 1
type: Position
HR job title: Walter Augustus Lecompte Distinguished Professor of Otology and Laryngology
position in organization: Massachusetts Eye and Ear Infirmary

Assistant Professor of Neurology
is primary position: true
position in department: Neurology
position in division: https://connects.catalyst.harvard.edu/Profiles/profile/1229413
sort order: 1
type: Position
HR job title: Assistant Professor of Neurology
position in organization: Massachusetts General Hospital

Associate Professor of Neurology
is primary position: true
position in department: Neurology
position in division: https://connects.catalyst.harvard.edu/Profiles/profile/1229413
sort order: 1
type: Position
HR job title: Associate Professor of Neurology
position in organization: Massachusetts General Hospital

Assistant Professor of Neurology
is primary position: true
position in department: Neurology
position in division: https://connects.catalyst.harvard.edu/Profiles/profile/1229413
sort order: 1
type: Position
HR job title: Assistant Professor of Neurology
position in organization: Massachusetts General Hospital

Professor of Psychology in the Department of Psychiatry
is primary position: true
position in department: Psychiatry
position in division: https://connects.catalyst.harvard.edu/Profiles/profile/1229413
sort order: 1
type: Position
HR job title: Professor of Psychology in the Department of Psychiatry
position in organization: Massachusetts General Hospital

Authorship 1684033
type: Authorship
author rank in publication: 3
linked author: Plotkin, Scott
linked information resource: Reply to L. Lucchino et al. on commentary on "Histologic correlates of "Choroidal Abnormalities" in Neurofibromatosis type 1".

Reply to L. Lucchino et al. on commentary on "Histologic correlates of "Choroidal Abnormalities" in Neurofibromatosis type 1".
PubMed Identifier: 39150565
author list: Stemmer-Rachamimov AO, Kozanno L, Plotkin SR, Jordan JT, Rizzo JF
published in: Acta neuropathologica
information resource reference: Reply to L. Lucchino et al. on commentary on "Histologic correlates of "Choroidal Abnormalities" in Neurofibromatosis type 1". Acta Neuropathol. 2024 08 16; 148(1):23.
journal title abbreviation: Acta Neuropathol
publication date: 2024-08-16T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma.
PubMed Identifier: 23828240
author list: Lu-Emerson C, Snuderl M, Kirkpatrick ND, Goveia J, Davidson C, Huang Y, Riedemann L, Taylor J, Ivy P, Duda DG, Ancukiewicz M, Plotkin SR, Chi AS, Gerstner ER, Eichler AF, Dietrich J, Stemmer-Rachamimov AO, Batchelor TT, Jain RK
published in: Neuro-oncology
information resource reference: Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma. Neuro Oncol. 2013 Aug; 15(8):1079-87.
journal title abbreviation: Neuro Oncol
publication date: 2013-07-04T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 343985
type: Authorship
author rank in publication: 2
linked author: Plotkin, Scott
linked information resource: Chemotherapy: present and future.

Authorship 633543
type: Authorship
author rank in publication: 7
linked author: Plotkin, Scott
linked information resource: Immunisation with canarypox virus expressing rabies glycoprotein.

Authorship 665858
type: Authorship
author rank in publication: 4
linked author: Plotkin, Scott
linked information resource: Quality of life among adult patients with neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis: a systematic review of the literature.

Authorship 659282
type: Authorship
author rank in publication: 11
linked author: Plotkin, Scott
linked information resource: Plasma S100ß is not a useful biomarker for tumor burden in neurofibromatosis.

Authorship 636399
type: Authorship
author rank in publication: 7
linked author: Plotkin, Scott
linked information resource: Human safety and immunogenicity of a canarypox-rabies glycoprotein recombinant vaccine: an alternative poxvirus vector system.

Authorship 660826
type: Authorship
author rank in publication: 9
linked author: Plotkin, Scott
linked information resource: Phase 2 study of dose-intense temozolomide in recurrent glioblastoma.

Authorship 665876
type: Authorship
author rank in publication: 12
linked author: Plotkin, Scott
linked information resource: Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma.

Immunisation with canarypox virus expressing rabies glycoprotein.
PubMed Identifier: 1351126
author list: Cadoz M, Strady A, Meignier B, Taylor J, Tartaglia J, Paoletti E, Plotkin S
published in: Lancet (London, England)
information resource reference: Immunisation with canarypox virus expressing rabies glycoprotein. Lancet. 1992 Jun 13; 339(8807):1429-32.
journal title abbreviation: Lancet
publication date: 1992-06-13T00:00:00
year: 1992
type: Academic Article
type: Article
type: Document
type: Information Resource

Human safety and immunogenicity of a canarypox-rabies glycoprotein recombinant vaccine: an alternative poxvirus vector system.
PubMed Identifier: 8735555
author list: Fries LF, Tartaglia J, Taylor J, Kauffman EK, Meignier B, Paoletti E, Plotkin S
published in: Vaccine
information resource reference: Human safety and immunogenicity of a canarypox-rabies glycoprotein recombinant vaccine: an alternative poxvirus vector system. Vaccine. 1996 Apr; 14(5):428-34.
journal title abbreviation: Vaccine
publication date: 1996-04-01T00:00:00
year: 1996
type: Academic Article
type: Article
type: Document
type: Information Resource

Quality of life among adult patients with neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis: a systematic review of the literature.
PubMed Identifier: 23817811
author list: Vranceanu AM, Merker VL, Park E, Plotkin SR
published in: Journal of neuro-oncology
information resource reference: Quality of life among adult patients with neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis: a systematic review of the literature. J Neurooncol. 2013 Sep; 114(3):257-62.
journal title abbreviation: J Neurooncol
publication date: 2013-07-02T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Phase 2 study of dose-intense temozolomide in recurrent glioblastoma.
PubMed Identifier: 23553268
author list: Norden AD, Lesser GJ, Drappatz J, Ligon KL, Hammond SN, Lee EQ, Reardon DR, Fadul CE, Plotkin SR, Batchelor TT, Zhu JJ, Beroukhim R, Muzikansky A, Doherty L, Lafrankie D, Smith K, Tafoya V, Lis R, Stack EC, Rosenfeld MR, Wen PY
published in: Neuro-oncology
information resource reference: Phase 2 study of dose-intense temozolomide in recurrent glioblastoma. Neuro Oncol. 2013 Jul; 15(7):930-5.
journal title abbreviation: Neuro Oncol
publication date: 2013-04-03T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1701342
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Expanding therapeutic options for people with NF2-related schwannomatosis: Encouraging results with brigatinib.

Expanding therapeutic options for people with NF2-related schwannomatosis: Encouraging results with brigatinib.
PubMed Identifier: 39389170
author list: Plotkin SR, Blakeley JO
published in: Neuro-oncology
information resource reference: Expanding therapeutic options for people with NF2-related schwannomatosis: Encouraging results with brigatinib. Neuro Oncol. 2024 Nov 04; 26(11):1949-1950.
journal title abbreviation: Neuro Oncol
publication date: 2024-11-04T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 628427
type: Authorship
linked author: Plotkin, Scott
linked information resource: Brain metastases

Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma.
PubMed Identifier: 39734810
author list: Mendez JS, Cohen AL, Eckenstein M, Jensen RL, Burt LM, Salzman KL, Chamberlain M, Hsu HH, Hutchinson M, Iwamoto F, Ligon KL, Mrugala MM, Pelayo M, Plotkin SR, Puduvalli VK, Raizer J, Reardon DA, Sterba M, Walbert T, West BL, Wong ET, Zhang C, Colman H
published in: Neuro-oncology advances
information resource reference: Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma. Neurooncol Adv. 2024 Jan-Dec; 6(1):vdae202.
journal title abbreviation: Neurooncol Adv
publication date: 2024-11-22T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1716666
type: Authorship
author rank in publication: 14
linked author: Plotkin, Scott
linked information resource: Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma.

Authorship 245488
type: Authorship
author rank in publication: 4
linked author: Plotkin, Scott
linked information resource: Identity analysis of schwannomatosis kindreds with recurrent constitutional SMARCB1 (INI1) alterations.

Authorship 678885
type: Authorship
author rank in publication: 6
linked author: Plotkin, Scott
linked information resource: Neurofibromatosis type 1 and pregnancy complications: a population-based study.

Neurosurgery
type: Department
type: Organization

Authorship 35307
type: Authorship
author rank in publication: 4
linked author: Plotkin, Scott
linked information resource: Use of video to facilitate end-of-life discussions with patients with cancer: a randomized controlled trial.

Authorship 693829
type: Authorship
author rank in publication: 11
linked author: Plotkin, Scott
linked information resource: Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation.

Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation.
PubMed Identifier: 24190997
author list: Batchelor TT, Gerstner ER, Emblem KE, Duda DG, Kalpathy-Cramer J, Snuderl M, Ancukiewicz M, Polaskova P, Pinho MC, Jennings D, Plotkin SR, Chi AS, Eichler AF, Dietrich J, Hochberg FH, Lu-Emerson C, Iafrate AJ, Ivy SP, Rosen BR, Loeffler JS, Wen PY, Sorensen AG, Jain RK
published in: Proceedings of the National Academy of Sciences of the United States of America
information resource reference: Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation. Proc Natl Acad Sci U S A. 2013 Nov 19; 110(47):19059-64.
journal title abbreviation: Proc Natl Acad Sci U S A
publication date: 2013-11-04T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 694672
type: Authorship
author rank in publication: 14
linked author: Plotkin, Scott
linked information resource: Recommendations for imaging tumor response in neurofibromatosis clinical trials.

Authorship 694780
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Hearing and facial function outcomes for neurofibromatosis 2 clinical trials.

Authorship 694404
type: Authorship
author rank in publication: 6
linked author: Plotkin, Scott
linked information resource: Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.

Authorship 694782
type: Authorship
author rank in publication: 8
linked author: Plotkin, Scott
linked information resource: Conclusions and future directions for the REiNS International Collaboration.

Authorship 695042
type: Authorship
author rank in publication: 6
linked author: Plotkin, Scott
linked information resource: Outbreak of poliomyelitis-like paralysis associated with enterovirus 71.

Authorship 695080
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Achieving consensus for clinical trials: the REiNS International Collaboration.

Authorship 694596
type: Authorship
author rank in publication: 7
linked author: Plotkin, Scott
linked information resource: A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group.

Achieving consensus for clinical trials: the REiNS International Collaboration.
PubMed Identifier: 24249801
author list: Plotkin SR, Blakeley JO, Dombi E, Fisher MJ, Hanemann CO, Walsh KS, Wolters PL, Widemann BC
published in: Neurology
information resource reference: Achieving consensus for clinical trials: the REiNS International Collaboration. Neurology. 2013 Nov 19; 81(21 Suppl 1):S1-5.
journal title abbreviation: Neurology
publication date: 2013-11-19T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Hearing and facial function outcomes for neurofibromatosis 2 clinical trials.
PubMed Identifier: 24249803
author list: Plotkin SR, Ardern-Holmes SL, Barker FG, Blakeley JO, Evans DG, Ferner RE, Hadlock TA, Halpin C
published in: Neurology
information resource reference: Hearing and facial function outcomes for neurofibromatosis 2 clinical trials. Neurology. 2013 Nov 19; 81(21 Suppl 1):S25-32.
journal title abbreviation: Neurology
publication date: 2013-11-19T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Recommendations for imaging tumor response in neurofibromatosis clinical trials.
PubMed Identifier: 24249804
author list: Dombi E, Ardern-Holmes SL, Babovic-Vuksanovic D, Barker FG, Connor S, Evans DG, Fisher MJ, Goutagny S, Harris GJ, Jaramillo D, Karajannis MA, Korf BR, Mautner V, Plotkin SR, Poussaint TY, Robertson K, Shih CS, Widemann BC
published in: Neurology
information resource reference: Recommendations for imaging tumor response in neurofibromatosis clinical trials. Neurology. 2013 Nov 19; 81(21 Suppl 1):S33-40.
journal title abbreviation: Neurology
publication date: 2013-11-19T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Conclusions and future directions for the REiNS International Collaboration.
PubMed Identifier: 24249805
author list: Widemann BC, Blakeley JO, Dombi E, Fisher MJ, Hanemann CO, Walsh KS, Wolters PL, Plotkin SR
published in: Neurology
information resource reference: Conclusions and future directions for the REiNS International Collaboration. Neurology. 2013 Nov 19; 81(21 Suppl 1):S41-4.
journal title abbreviation: Neurology
publication date: 2013-11-19T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Outbreak of poliomyelitis-like paralysis associated with enterovirus 71.
PubMed Identifier: 2797956
author list: Hayward JC, Gillespie SM, Kaplan KM, Packer R, Pallansch M, Plotkin S, Schonberger LB
published in: The Pediatric infectious disease journal
information resource reference: Outbreak of poliomyelitis-like paralysis associated with enterovirus 71. Pediatr Infect Dis J. 1989 Sep; 8(9):611-6.
journal title abbreviation: Pediatr Infect Dis J
publication date: 1989-09-01T00:00:00
year: 1989
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1741282
type: Authorship
author rank in publication: 8
linked author: Plotkin, Scott
linked information resource: Self-reported access to specialty clinics and receipt of health surveillance among U.S. patients with neurofibromatosis 1: a national survey.

Authorship 1747996
type: Authorship
author rank in publication: 15
linked author: Plotkin, Scott
linked information resource: A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations.

Authorship 1750732
type: Authorship
author rank in publication: 5
linked author: Plotkin, Scott
linked information resource: Challenges in Assessing Response in Clinical Trials for Neurofibromatosis Type 1 Plexiform Neurofibromas.

Challenges in Assessing Response in Clinical Trials for Neurofibromatosis Type 1 Plexiform Neurofibromas.
PubMed Identifier: 40106744
author list: Dombi E, Gross AM, Widemann BC, Weiss BD, Plotkin SR, Ahlawat S
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Challenges in Assessing Response in Clinical Trials for Neurofibromatosis Type 1 Plexiform Neurofibromas. J Clin Oncol. 2025 May 20; 43(15):1843-1844.
journal title abbreviation: J Clin Oncol
publication date: 2025-03-19T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations.
PubMed Identifier: 40217315
author list: Gonzalez Castro LN, Gavish A, Bussema L, Mount CW, Neftel C, Nomura M, Chiocca EA, Bi WL, Arnaout O, Barker FG, Brown JM, Jordan JT, Batchelor TT, Stemmer-Rachamimov A, Plotkin SR, Tirosh I, Suvà ML
published in: Genome medicine
information resource reference: A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations. Genome Med. 2025 Apr 11; 17(1):37.
journal title abbreviation: Genome Med
publication date: 2025-04-11T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Self-reported access to specialty clinics and receipt of health surveillance among U.S. patients with neurofibromatosis 1: a national survey.
PubMed Identifier: 40241092
author list: Merker VL, Ma Y, Chibnik LB, Radtke HB, Kelts K, Yohay K, Ullrich NJ, Plotkin SR, Jordan JT
published in: Orphanet journal of rare diseases
information resource reference: Self-reported access to specialty clinics and receipt of health surveillance among U.S. patients with neurofibromatosis 1: a national survey. Orphanet J Rare Dis. 2025 Apr 16; 20(1):185.
journal title abbreviation: Orphanet J Rare Dis
publication date: 2025-04-16T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 696955
type: Authorship
author rank in publication: 3
linked author: Plotkin, Scott
linked information resource: Appearance concerns among women with neurofibromatosis: examining sexual/bodily and social self-consciousness.

Appearance concerns among women with neurofibromatosis: examining sexual/bodily and social self-consciousness.
PubMed Identifier: 23873824
author list: Smith KB, Wang DL, Plotkin SR, Park ER
published in: Psycho-oncology
information resource reference: Appearance concerns among women with neurofibromatosis: examining sexual/bodily and social self-consciousness. Psychooncology. 2013 Dec; 22(12):2711-9.
journal title abbreviation: Psychooncology
publication date: 2013-07-19T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 698060
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Natural history of vestibular schwannoma growth and hearing decline in newly diagnosed neurofibromatosis type 2 patients.

Natural history of vestibular schwannoma growth and hearing decline in newly diagnosed neurofibromatosis type 2 patients.
PubMed Identifier: 24335938
author list: Plotkin SR, Merker VL, Muzikansky A, Barker FG, Slattery W
published in: Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
information resource reference: Natural history of vestibular schwannoma growth and hearing decline in newly diagnosed neurofibromatosis type 2 patients. Otol Neurotol. 2014 Jan; 35(1):e50-6.
journal title abbreviation: Otol Neurotol
publication date: 2014-01-01T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1752181
type: Authorship
author rank in publication: 17
linked author: Plotkin, Scott
linked information resource: Effect of bevacizumab on non-target intracranial meningiomas and non-vestibular schwannomas in NF2-related schwannomatosis: NF104.

Effect of bevacizumab on non-target intracranial meningiomas and non-vestibular schwannomas in NF2-related schwannomatosis: NF104.
PubMed Identifier: 40434540
author list: Nakhate V, Ly I, Muzikansky A, Rapalino O, Allen JC, Blakeley JO, Campian JL, Clapp DW, Dhall G, Jain RK, Karajannis MA, Packer RJ, Tonsgard J, Ullrich NJ, Korf BR, Fisher MJ, Plotkin SR
published in: Journal of neuro-oncology
information resource reference: Effect of bevacizumab on non-target intracranial meningiomas and non-vestibular schwannomas in NF2-related schwannomatosis: NF104. J Neurooncol. 2025 Jul; 173(3):751-757.
journal title abbreviation: J Neurooncol
publication date: 2025-05-28T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 232993
type: Authorship
author rank in publication: 2
linked author: Plotkin, Scott
linked information resource: The neurofibromatoses. Part 2: NF2 and schwannomatosis.

Welling, D.
eCommons Login: DBW10
first name: D.
last name: Welling
full name: D. Bradley Welling, M.D., Ph.D.
has faculty rank: Full Professor
Person ID: 125020
person in primary position: Walter Augustus Lecompte Distinguished Professor of Otology and Laryngology
type: Agent
type: Person
preferred title: Walter Augustus Lecompte Distinguished Professor of Otology and Laryngology

Authorship 74094
type: Authorship
author rank in publication: 3
linked author: Plotkin, Scott
linked information resource: Phase I trial with biomarker studies of vatalanib (PTK787) in patients with newly diagnosed glioblastoma treated with enzyme inducing anti-epileptic drugs and standard radiation and temozolomide.

Mesothelin is a surface antigen present on human meningioma and can be effectively targeted by CAR T-cells.
PubMed Identifier: 40579924
author list: Ramapriyan R, Barker FG, Richardson LG, Sun J, Vandecandelaere G, Shim JM, De Vlaminck G, Gaffey M, Grewal EP, Tazhibi M, Morshedy K, Aref AR, Batool SM, Guo X, Ijad N, Balaj L, Wakimoto H, Martinez-Lage M, Frigault MJ, Leick MB, Bernstock JD, Bi WL, Carter BS, Chiocca EA, Dietrich J, Gerstner ER, Boland GM, Nahed BV, Plotkin SR, Jenkins RW, Brastianos PK, Curry WT, Maus MV, Choi BD
published in: Neuro-oncology
information resource reference: Mesothelin is a surface antigen present on human meningioma and can be effectively targeted by CAR T-cells. Neuro Oncol. 2025 Dec 01; 27(12):3104-3118.
journal title abbreviation: Neuro Oncol
publication date: 2025-12-01T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 721205
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Chemoprevention for neurofibromatosis 2: just over the horizon?

Authorship 714312
type: Authorship
author rank in publication: 29
linked author: Plotkin, Scott
linked information resource: CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies.

Authorship 714705
type: Authorship
author rank in publication: 8
linked author: Plotkin, Scott
linked information resource: Anatomic and metabolic evaluation of peripheral nerve sheath tumors in patients with neurofibromatosis 1 using whole-body MRI and (18)F-FDG PET fusion.

Anatomic and metabolic evaluation of peripheral nerve sheath tumors in patients with neurofibromatosis 1 using whole-body MRI and (18)F-FDG PET fusion.
PubMed Identifier: 24152623
author list: Urban T, Lim R, Merker VL, Muzikansky A, Harris GJ, Kassarjian A, Bredella MA, Plotkin SR
published in: Clinical nuclear medicine
information resource reference: Anatomic and metabolic evaluation of peripheral nerve sheath tumors in patients with neurofibromatosis 1 using whole-body MRI and (18)F-FDG PET fusion. Clin Nucl Med. 2014 May; 39(5):e301-7.
journal title abbreviation: Clin Nucl Med
publication date: 2014-05-01T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

Chemoprevention for neurofibromatosis 2: just over the horizon?
PubMed Identifier: 24637549
author list: Plotkin SR
published in: Neuro-oncology
information resource reference: Chemoprevention for neurofibromatosis 2: just over the horizon? Neuro Oncol. 2014 Apr; 16(4):471-2.
journal title abbreviation: Neuro Oncol
publication date: 2014-04-01T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies.
PubMed Identifier: 24443315
author list: Widemann BC, Acosta MT, Ammoun S, Belzberg AJ, Bernards A, Blakeley J, Bretscher A, Cichowski K, Clapp DW, Dombi E, Evans GD, Ferner R, Fernandez-Valle C, Fisher MJ, Giovannini M, Gutmann DH, Hanemann CO, Hennigan R, Huson S, Ingram D, Kissil J, Korf BR, Legius E, Packer RJ, McClatchey AI, McCormick F, North K, Pehrsson M, Plotkin SR, Ramesh V, Ratner N, Schirmer S, Sherman L, Schorry E, Stevenson D, Stewart DR, Ullrich N, Bakker AC, Morrison H
published in: American journal of medical genetics. Part A
information resource reference: CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies. Am J Med Genet A. 2014 Mar; 164A(3):563-78.
journal title abbreviation: Am J Med Genet A
publication date: 2014-01-17T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 728575
type: Authorship
author rank in publication: 9
linked author: Plotkin, Scott
linked information resource: Relationship between whole-body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis.

Authorship 725777
type: Authorship
author rank in publication: 4
linked author: Plotkin, Scott
linked information resource: Teaching NeuroImages: brain mass with hilar adenopathy: the importance of histologic diagnosis.

Relationship between whole-body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis.
PubMed Identifier: 24664633
author list: Merker VL, Bredella MA, Cai W, Kassarjian A, Harris GJ, Muzikansky A, Nguyen R, Mautner VF, Plotkin SR
published in: American journal of medical genetics. Part A
information resource reference: Relationship between whole-body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis. Am J Med Genet A. 2014 Jun; 164A(6):1431-7.
journal title abbreviation: Am J Med Genet A
publication date: 2014-03-24T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

Teaching NeuroImages: brain mass with hilar adenopathy: the importance of histologic diagnosis.
PubMed Identifier: 24799521
author list: Jordan JT, Yang HS, Narendra D, Plotkin SR
published in: Neurology
information resource reference: Teaching NeuroImages: brain mass with hilar adenopathy: the importance of histologic diagnosis. Neurology. 2014 May 06; 82(18):e161-2.
journal title abbreviation: Neurology
publication date: 2014-05-06T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

Prognostic significance of O6-methylguanine-DNA methyltransferase promoter methylation status in isocitrate dehydrogenase-mutant glioma.
PubMed Identifier: 41397912
author list: Youssef G, Aquilanti E, Miller JJ, Lan Z, Lasica AB, Arrillaga-Romany I, Batchelor TT, Berger TR, Beroukhim R, Chukwueke U, Dietrich J, Forst DA, Gerstner ER, Castro LNG, Jordan JT, Mcfaline-Figueroa JR, Lee EQ, Nayak L, Nakhate V, Ospina JP, Plotkin SR, Wang N, Rhee JY, Reardon DA, Wen PY
published in: Neuro-oncology
information resource reference: Prognostic significance of O6-methylguanine-DNA methyltransferase promoter methylation status in isocitrate dehydrogenase-mutant glioma. Neuro Oncol. 2026 Mar 01; 28(3):752-764.
journal title abbreviation: Neuro Oncol
publication date: 2026-03-01T00:00:00
year: 2026
type: Academic Article
type: Article
type: Document
type: Information Resource

Posterior reversible encephalopathy syndrome (PRES) complicating newly-diagnosed diffuse large B-cell lymphoma.
PubMed Identifier: 24581553
author list: Sengupta S, Benkers T, Blitstein M, Palmer E, Plotkin SR, Abramson JS
published in: Clinical lymphoma, myeloma & leukemia
information resource reference: Posterior reversible encephalopathy syndrome (PRES) complicating newly-diagnosed diffuse large B-cell lymphoma. Clin Lymphoma Myeloma Leuk. 2014 Aug; 14(4):e111-3.
journal title abbreviation: Clin Lymphoma Myeloma Leuk
publication date: 2014-02-02T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 733367
type: Authorship
author rank in publication: 5
linked author: Plotkin, Scott
linked information resource: Long-term toxicity of bevacizumab therapy in neurofibromatosis 2 patients.

Authorship 733812
type: Authorship
author rank in publication: 3
linked author: Plotkin, Scott
linked information resource: Turner syndrome and meningioma: support for a possible increased risk of neoplasia in Turner syndrome.

Long-term toxicity of bevacizumab therapy in neurofibromatosis 2 patients.
PubMed Identifier: 24710627
author list: Slusarz KM, Merker VL, Muzikansky A, Francis SA, Plotkin SR
published in: Cancer chemotherapy and pharmacology
information resource reference: Long-term toxicity of bevacizumab therapy in neurofibromatosis 2 patients. Cancer Chemother Pharmacol. 2014 Jun; 73(6):1197-204.
journal title abbreviation: Cancer Chemother Pharmacol
publication date: 2014-04-08T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

Turner syndrome and meningioma: support for a possible increased risk of neoplasia in Turner syndrome.
PubMed Identifier: 24675142
author list: Pier DB, Nunes FP, Plotkin SR, Stemmer-Rachamimov AO, Kim JC, Shih HA, Brastianos P, Lin AE
published in: European journal of medical genetics
information resource reference: Turner syndrome and meningioma: support for a possible increased risk of neoplasia in Turner syndrome. Eur J Med Genet. 2014 May-Jun; 57(6):269-74.
journal title abbreviation: Eur J Med Genet
publication date: 2014-03-25T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1779047
type: Authorship
author rank in publication: 21
linked author: Plotkin, Scott
linked information resource: Prognostic significance of O6-methylguanine-DNA methyltransferase promoter methylation status in isocitrate dehydrogenase-mutant glioma.

Authorship 1783577
type: Authorship
author rank in publication: 29
linked author: Plotkin, Scott
linked information resource: Mesothelin is a surface antigen present on human meningioma and can be effectively targeted by CAR T-cells.

Authorship 269343
type: Authorship
author rank in publication: 13
linked author: Plotkin, Scott
linked information resource: AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

Authorship 1786531
type: Authorship
author rank in publication: 4
linked author: Plotkin, Scott
linked information resource: Maturational changes in blood serotonin levels and platelet counts.

Authorship 1796232
type: Authorship
author rank in publication: 2
linked author: Plotkin, Scott
linked information resource: Viral vaccine meeting held in Barcelona, October 25-28, 2003.

Authorship 1810743
type: Authorship
author rank in publication: 7
linked author: Plotkin, Scott
linked information resource: Increased Hemorrhage During Excision of Bevacizumab-Treated NF2-Related Vestibular Schwannomas.

Authorship 1814479
type: Authorship
author rank in publication: 3
linked author: Plotkin, Scott
linked information resource: Advancements in Preclinical Models for NF2-Related Schwannomatosis Research.

Authorship 1819508
type: Authorship
author rank in publication: 14
linked author: Plotkin, Scott
linked information resource: A cochlea-sparing strategy for non-invasive control of intracranial schwannomas via peripheral irradiation and anti-PD-1 therapy enhanced by STING activation.

Authorship 1820144
type: Authorship
author rank in publication: 16
linked author: Plotkin, Scott
linked information resource: Enhanced Tumor Control and Hearing Loss Prevention Achieved with Combined Immune Checkpoint Inhibitor and Anti-VEGF Therapy in Vestibular Schwannoma Model.

Authorship 1827414
type: Authorship
author rank in publication: 15
linked author: Plotkin, Scott
linked information resource: Clinical presentation, management, and outcome of TIAN in CNS lymphoma treated with CD19-CAR T-cell therapy.

Authorship 1831312
type: Authorship
author rank in publication: 2
linked author: Plotkin, Scott
linked information resource: Clinical epidemiology of NF2-related schwannomatosis.

Authorship 1831313
type: Authorship
author rank in publication: 2
linked author: Plotkin, Scott
linked information resource: Medical therapy for vestibular schwannoma.

Authorship 1832015
type: Authorship
author rank in publication: 15
linked author: Plotkin, Scott
linked information resource: A retrospective study of treatment and outcomes in synchronous systemic and central nervous system large B-cell lymphoma.

Authorship 1833941
type: Authorship
author rank in publication: 6
linked author: Plotkin, Scott
linked information resource: Hearing preservation and restoration surgery in NF2-related schwannomatosis.

Authorship 1833424
type: Authorship
author rank in publication: 9
linked author: Plotkin, Scott
linked information resource: "It's not any one thing, it's always all of them, all at the same time": quality of life in NF2-related schwannomatosis from patient and clinician perspectives.

Authorship 1834614
type: Authorship
author rank in publication: 17
linked author: Plotkin, Scott
linked information resource: Deciphering and Targeting the Schwannoma-Neuron-Macrophage Crosstalk for the Treatment of Schwannomatosis and Associated Pain.

Authorship 1844452
type: Authorship
author rank in publication: 4
linked author: Plotkin, Scott
linked information resource: Whole Body-MRI assessment of peripheral lesions in patients with NF2-related schwannomatosis on systemic bevacizumab.

Authorship 1849145
type: Authorship
author rank in publication: 3
linked author: Plotkin, Scott
linked information resource: History and clinical epidemiology of NF2-related schwannomatosis.

Authorship 1852673
type: Authorship
author rank in publication: 16
linked author: Plotkin, Scott
linked information resource: NKG2D upregulation sensitizes tumors to combined anti-PD1 and anti-VEGF therapy and prevents hearing loss.

Maturational changes in blood serotonin levels and platelet counts.
PubMed Identifier: 5131446
author list: Ritvo E, Yuwiler A, Geller E, Plotkin S, Mason A, Saeger K
published in: Biochemical medicine
information resource reference: Maturational changes in blood serotonin levels and platelet counts. Biochem Med. 1971 Feb; 5(1):90-6.
journal title abbreviation: Biochem Med
publication date: 1971-02-01T00:00:00
year: 1971
type: Academic Article
type: Article
type: Document
type: Information Resource

Viral vaccine meeting held in Barcelona, October 25-28, 2003.
PubMed Identifier: 15098545
author list: Boon AC, Plotkin S, Rimmelzwaan GF, Osterhaus AD
published in: Vaccine
information resource reference: Viral vaccine meeting held in Barcelona, October 25-28, 2003. Vaccine. 2004 Mar 29; 22(11-12):1327-34.
journal title abbreviation: Vaccine
publication date: 2004-03-29T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Whole Body-MRI assessment of peripheral lesions in patients with NF2-related schwannomatosis on systemic bevacizumab.
PubMed Identifier: 40493293
author list: Ahlawat S, Debs P, Fayad LM, Plotkin SR, Widemann BC, Blakeley JO
published in: Journal of neuro-oncology
information resource reference: Whole Body-MRI assessment of peripheral lesions in patients with NF2-related schwannomatosis on systemic bevacizumab. J Neurooncol. 2025 Sep; 174(3):699-708.
journal title abbreviation: J Neurooncol
publication date: 2025-06-10T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

A cochlea-sparing strategy for non-invasive control of intracranial schwannomas via peripheral irradiation and anti-PD-1 therapy enhanced by STING activation.
PubMed Identifier: 41695475
author list: Yin Z, Lu S, Wu L, Sun Y, Blake DC, Chen J, Landegger LD, Ho W, Xiu B, Jones AP, Muzikansky A, Shih HA, Stankovic KM, Plotkin SR, Xu L
published in: Theranostics
information resource reference: A cochlea-sparing strategy for non-invasive control of intracranial schwannomas via peripheral irradiation and anti-PD-1 therapy enhanced by STING activation. Theranostics. 2026; 16(8):4076-4089.
journal title abbreviation: Theranostics
publication date: 2026-01-21T00:00:00
year: 2026
type: Academic Article
type: Article
type: Document
type: Information Resource

Enhanced Tumor Control and Hearing Loss Prevention Achieved with Combined Immune Checkpoint Inhibitor and Anti-VEGF Therapy in Vestibular Schwannoma Model.
PubMed Identifier: 39763968
author list: Lu S, Yin Z, Wu L, Sun Y, Chen J, Wu LMN, Oblinger JL, Blake DC, Landegger LD, Seist R, Ho W, Xiu B, Jones AP, Muzikansky A, Stankovic KM, Plotkin SR, Chang LS, Xu L
published in: bioRxiv : the preprint server for biology
information resource reference: Enhanced Tumor Control and Hearing Loss Prevention Achieved with Combined Immune Checkpoint Inhibitor and Anti-VEGF Therapy in Vestibular Schwannoma Model. bioRxiv. 2024 Dec 29.
journal title abbreviation: bioRxiv
publication date: 2024-12-29T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

A retrospective study of treatment and outcomes in synchronous systemic and central nervous system large B-cell lymphoma.
PubMed Identifier: 41170917
author list: Haydu JE, Redd RA, Lei MM, Hochberg EP, Barnes JA, Armand P, Soumerai JD, Eichler AF, Jacobsen ED, Jordan JT, Jacobson CA, LaCasce AS, Arrillaga-Romany I, McFaline-Figueroa JR, Plotkin SR, Takvorian RW, Chukwueke UN, Crombie JL, Johnson PC, Karschnia P, Dietrich J, Nayak L, Abramson JS
published in: Blood advances
information resource reference: A retrospective study of treatment and outcomes in synchronous systemic and central nervous system large B-cell lymphoma. Blood Adv. 2026 Jan 27; 10(2):479-491.
journal title abbreviation: Blood Adv
publication date: 2026-01-27T00:00:00
year: 2026
type: Academic Article
type: Article
type: Document
type: Information Resource

History and clinical epidemiology of NF2-related schwannomatosis.
PubMed Identifier: 41160189
author list: Evans DG, Blakeley JO, Plotkin SR
published in: Familial cancer
information resource reference: History and clinical epidemiology of NF2-related schwannomatosis. Fam Cancer. 2025 Oct 29; 24(4):79.
journal title abbreviation: Fam Cancer
publication date: 2025-10-29T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Advancements in Preclinical Models for NF2-Related Schwannomatosis Research.
PubMed Identifier: 41595145
author list: Zhang BS, Lu S, Plotkin SR, Xu L
published in: Cancers
information resource reference: Advancements in Preclinical Models for NF2-Related Schwannomatosis Research. Cancers (Basel). 2026 Jan 11; 18(2).
journal title abbreviation: Cancers (Basel)
publication date: 2026-01-11T00:00:00
year: 2026
type: Academic Article
type: Article
type: Document
type: Information Resource

"It's not any one thing, it's always all of them, all at the same time": quality of life in NF2-related schwannomatosis from patient and clinician perspectives.
PubMed Identifier: 41400724
author list: Carias SC, Buono FD, Von Imhof L, Yelamanchili SM, Chan H, Yohay KH, Nghiemphu PL, Babovic-Vuksanovic D, Plotkin SR, Merker VL
published in: Familial cancer
information resource reference: "It's not any one thing, it's always all of them, all at the same time": quality of life in NF2-related schwannomatosis from patient and clinician perspectives. Fam Cancer. 2025 Dec 16; 25(1):4.
journal title abbreviation: Fam Cancer
publication date: 2025-12-16T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Increased Hemorrhage During Excision of Bevacizumab-Treated NF2-Related Vestibular Schwannomas.
PubMed Identifier: 40511882
author list: Wood CG, Kozanno L, Stemmer-Rachamimov A, Lee DJ, Barker FG, Carter BS, Plotkin SR, Jordan JT, Chang LS, Welling DB
published in: The Laryngoscope
information resource reference: Increased Hemorrhage During Excision of Bevacizumab-Treated NF2-Related Vestibular Schwannomas. Laryngoscope. 2025 Nov; 135(11):4355-4363.
journal title abbreviation: Laryngoscope
publication date: 2025-06-13T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Clinical presentation, management, and outcome of TIAN in CNS lymphoma treated with CD19-CAR T-cell therapy.
PubMed Identifier: 40663771
author list: Kaulen LD, Martinez-Lage M, Abramson JS, Karschnia P, Doubrovinskaia S, Shankar GM, Choi BD, Ramundo CM, Ehret F, Barnes JA, El-Jawahri A, Hochberg EP, Johnson PC, Soumerai JD, Plotkin SR, Batchelor TT, Wick W, Maus MV, Chen YB, Frigault MJ, Dietrich J
published in: Blood
information resource reference: Clinical presentation, management, and outcome of TIAN in CNS lymphoma treated with CD19-CAR T-cell therapy. Blood. 2025 Oct 16; 146(16):1902-1913.
journal title abbreviation: Blood
publication date: 2025-10-16T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Clinical epidemiology of NF2-related schwannomatosis.
PubMed Identifier: 41052833
author list: Evans DG, Plotkin SR
published in: Handbook of clinical neurology
information resource reference: Clinical epidemiology of NF2-related schwannomatosis. Handb Clin Neurol. 2025; 212:129-134.
journal title abbreviation: Handb Clin Neurol
publication date: 2025-01-01T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Medical therapy for vestibular schwannoma.
PubMed Identifier: 41052835
author list: Evans DG, Plotkin SR
published in: Handbook of clinical neurology
information resource reference: Medical therapy for vestibular schwannoma. Handb Clin Neurol. 2025; 212:145-148.
journal title abbreviation: Handb Clin Neurol
publication date: 2025-01-01T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Deciphering and Targeting the Schwannoma-Neuron-Macrophage Crosstalk for the Treatment of Schwannomatosis and Associated Pain.
PubMed Identifier: 41758723
author list: Yin Z, Wu L, Zhang Y, Sun Y, Lee GY, Lu S, Gao X, Chen JW, Subudhi S, Ho W, Zhu C, Ren J, Ferraro GB, Muzikansky A, Stemmer-Rachamimov A, Mao J, Plotkin SR, Xu L
published in: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
information resource reference: Deciphering and Targeting the Schwannoma-Neuron-Macrophage Crosstalk for the Treatment of Schwannomatosis and Associated Pain. Adv Sci (Weinh). 2026 Feb 27; e15597.
journal title abbreviation: Adv Sci (Weinh)
publication date: 2026-02-27T00:00:00
year: 2026
type: Academic Article
type: Article
type: Document
type: Information Resource

Hearing preservation and restoration surgery in NF2-related schwannomatosis.
PubMed Identifier: 41618020
author list: Wood CG, Huey N, Carter C, Truong N, Ii Barker FG, Plotkin SR, Welling DB
published in: Familial cancer
information resource reference: Hearing preservation and restoration surgery in NF2-related schwannomatosis. Fam Cancer. 2026 Jan 31; 25(1):14.
journal title abbreviation: Fam Cancer
publication date: 2026-01-31T00:00:00
year: 2026
type: Academic Article
type: Article
type: Document
type: Information Resource

NKG2D upregulation sensitizes tumors to combined anti-PD1 and anti-VEGF therapy and prevents hearing loss.
PubMed Identifier: 41673019
author list: Lu S, Yin Z, Wu L, Sun Y, Chen J, Wu LMN, Oblinger JL, Blake DC, Xiu B, Landegger LD, Seist R, Ho W, Jones AP, Muzikansky A, Stankovic KM, Plotkin SR, Chang LS, Xu L
published in: Nature communications
information resource reference: NKG2D upregulation sensitizes tumors to combined anti-PD1 and anti-VEGF therapy and prevents hearing loss. Nat Commun. 2026 Feb 11; 17(1):1148.
journal title abbreviation: Nat Commun
publication date: 2026-02-11T00:00:00
year: 2026
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 738159
type: Authorship
author rank in publication: 3
linked author: Plotkin, Scott
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/32353753

https://connects.catalyst.harvard.edu/Profiles/profile/32353753
PubMed Identifier: 24967287
author list: Fayad LM, Blakeley J, Plotkin S, Widemann B, Jacobs MA
published in: ISRN radiology
information resource reference: Whole Body MRI at 3T with Quantitative Diffusion Weighted Imaging and Contrast-Enhanced Sequences for the Characterization of Peripheral Lesions in Patients with Neurofibromatosis Type 2 and Schwannomatosis. ISRN Radiol. 2013; 2013:627932.
journal title abbreviation: ISRN Radiol
publication date: 2013-10-07T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Whole Body MRI at 3T with Quantitative Diffusion Weighted Imaging and Contrast-Enhanced Sequences for the Characterization of Peripheral Lesions in Patients with Neurofibromatosis Type 2 and Schwannomatosis.

William and Elizabeth Sweet Professor of Neurosurgery
is primary position: true
position in department: Neurosurgery
position in division: CTNS
sort order: 1
type: Position
HR job title: William and Elizabeth Sweet Professor of Neurosurgery
position in organization: Massachusetts General Hospital

CTNS
type: Division
type: Organization

Martin A. Samuels Professor of Neurology
is primary position: true
position in department: Neurology
position in division: Oncology
sort order: 1
type: Position
HR job title: Martin A. Samuels Professor of Neurology
position in organization: Brigham and Women's Hospital

Corresponding Member of the Faculty of Neurology
is primary position: true
position in department: Neurology
position in division: https://connects.catalyst.harvard.edu/Profiles/profile/1229413
sort order: 1
type: Position
HR job title: Corresponding Member of the Faculty of Neurology
position in organization: Massachusetts General Hospital

Authorship 744452
type: Authorship
author rank in publication: 2
linked author: Plotkin, Scott
linked information resource: Magnetic resonance imaging observations in primary central nervous system lymphoma.

Magnetic resonance imaging observations in primary central nervous system lymphoma.
PubMed Identifier: 24861724
author list: Jordan JT, Plotkin S, Dietrich J
published in: JAMA neurology
information resource reference: Magnetic resonance imaging observations in primary central nervous system lymphoma. JAMA Neurol. 2014 Jul 01; 71(7):918-9.
journal title abbreviation: JAMA Neurol
publication date: 2014-07-01T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 408270
type: Authorship
author rank in publication: 6
linked author: Plotkin, Scott
linked information resource: St. Thomas Immunization Initiative. A student-run community action project.

The relaxation response resiliency program (3RP) in patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis: results from a pilot study.
PubMed Identifier: 25022450
author list: Vranceanu AM, Merker VL, Plotkin SR, Park ER
published in: Journal of neuro-oncology
information resource reference: The relaxation response resiliency program (3RP) in patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis: results from a pilot study. J Neurooncol. 2014 Oct; 120(1):103-9.
journal title abbreviation: J Neurooncol
publication date: 2014-07-15T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

Professor of Neurology
is primary position: true
position in department: Neurology
position in division: https://connects.catalyst.harvard.edu/Profiles/profile/1229413
sort order: 1
type: Position
HR job title: Professor of Neurology
position in organization: Boston Children's Hospital

Authorship 394919
type: Authorship
author rank in publication: 9
linked author: Plotkin, Scott
linked information resource: Understanding relationships between autism, intelligence, and epilepsy: a cross-disorder approach.

Authorship 746036
type: Authorship
author rank in publication: 5
linked author: Plotkin, Scott
linked information resource: Posterior reversible encephalopathy syndrome (PRES) complicating newly-diagnosed diffuse large B-cell lymphoma.

Authorship 746701
type: Authorship
author rank in publication: 11
linked author: Plotkin, Scott
linked information resource: Increased perfusion due to vascular normalization improves oxygenation and survival in glioblastoma patients treated with cediranib with or without chemoradiation.

Increased perfusion due to vascular normalization improves oxygenation and survival in glioblastoma patients treated with cediranib with or without chemoradiation.
PubMed Identifier: 25165209
author list: Batchelor TT, Gerstner ER, Emblem KE, Duda DG, Kalpathy-Cramer J, Snuderl M, Ancukiewicz M, Polaskova P, Pinho MC, Jennings D, Plotkin SR, Chi AS, Eichler AF, Dietrich J, Hochberg FH, Lu-Emerson C, Iafrate AJ, Ivy SP, Rosen B, Loeffler JS, Wen PY, Sorensen AG, Jain RK
published in: Neuro-oncology
information resource reference: Increased perfusion due to vascular normalization improves oxygenation and survival in glioblastoma patients treated with cediranib with or without chemoradiation. Neuro Oncol. 2014 Jul; 16 Suppl 3:iii12.
journal title abbreviation: Neuro Oncol
publication date: 2014-07-01T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 761561
type: Authorship
author rank in publication: 3
linked author: Plotkin, Scott
linked information resource: The relaxation response resiliency program (3RP) in patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis: results from a pilot study.

Authorship 769861
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Update from the 2013 International Neurofibromatosis Conference.

Update from the 2013 International Neurofibromatosis Conference.
PubMed Identifier: 25255738
author list: Plotkin SR, Albers AC, Babovic-Vuksanovic D, Blakeley JO, Breakefield XO, Dunn CM, Evans DG, Fisher MJ, Friedman JM, Giovannini M, Gutmann DH, Kalamarides M, McClatchey AI, Messiaen L, Morrison H, Parkinson DB, Stemmer-Rachamimov AO, Van Raamsdonk CD, Riccardi VM, Rosser T, Schindeler A, Smith MJ, Stevenson DA, Ullrich NJ, van der Vaart T, Weiss B, Widemann BC, Zhu Y, Bakker AC, Lloyd AC
published in: American journal of medical genetics. Part A
information resource reference: Update from the 2013 International Neurofibromatosis Conference. Am J Med Genet A. 2014 Dec; 164A(12):2969-78.
journal title abbreviation: Am J Med Genet A
publication date: 2014-09-24T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 427356
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Advances in the therapy of primary central nervous system lymphoma.

Authorship 428057
type: Authorship
author rank in publication: 2
linked author: Plotkin, Scott
linked information resource: Genetic causes of brain tumors: neurofibromatosis, tuberous sclerosis, von Hippel-Lindau, and other syndromes.

Authorship 777780
type: Authorship
author rank in publication: 15
linked author: Plotkin, Scott
linked information resource: Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma.

Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma.
PubMed Identifier: 25100872
author list: Kaley TJ, Wen P, Schiff D, Ligon K, Haidar S, Karimi S, Lassman AB, Nolan CP, DeAngelis LM, Gavrilovic I, Norden A, Drappatz J, Lee EQ, Purow B, Plotkin SR, Batchelor T, Abrey LE, Omuro A
published in: Neuro-oncology
information resource reference: Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma. Neuro Oncol. 2015 Jan; 17(1):116-21.
journal title abbreviation: Neuro Oncol
publication date: 2014-08-06T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 529939
type: Authorship
author rank in publication: 5
linked author: Plotkin, Scott
linked information resource: Clinical features of schwannomatosis: a retrospective analysis of 87 patients.

Authorship 623849
type: Authorship
linked author: Plotkin, Scott
linked information resource: Activity of Cilengitide, an Integrin-Targeting RGD Peptide, Among Adults with Recurrent Glioblastoma Multiforme: Results of a Randomized Phase 2 Study

Authorship 626789
type: Authorship
linked author: Plotkin, Scott
linked information resource: Neurofibromatosis type 2 and related disorders

Pregnancy complications in women with rare tumor suppressor syndromes affecting central and peripheral nervous system.
PubMed Identifier: 25687565
author list: Terry AR, Merker VL, Barker FG, Leffert L, Bateman BT, Souter I, Plotkin SR
published in: American journal of obstetrics and gynecology
information resource reference: Pregnancy complications in women with rare tumor suppressor syndromes affecting central and peripheral nervous system. Am J Obstet Gynecol. 2015 Jul; 213(1):108-109.
journal title abbreviation: Am J Obstet Gynecol
publication date: 2015-02-14T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 449313
type: Authorship
author rank in publication: 4
linked author: Plotkin, Scott
linked information resource: NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth.

Authorship 490260
type: Authorship
author rank in publication: 3
linked author: Plotkin, Scott
linked information resource: Case records of the Massachusetts General Hospital. Case 11-2007. A 59-year-old man with neck pain, weakness in the arms, and cranial-nerve palsies.

Authorship 500251
type: Authorship
author rank in publication: 10
linked author: Plotkin, Scott
linked information resource: Diagnostic criteria for schwannomatosis.

Authorship 50078
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Folk remedy use in the inner city.

Authorship 493855
type: Authorship
author rank in publication: 10
linked author: Plotkin, Scott
linked information resource: Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escape.

Authorship 558160
type: Authorship
author rank in publication: 8
linked author: Plotkin, Scott
linked information resource: Value of PET in the assessment of patients with neurofibromatosis type 1.

Authorship 585425
type: Authorship
linked author: Plotkin, Scott
linked information resource: Metastatic brain tumors

Authorship 79965
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Ethanol alters the concentration of Met-enkephalin in brain by affecting peptide transport system-1 independent of preproenkephalin mRNA.

Authorship 506083
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Update on primary central nervous system lymphoma.

Quality of life among children and adolescents with neurofibromatosis 1: a systematic review of the literature.
PubMed Identifier: 25663248
author list: Vranceanu AM, Merker VL, Park ER, Plotkin SR
published in: Journal of neuro-oncology
information resource reference: Quality of life among children and adolescents with neurofibromatosis 1: a systematic review of the literature. J Neurooncol. 2015 Apr; 122(2):219-28.
journal title abbreviation: J Neurooncol
publication date: 2015-02-07T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Examining perceived cancer risk among patients with neurofibromatosis type 1.
PubMed Identifier: 25559686
author list: Park ER, Smith KB, Merker VL, Muzikansky A, Vranceanu AM, Wang DL, Plotkin SR
published in: Journal of neuro-oncology
information resource reference: Examining perceived cancer risk among patients with neurofibromatosis type 1. J Neurooncol. 2015 Mar; 122(1):127-33.
journal title abbreviation: J Neurooncol
publication date: 2015-01-06T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 286353
type: Authorship
author rank in publication: 2
linked author: Plotkin, Scott
linked information resource: Three-dimensional volumetrics for tracking vestibular schwannoma growth in neurofibromatosis type II.

Authorship 339262
type: Authorship
author rank in publication: 8
linked author: Plotkin, Scott
linked information resource: Tumor burden in patients with neurofibromatosis types 1 and 2 and schwannomatosis: determination on whole-body MR images.

Authorship 270121
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Facial numbness in a man with inguinal and retroperitoneal masses.

Authorship 273832
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Treatment of relapsed central nervous system lymphoma with high-dose methotrexate.

Authorship 488891
type: Authorship
author rank in publication: 2
linked author: Plotkin, Scott
linked information resource: Permeability of the blood-brain barrier to soluble cytokine receptors.

Authorship 90459
type: Authorship
author rank in publication: 2
linked author: Plotkin, Scott
linked information resource: Brain metastases.

Authorship 96588
type: Authorship
author rank in publication: 5
linked author: Plotkin, Scott
linked information resource: Exacerbation of cerebral radiation necrosis by bevacizumab.

Authorship 377570
type: Authorship
author rank in publication: 2
linked author: Plotkin, Scott
linked information resource: Neurofibromatoses.

Authorship 277613
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Differential transport of rat and human interleukin-1alpha across the blood-brain barrier and blood-testis barrier in rats.

Authorship 506802
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Traumatic cervical-spine disruption.

Authorship 472078
type: Authorship
author rank in publication: 2
linked author: Plotkin, Scott
linked information resource: Case records of the Massachusetts General Hospital. Case 29-2012. A 49-year-old man with pain and cranial-nerve palsies after treatment of oral cancer.

Authorship 239377
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria.

Authorship 340043
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Erlotinib for progressive vestibular schwannoma in neurofibromatosis 2 patients.

Authorship 495119
type: Authorship
author rank in publication: 3
linked author: Plotkin, Scott
linked information resource: Human interleukin (IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism.

Authorship 789021
type: Authorship
author rank in publication: 4
linked author: Plotkin, Scott
linked information resource: Quality of life among children and adolescents with neurofibromatosis 1: a systematic review of the literature.

Authorship 805958
type: Authorship
author rank in publication: 7
linked author: Plotkin, Scott
linked information resource: A phase I trial of high dose gefitinib for patients with leptomeningeal metastases from non-small cell lung cancer.

Authorship 792127
type: Authorship
author rank in publication: 7
linked author: Plotkin, Scott
linked information resource: Outcomes of preimplantation genetic diagnosis in neurofibromatosis type 1.

Authorship 792258
type: Authorship
author rank in publication: 8
linked author: Plotkin, Scott
linked information resource: Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma.

Authorship 798932
type: Authorship
author rank in publication: 7
linked author: Plotkin, Scott
linked information resource: Examining perceived cancer risk among patients with neurofibromatosis type 1.

Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma.
PubMed Identifier: 25527270
author list: Norden AD, Ligon KL, Hammond SN, Muzikansky A, Reardon DA, Kaley TJ, Batchelor TT, Plotkin SR, Raizer JJ, Wong ET, Drappatz J, Lesser GJ, Haidar S, Beroukhim R, Lee EQ, Doherty L, Lafrankie D, Gaffey SC, Gerard M, Smith KH, McCluskey C, Phuphanich S, Wen PY
published in: Neurology
information resource reference: Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma. Neurology. 2015 Jan 20; 84(3):280-6.
journal title abbreviation: Neurology
publication date: 2014-12-19T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

A phase I trial of high dose gefitinib for patients with leptomeningeal metastases from non-small cell lung cancer.
PubMed Identifier: 25784657
author list: Jackman DM, Cioffredi LA, Jacobs L, Sharmeen F, Morse LK, Lucca J, Plotkin SR, Marcoux PJ, Rabin MS, Lynch TJ, Johnson BE, Kesari S
published in: Oncotarget
information resource reference: A phase I trial of high dose gefitinib for patients with leptomeningeal metastases from non-small cell lung cancer. Oncotarget. 2015 Feb 28; 6(6):4527-36.
journal title abbreviation: Oncotarget
publication date: 2015-02-28T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Outcomes of preimplantation genetic diagnosis in neurofibromatosis type 1.
PubMed Identifier: 25557241
author list: Merker VL, Murphy TP, Hughes JB, Muzikansky A, Hughes MR, Souter I, Plotkin SR
published in: Fertility and sterility
information resource reference: Outcomes of preimplantation genetic diagnosis in neurofibromatosis type 1. Fertil Steril. 2015 Mar; 103(3):761-8.e1.
journal title abbreviation: Fertil Steril
publication date: 2014-12-31T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 595574
type: Authorship
linked author: Plotkin, Scott
linked information resource: Neurologic complications of cancer therapy

Authorship 353654
type: Authorship
author rank in publication: 6
linked author: Plotkin, Scott
linked information resource: Genomic profiling distinguishes familial multiple and sporadic multiple meningiomas.

Authorship 378327
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Withdrawal from alcohol in withdrawal seizure-prone and -resistant mice: evidence for enkephalin resistance.

Authorship 564286
type: Authorship
author rank in publication: 6
linked author: Plotkin, Scott
linked information resource: Expression of SMARCB1 (INI1) mutations in familial schwannomatosis.

Authorship 581987
type: Authorship
linked author: Plotkin, Scott
linked information resource: Neurofibromatosis and Schwannomatosis

Authorship 812274
type: Authorship
author rank in publication: 7
linked author: Plotkin, Scott
linked information resource: Pregnancy complications in women with rare tumor suppressor syndromes affecting central and peripheral nervous system.

Authorship 817625
type: Authorship
author rank in publication: 20
linked author: Plotkin, Scott
linked information resource: The third international meeting on genetic disorders in the RAS/MAPK pathway: towards a therapeutic approach.

The third international meeting on genetic disorders in the RAS/MAPK pathway: towards a therapeutic approach.
PubMed Identifier: 25900621
author list: Korf B, Ahmadian R, Allanson J, Aoki Y, Bakker A, Wright EB, Denger B, Elgersma Y, Gelb BD, Gripp KW, Kerr B, Kontaridis M, Lazaro C, Linardic C, Lozano R, MacRae CA, Messiaen L, Mulero-Navarro S, Neel B, Plotkin S, Rauen KA, Roberts A, Silva AJ, Sittampalam SG, Zhang C, Schoyer L
published in: American journal of medical genetics. Part A
information resource reference: The third international meeting on genetic disorders in the RAS/MAPK pathway: towards a therapeutic approach. Am J Med Genet A. 2015 Aug; 167A(8):1741-6.
journal title abbreviation: Am J Med Genet A
publication date: 2015-04-21T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.
PubMed Identifier: 26219339
author list: Beauchamp RL, James MF, DeSouza PA, Wagh V, Zhao WN, Jordan JT, Stemmer-Rachamimov A, Plotkin SR, Gusella JF, Haggarty SJ, Ramesh V
published in: Oncotarget
information resource reference: A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas. Oncotarget. 2015 Jul 10; 6(19):16981-97.
journal title abbreviation: Oncotarget
publication date: 2015-07-10T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 819017
type: Authorship
author rank in publication: 8
linked author: Plotkin, Scott
linked information resource: A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.

Authorship 818341
type: Authorship
author rank in publication: 4
linked author: Plotkin, Scott
linked information resource: Multiple synchronous sites of origin of vestibular schwannomas in neurofibromatosis Type 2.

Authorship 819735
type: Authorship
author rank in publication: 6
linked author: Plotkin, Scott
linked information resource: Distribution of bacteria in the operating room environment and its relation to ventricular shunt infections: a prospective study.

Authorship 819734
type: Authorship
author rank in publication: 6
linked author: Plotkin, Scott
linked information resource: Generation of deletion mutants of simian immunodeficiency virus incapable of proviral integration.

Generation of deletion mutants of simian immunodeficiency virus incapable of proviral integration.
PubMed Identifier: 1727479
author list: Prakash K, Ranganathan PN, Mettus R, Reddy P, Srinivasan A, Plotkin S
published in: Journal of virology
information resource reference: Generation of deletion mutants of simian immunodeficiency virus incapable of proviral integration. J Virol. 1992 Jan; 66(1):167-71.
journal title abbreviation: J Virol
publication date: 1992-01-01T00:00:00
year: 1992
type: Academic Article
type: Article
type: Document
type: Information Resource

Multiple synchronous sites of origin of vestibular schwannomas in neurofibromatosis Type 2.
PubMed Identifier: 26104281
author list: Stivaros SM, Stemmer-Rachamimov AO, Alston R, Plotkin SR, Nadol JB, Quesnel A, O'Malley J, Whitfield GA, McCabe MG, Freeman SR, Lloyd SK, Wright NB, Kilday JP, Kamaly-Asl ID, Mills SJ, Rutherford SA, King AT, Evans DG
published in: Journal of medical genetics
information resource reference: Multiple synchronous sites of origin of vestibular schwannomas in neurofibromatosis Type 2. J Med Genet. 2015 Aug; 52(8):557-62.
journal title abbreviation: J Med Genet
publication date: 2015-06-23T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 597848
type: Authorship
linked author: Plotkin, Scott
linked information resource: Increased intracranial pressure and extradural compression syndromes

Authorship 616020
type: Authorship
linked author: Plotkin, Scott
linked information resource: Regulation of met-enkephalin in animal models of alcoholism

Authorship 82930
type: Authorship
author rank in publication: 5
linked author: Plotkin, Scott
linked information resource: Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma.

Anti-VEGF treatment improves neurological function and augments radiation response in NF2 schwannoma model.
PubMed Identifier: 26554010
author list: Gao X, Zhao Y, Stemmer-Rachamimov AO, Liu H, Huang P, Chin S, Selig MK, Plotkin SR, Jain RK, Xu L
published in: Proceedings of the National Academy of Sciences of the United States of America
information resource reference: Anti-VEGF treatment improves neurological function and augments radiation response in NF2 schwannoma model. Proc Natl Acad Sci U S A. 2015 Nov 24; 112(47):14676-81.
journal title abbreviation: Proc Natl Acad Sci U S A
publication date: 2015-11-09T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 460279
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma.

Authorship 469307
type: Authorship
author rank in publication: 6
linked author: Plotkin, Scott
linked information resource: Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme.

Glioblastoma care in the elderly.
PubMed Identifier: 26618888
author list: Jordan JT, Gerstner ER, Batchelor TT, Cahill DP, Plotkin SR
published in: Cancer
information resource reference: Glioblastoma care in the elderly. Cancer. 2016 Jan 15; 122(2):189-97.
journal title abbreviation: Cancer
publication date: 2015-11-30T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 849980
type: Authorship
author rank in publication: 8
linked author: Plotkin, Scott
linked information resource: Anti-VEGF treatment improves neurological function and augments radiation response in NF2 schwannoma model.

Authorship 855634
type: Authorship
author rank in publication: 4
linked author: Plotkin, Scott
linked information resource: Increased Risk of Cerebrovascular Disease Among Patients With Neurofibromatosis Type 1: Population-Based Approach.

Increased Risk of Cerebrovascular Disease Among Patients With Neurofibromatosis Type 1: Population-Based Approach.
PubMed Identifier: 26645253
author list: Terry AR, Jordan JT, Schwamm L, Plotkin SR
published in: Stroke
information resource reference: Increased Risk of Cerebrovascular Disease Among Patients With Neurofibromatosis Type 1: Population-Based Approach. Stroke. 2016 Jan; 47(1):60-5.
journal title abbreviation: Stroke
publication date: 2015-12-08T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 857657
type: Authorship
author rank in publication: 5
linked author: Plotkin, Scott
linked information resource: Glioblastoma care in the elderly.

Authorship 866694
type: Authorship
author rank in publication: 2
linked author: Plotkin, Scott
linked information resource: Laryngeal Manifestations of Neurofibromatosis.

Laryngeal Manifestations of Neurofibromatosis.
PubMed Identifier: 26786267
author list: Naunheim MR, Plotkin SR, Franco RA, Song PC
published in: Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
information resource reference: Laryngeal Manifestations of Neurofibromatosis. Otolaryngol Head Neck Surg. 2016 Mar; 154(3):494-7.
journal title abbreviation: Otolaryngol Head Neck Surg
publication date: 2016-01-19T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 303725
type: Authorship
author rank in publication: 4
linked author: Plotkin, Scott
linked information resource: Modeling NF2 with human arachnoidal and meningioma cell culture systems: NF2 silencing reflects the benign character of tumor growth.

Authorship 875044
type: Authorship
author rank in publication: 6
linked author: Plotkin, Scott
linked information resource: Bevacizumab treatment for symptomatic spinal ependymomas in neurofibromatosis type 2.

Bevacizumab treatment for symptomatic spinal ependymomas in neurofibromatosis type 2.
PubMed Identifier: 26369495
author list: Farschtschi S, Merker VL, Wolf D, Schuhmann M, Blakeley J, Plotkin SR, Hagel C, Mautner VF
published in: Acta neurologica Scandinavica
information resource reference: Bevacizumab treatment for symptomatic spinal ependymomas in neurofibromatosis type 2. Acta Neurol Scand. 2016 Jun; 133(6):475-80.
journal title abbreviation: Acta Neurol Scand
publication date: 2015-09-15T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas.
PubMed Identifier: 26976425
author list: Blakeley JO, Ye X, Duda DG, Halpin CF, Bergner AL, Muzikansky A, Merker VL, Gerstner ER, Fayad LM, Ahlawat S, Jacobs MA, Jain RK, Zalewski C, Dombi E, Widemann BC, Plotkin SR
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas. J Clin Oncol. 2016 05 10; 34(14):1669-75.
journal title abbreviation: J Clin Oncol
publication date: 2016-03-14T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 879887
type: Authorship
author rank in publication: 16
linked author: Plotkin, Scott
linked information resource: Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas.

Authorship 881494
type: Authorship
author rank in publication: 6
linked author: Plotkin, Scott
linked information resource: Health-related Quality of Life of Individuals With Neurofibromatosis Type 2: Results From the NF2 Natural History Study.

Health-related Quality of Life of Individuals With Neurofibromatosis Type 2: Results From the NF2 Natural History Study.
PubMed Identifier: 27050651
author list: Merker VL, Bergner AL, Vranceanu AM, Muzikansky A, Slattery W, Plotkin SR
published in: Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
information resource reference: Health-related Quality of Life of Individuals With Neurofibromatosis Type 2: Results From the NF2 Natural History Study. Otol Neurotol. 2016 06; 37(5):574-9.
journal title abbreviation: Otol Neurotol
publication date: 2016-06-01T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 884953
type: Authorship
author rank in publication: 2
linked author: Plotkin, Scott
linked information resource: Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis.

Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis.
PubMed Identifier: 26851632
author list: Blakeley JO, Plotkin SR
published in: Neuro-oncology
information resource reference: Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis. Neuro Oncol. 2016 05; 18(5):624-38.
journal title abbreviation: Neuro Oncol
publication date: 2016-02-06T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Assistant Professor
sort order: 2
type: Faculty Rank

Associate Professor
sort order: 1
type: Faculty Rank

Full Professor
sort order: 0
type: Faculty Rank

Other Faculty
sort order: 5
type: Faculty Rank

Authorship 892628
type: Authorship
author rank in publication: 22
linked author: Plotkin, Scott
linked information resource: The Fourth International Symposium on Genetic Disorders of the Ras/MAPK pathway.

The Fourth International Symposium on Genetic Disorders of the Ras/MAPK pathway.
PubMed Identifier: 27155140
author list: Stevenson DA, Schill L, Schoyer L, Andresen BS, Bakker A, Bayrak-Toydemir P, Burkitt-Wright E, Chatfield K, Elefteriou F, Elgersma Y, Fisher MJ, Franz D, Gelb BD, Goriely A, Gripp KW, Hardan AY, Keppler-Noreuil KM, Kerr B, Korf B, Leoni C, McCormick F, Plotkin SR, Rauen KA, Reilly K, Roberts A, Sandler A, Siegel D, Walsh K, Widemann BC
published in: American journal of medical genetics. Part A
information resource reference: The Fourth International Symposium on Genetic Disorders of the Ras/MAPK pathway. Am J Med Genet A. 2016 08; 170(8):1959-66.
journal title abbreviation: Am J Med Genet A
publication date: 2016-05-07T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 575474
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis.

Authorship 53025
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Spinal ependymomas in neurofibromatosis Type 2: a retrospective analysis of 55 patients.

Authorship 595289
type: Authorship
linked author: Plotkin, Scott
linked information resource: About Neurofibromatosis 2

Authorship 606523
type: Authorship
linked author: Plotkin, Scott
linked information resource: Histopathology and Molecular Pathogenesis of Schwannomas

Authorship 607378
type: Authorship
linked author: Plotkin, Scott
linked information resource: The Phakomatoses

Authorship 619370
type: Authorship
linked author: Plotkin, Scott
linked information resource: Phakomatoses: Neurofibromatosis 2

Authorship 897775
type: Authorship
author rank in publication: 15
linked author: Plotkin, Scott
linked information resource: Current whole-body MRI applications in the neurofibromatoses: NF1, NF2, and schwannomatosis.

Authorship 903851
type: Authorship
author rank in publication: 16
linked author: Plotkin, Scott
linked information resource: Current status and recommendations for biomarkers and biobanking in neurofibromatosis.

Authorship 907011
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Sleep and pulmonary outcomes for clinical trials of airway plexiform neurofibromas in NF1.

Current status and recommendations for biomarkers and biobanking in neurofibromatosis.
PubMed Identifier: 27527649
author list: Hanemann CO, Blakeley JO, Nunes FP, Robertson K, Stemmer-Rachamimov A, Mautner V, Kurtz A, Ferguson M, Widemann BC, Evans DG, Ferner R, Carroll SL, Korf B, Wolkenstein P, Knight P, Plotkin SR
published in: Neurology
information resource reference: Current status and recommendations for biomarkers and biobanking in neurofibromatosis. Neurology. 2016 Aug 16; 87(7 Suppl 1):S40-8.
journal title abbreviation: Neurology
publication date: 2016-08-16T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Current whole-body MRI applications in the neurofibromatoses: NF1, NF2, and schwannomatosis.
PubMed Identifier: 27527647
author list: Ahlawat S, Fayad LM, Khan MS, Bredella MA, Harris GJ, Evans DG, Farschtschi S, Jacobs MA, Chhabra A, Salamon JM, Wenzel R, Mautner VF, Dombi E, Cai W, Plotkin SR, Blakeley JO
published in: Neurology
information resource reference: Current whole-body MRI applications in the neurofibromatoses: NF1, NF2, and schwannomatosis. Neurology. 2016 Aug 16; 87(7 Suppl 1):S31-9.
journal title abbreviation: Neurology
publication date: 2016-08-16T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Sleep and pulmonary outcomes for clinical trials of airway plexiform neurofibromas in NF1.
PubMed Identifier: 27527645
author list: Plotkin SR, Davis SD, Robertson KA, Akshintala S, Allen J, Fisher MJ, Blakeley JO, Widemann BC, Ferner RE, Marcus CL
published in: Neurology
information resource reference: Sleep and pulmonary outcomes for clinical trials of airway plexiform neurofibromas in NF1. Neurology. 2016 Aug 16; 87(7 Suppl 1):S13-20.
journal title abbreviation: Neurology
publication date: 2016-08-16T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 908944
type: Authorship
author rank in publication: 6
linked author: Plotkin, Scott
linked information resource: Mind-body therapy via videoconferencing in patients with neurofibromatosis: An RCT.

Mind-body therapy via videoconferencing in patients with neurofibromatosis: An RCT.
PubMed Identifier: 27449066
author list: Vranceanu AM, Riklin E, Merker VL, Macklin EA, Park ER, Plotkin SR
published in: Neurology
information resource reference: Mind-body therapy via videoconferencing in patients with neurofibromatosis: An RCT. Neurology. 2016 Aug 23; 87(8):806-14.
journal title abbreviation: Neurology
publication date: 2016-07-22T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Developing Endpoints to Facilitate Clinical Trials in Rare Diseases
end date: 2016-11-30
principal investigator name: PLOTKIN, SCOTT R
start date: 2015-12-04
type: Grant
sponsor award id: R13CA203289

Phase II trial of mTORC1/mTORC2 inhibitor AZD2014 for sporadic meningioma
end date: 2021-07-31
principal investigator name: RAMESH, VIJAYA
start date: 2016-08-10
type: Grant
sponsor award id: R01CA201130

Training Program in Nervous System Tumors
end date: 2026-08-31
principal investigator name: PLOTKIN, SCOTT R
start date: 2001-09-26
type: Grant
sponsor award id: K12CA090354

FETAL ALCOHOL EFFECTS ON BLOOD BRAIN BARRIER TRANSPORT
end date: 1900-01-01
principal investigator name: PLOTKIN, SCOTT RANDALL
start date: 1995-08-11
type: Grant
sponsor award id: F30AA005401

Children's Tumor Foundation 2016 Neurofibromatosis (NF) Conference
end date: 2017-06-12
principal investigator name: FISHER, MICHAEL
start date: 2013-06-08
type: Grant
sponsor award id: R13NS084619

FETAL ALCOHOL EFFECTS ON BLOOD BRAIN BARRIER TRANSPORT
end date: 1900-01-01
principal investigator name: PLOTKIN, SCOTT RANDALL
start date: 1995-02-01
type: Grant
sponsor award id: F31AA005401

Principal Investigator
type: Researcher Role
researcher role of: Plotkin, Scott
contributes to: Phase II trial of mTORC1/mTORC2 inhibitor AZD2014 for sporadic meningioma

Principal Investigator
type: Researcher Role
researcher role of: Plotkin, Scott
contributes to: Developing Endpoints to Facilitate Clinical Trials in Rare Diseases

Principal Investigator
type: Researcher Role
researcher role of: Plotkin, Scott
contributes to: FETAL ALCOHOL EFFECTS ON BLOOD BRAIN BARRIER TRANSPORT

Principal Investigator
type: Researcher Role
researcher role of: Plotkin, Scott
contributes to: FETAL ALCOHOL EFFECTS ON BLOOD BRAIN BARRIER TRANSPORT

Co-Principal Investigator
type: Researcher Role
researcher role of: Plotkin, Scott
contributes to: Children's Tumor Foundation 2016 Neurofibromatosis (NF) Conference

Authorship 613193
type: Authorship
linked author: Plotkin, Scott
linked information resource: Determination of Tumor Burden in NF1, NF2, and Schwannomatosis on Whole Body MR Images

Authorship 344180
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Neurologic complications of cancer therapy.

Authorship 922957
type: Authorship
author rank in publication: 15
linked author: Plotkin, Scott
linked information resource: Creation of an international registry to support discovery in schwannomatosis.

Creation of an international registry to support discovery in schwannomatosis.
PubMed Identifier: 27759912
author list: Ostrow KL, Bergner AL, Blakeley J, Evans DG, Ferner R, Friedman JM, Harris GJ, Jordan JT, Korf B, Langmead S, Leschziner G, Mautner V, Merker VL, Papi L, Plotkin SR, Slopis JM, Smith MJ, Stemmer-Rachamimov A, Yohay K, Belzberg AJ
published in: American journal of medical genetics. Part A
information resource reference: Creation of an international registry to support discovery in schwannomatosis. Am J Med Genet A. 2017 Feb; 173(2):407-413.
journal title abbreviation: Am J Med Genet A
publication date: 2016-10-19T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 420534
type: Authorship
author rank in publication: 3
linked author: Plotkin, Scott
linked information resource: Ramsay Hunt syndrome in a patient with metastatic lung cancer to brain.

Authorship 345635
type: Authorship
author rank in publication: 6
linked author: Plotkin, Scott
linked information resource: Anti-vascular endothelial growth factor therapies as a novel therapeutic approach to treating neurofibromatosis-related tumors.

Authorship 375157
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Comparison of saturable transport and extracellular pathways in the passage of interleukin-1 alpha across the blood-brain barrier.

Authorship 943810
type: Authorship
author rank in publication: 3
linked author: Plotkin, Scott
linked information resource: Phase I trial of vatalanib (PTK787) in combination with standard radiation and temozolomide in patients with newly diagnosed glioblastoma.

Authorship 941844
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Whole-body MRI evaluation of tumor burden in the neurofibromatosis tumor suppressor syndromes.

Phase I trial of vatalanib (PTK787) in combination with standard radiation and temozolomide in patients with newly diagnosed glioblastoma.
PubMed Identifier: 27964624
author list: Batchelor T, Eichler AF, Plotkin SR, Drappatz J, Wen P, Sorensen AG, Gerstner E
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Phase I trial of vatalanib (PTK787) in combination with standard radiation and temozolomide in patients with newly diagnosed glioblastoma. J Clin Oncol. 2009 May 20; 27(15_suppl):2035.
journal title abbreviation: J Clin Oncol
publication date: 2009-05-20T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Whole-body MRI evaluation of tumor burden in the neurofibromatosis tumor suppressor syndromes.
PubMed Identifier: 27964382
author list: Plotkin SR, Singh M, Cai W, O'Donnell C, Esparza S, Smith MJ, Harris GJ, Muzikansky A, Bredella MA, Kassarjian A
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Whole-body MRI evaluation of tumor burden in the neurofibromatosis tumor suppressor syndromes. J Clin Oncol. 2009 May 20; 27(15_suppl):2074.
journal title abbreviation: J Clin Oncol
publication date: 2009-05-20T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 944762
type: Authorship
author rank in publication: 7
linked author: Plotkin, Scott
linked information resource: Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma.

Authorship 944779
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Vascular hemodynamic profiles of vestibular schwannomas and glioblastoma using MRI.

Vascular hemodynamic profiles of vestibular schwannomas and glioblastoma using MRI.
PubMed Identifier: 28023808
author list: Plotkin SR, Jennings D, Mouridsen K, Emblem KE, Sorensen AG
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Vascular hemodynamic profiles of vestibular schwannomas and glioblastoma using MRI. J Clin Oncol. 2011 May 20; 29(15_suppl):2047.
journal title abbreviation: J Clin Oncol
publication date: 2011-05-20T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma.
PubMed Identifier: 28023794
author list: Norden AD, Hammond S, Drappatz J, Phuphanich S, Reardon DA, Wong E, Plotkin SR, Lesser GJ, Raizer JJ, Batchelor T, Quant EC, Beroukhim R, Kaley TJ, Muzikansky A, Ciampa AS, Doherty LM, Smith KH, Gerard M, Sceppa C, Wen PY
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma. J Clin Oncol. 2011 May 20; 29(15_suppl):2040.
journal title abbreviation: J Clin Oncol
publication date: 2011-05-20T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 584775
type: Authorship
linked author: Plotkin, Scott
linked information resource: Primary CNS Post-Transplant Lymphoproliferative Disorder: The International PCNSL Collaborative Group Experience

Authorship 956344
type: Authorship
author rank in publication: 6
linked author: Plotkin, Scott
linked information resource: First use of patient reported outcomes measurement information system (PROMIS) measures in adults with neurofibromatosis.

First use of patient reported outcomes measurement information system (PROMIS) measures in adults with neurofibromatosis.
PubMed Identifier: 27900643
author list: Talaei-Khoei M, Riklin E, Merker VL, Sheridan MR, Jordan JT, Plotkin SR, Vranceanu AM
published in: Journal of neuro-oncology
information resource reference: First use of patient reported outcomes measurement information system (PROMIS) measures in adults with neurofibromatosis. J Neurooncol. 2017 01; 131(2):413-419.
journal title abbreviation: J Neurooncol
publication date: 2016-11-29T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 64703
type: Authorship
author rank in publication: 17
linked author: Plotkin, Scott
linked information resource: Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2.

A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group.
PubMed Identifier: 1988829
author list: Whitley R, Arvin A, Prober C, Burchett S, Corey L, Powell D, Plotkin S, Starr S, Alford C, Connor J
published in: The New England journal of medicine
information resource reference: A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med. 1991 Feb 14; 324(7):444-9.
journal title abbreviation: N Engl J Med
publication date: 1991-02-14T00:00:00
year: 1991
type: Academic Article
type: Article
type: Document
type: Information Resource

Primary nervous system lymphoma.
PubMed Identifier: 12392641
author list: Plotkin SR, Batchelor TT
published in: Current treatment options in oncology
information resource reference: Primary nervous system lymphoma. Curr Treat Options Oncol. 2002 Dec; 3(6):525-35.
journal title abbreviation: Curr Treat Options Oncol
publication date: 2002-12-01T00:00:00
year: 2002
type: Academic Article
type: Article
type: Document
type: Information Resource

Neurologic complications of cancer therapy.
PubMed Identifier: 12690653
author list: Plotkin SR, Wen PY
published in: Neurologic clinics
information resource reference: Neurologic complications of cancer therapy. Neurol Clin. 2003 Feb; 21(1):279-318, x.
journal title abbreviation: Neurol Clin
publication date: 2003-02-01T00:00:00
year: 2003
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 965968
type: Authorship
author rank in publication: 6
linked author: Plotkin, Scott
linked information resource: Characterization of blood vessels in brain autopsies of GBM patients who received antiangiogenic treatment.

Authorship 964778
type: Authorship
author rank in publication: 1
linked author: Plotkin, Scott
linked information resource: Treatment of progressive neurofibromatosis type 2-related vestibular schwannoma with erlotinib.

Treatment of progressive neurofibromatosis type 2-related vestibular schwannoma with erlotinib.
PubMed Identifier: 27948119
author list: Plotkin SR, Halpin CF, McKenna MJ, Batchelor TT, Loeffler JS, Barker FG
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Treatment of progressive neurofibromatosis type 2-related vestibular schwannoma with erlotinib. J Clin Oncol. 2008 May 20; 26(15_suppl):2045.
journal title abbreviation: J Clin Oncol
publication date: 2008-05-20T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Characterization of blood vessels in brain autopsies of GBM patients who received antiangiogenic treatment.
PubMed Identifier: 27948447
author list: di Tomaso E, Frosch MP, Auluck PK, Cahill D, Duda DG, Plotkin SR, Loeffler JS, Sorensen AG, Batchelor TT, Jain RK
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Characterization of blood vessels in brain autopsies of GBM patients who received antiangiogenic treatment. J Clin Oncol. 2008 May 20; 26(15_suppl):2009.
journal title abbreviation: J Clin Oncol
publication date: 2008-05-20T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 969798
type: Authorship
author rank in publication: 6
linked author: Plotkin, Scott
linked information resource: First report of factors associated with satisfaction in patients with neurofibromatosis.

First report of factors associated with satisfaction in patients with neurofibromatosis.
PubMed Identifier: 28211981
author list: Riklin E, Talaei-Khoei M, Merker VL, Sheridan MR, Jordan JT, Plotkin SR, Vranceanu AM
published in: American journal of medical genetics. Part A
information resource reference: First report of factors associated with satisfaction in patients with neurofibromatosis. Am J Med Genet A. 2017 03; 173(3):671-677.
journal title abbreviation: Am J Med Genet A
publication date: 2017-03-01T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

St. Thomas Immunization Initiative. A student-run community action project.
PubMed Identifier: 9188243
author list: Ramsey AH, Steinmann WC, Capps A, Diaz A, Netland K, Plotkin S, Wuttke J
published in: The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society
information resource reference: St. Thomas Immunization Initiative. A student-run community action project. J La State Med Soc. 1997 Jun; 149(6):197-9.
journal title abbreviation: J La State Med Soc
publication date: 1997-06-01T00:00:00
year: 1997
type: Academic Article
type: Article
type: Document
type: Information Resource

Folk remedy use in the inner city.
PubMed Identifier: 10456718
author list: Plotkin SR, Post R
published in: Southern medical journal
information resource reference: Folk remedy use in the inner city. South Med J. 1999 Aug; 92(8):795-8.
journal title abbreviation: South Med J
publication date: 1999-08-01T00:00:00
year: 1999
type: Academic Article
type: Article
type: Document
type: Information Resource

Primary nervous-system lymphoma.
PubMed Identifier: 11905752
author list: Plotkin SR, Batchelor TT
published in: The Lancet. Oncology
information resource reference: Primary nervous-system lymphoma. Lancet Oncol. 2001 Jun; 2(6):354-65.
journal title abbreviation: Lancet Oncol
publication date: 2001-06-01T00:00:00
year: 2001
type: Academic Article
type: Article
type: Document
type: Information Resource

Advances in the therapy of primary central nervous system lymphoma.
PubMed Identifier: 11707839
author list: Plotkin SR, Batchelor TT
published in: Clinical lymphoma
information resource reference: Advances in the therapy of primary central nervous system lymphoma. Clin Lymphoma. 2001 Mar; 1(4):263-75; discussion 276-7.
journal title abbreviation: Clin Lymphoma
publication date: 2001-03-01T00:00:00
year: 2001
type: Academic Article
type: Article
type: Document
type: Information Resource

Histopathology and Molecular Pathogenesis of Schwannomas
author list: Fabio P. Nunes, Scott R. Plotkin, Anat Stemmer-Rachamimov
published in: Principles and Practices of Neuro-Oncology: A Multidisciplinary Approach (Mehta, Chang, Vogelbaum, Guha, et al., Editors)
information resource reference: Histopathology and Molecular Pathogenesis of Schwannomas. Principles and Practices of Neuro-Oncology: A Multidisciplinary Approach (Mehta, Chang, Vogelbaum, Guha, et al., Editors). 2010; in press.
publication date: 2010-06-01T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource

55 Fruit St
type: Address
address line 1: Massachusetts General Hospital
address line 2: Pappas Ctr for Neuro-Oncology, Yawkey 9E
address line 3: 55 Fruit St
city: Boston
postal code: 02114
state or province: MA

Human interleukin (IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism.
PubMed Identifier: 1762091
author list: Banks WA, Ortiz L, Plotkin SR, Kastin AJ
published in: The Journal of pharmacology and experimental therapeutics
information resource reference: Human interleukin (IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism. J Pharmacol Exp Ther. 1991 Dec; 259(3):988-96.
journal title abbreviation: J Pharmacol Exp Ther
publication date: 1991-12-01T00:00:00
year: 1991
type: Academic Article
type: Article
type: Document
type: Information Resource

Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme.
PubMed Identifier: 18981465
author list: Reardon DA, Fink KL, Mikkelsen T, Cloughesy TF, O'Neill A, Plotkin S, Glantz M, Ravin P, Raizer JJ, Rich KM, Schiff D, Shapiro WR, Burdette-Radoux S, Dropcho EJ, Wittemer SM, Nippgen J, Picard M, Nabors LB
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme. J Clin Oncol. 2008 Dec 01; 26(34):5610-7.
journal title abbreviation: J Clin Oncol
publication date: 2008-11-03T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Tumor burden in patients with neurofibromatosis types 1 and 2 and schwannomatosis: determination on whole-body MR images.
PubMed Identifier: 19244040
author list: Cai W, Kassarjian A, Bredella MA, Harris GJ, Yoshida H, Mautner VF, Wenzel R, Plotkin SR
published in: Radiology
information resource reference: Tumor burden in patients with neurofibromatosis types 1 and 2 and schwannomatosis: determination on whole-body MR images. Radiology. 2009 Mar; 250(3):665-73.
journal title abbreviation: Radiology
publication date: 2009-03-01T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Distribution of bacteria in the operating room environment and its relation to ventricular shunt infections: a prospective study.
PubMed Identifier: 1933917
author list: Duhaime AC, Bonner K, McGowan KL, Schut L, Sutton LN, Plotkin S
published in: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
information resource reference: Distribution of bacteria in the operating room environment and its relation to ventricular shunt infections: a prospective study. Childs Nerv Syst. 1991 Aug; 7(4):211-4.
journal title abbreviation: Childs Nerv Syst
publication date: 1991-08-01T00:00:00
year: 1991
type: Academic Article
type: Article
type: Document
type: Information Resource

Diagnostic criteria for schwannomatosis.
PubMed Identifier: 15955931
author list: MacCollin M, Chiocca EA, Evans DG, Friedman JM, Horvitz R, Jaramillo D, Lev M, Mautner VF, Niimura M, Plotkin SR, Sang CN, Stemmer-Rachamimov A, Roach ES
published in: Neurology
information resource reference: Diagnostic criteria for schwannomatosis. Neurology. 2005 Jun 14; 64(11):1838-45.
journal title abbreviation: Neurology
publication date: 2005-06-14T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Ramsay Hunt syndrome in a patient with metastatic lung cancer to brain.
PubMed Identifier: 17634859
author list: Alcalay RN, Shulman JM, Plotkin SR
published in: Journal of neuro-oncology
information resource reference: Ramsay Hunt syndrome in a patient with metastatic lung cancer to brain. J Neurooncol. 2008 Jan; 86(1):55-6.
journal title abbreviation: J Neurooncol
publication date: 2007-07-19T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Modeling NF2 with human arachnoidal and meningioma cell culture systems: NF2 silencing reflects the benign character of tumor growth.
PubMed Identifier: 17962031
author list: James MF, Lelke JM, Maccollin M, Plotkin SR, Stemmer-Rachamimov AO, Ramesh V, Gusella JF
published in: Neurobiology of disease
information resource reference: Modeling NF2 with human arachnoidal and meningioma cell culture systems: NF2 silencing reflects the benign character of tumor growth. Neurobiol Dis. 2008 Feb; 29(2):278-92.
journal title abbreviation: Neurobiol Dis
publication date: 2007-09-19T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Use of video to facilitate end-of-life discussions with patients with cancer: a randomized controlled trial.
PubMed Identifier: 19949010
author list: El-Jawahri A, Podgurski LM, Eichler AF, Plotkin SR, Temel JS, Mitchell SL, Chang Y, Barry MJ, Volandes AE
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Use of video to facilitate end-of-life discussions with patients with cancer: a randomized controlled trial. J Clin Oncol. 2010 Jan 10; 28(2):305-10.
journal title abbreviation: J Clin Oncol
publication date: 2009-11-30T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Hearing improvement after bevacizumab in patients with neurofibromatosis type 2.
PubMed Identifier: 19587327
author list: Plotkin SR, Stemmer-Rachamimov AO, Barker FG, Halpin C, Padera TP, Tyrrell A, Sorensen AG, Jain RK, di Tomaso E
published in: The New England journal of medicine
information resource reference: Hearing improvement after bevacizumab in patients with neurofibromatosis type 2. N Engl J Med. 2009 Jul 23; 361(4):358-67.
journal title abbreviation: N Engl J Med
publication date: 2009-07-08T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Phase I trial with biomarker studies of vatalanib (PTK787) in patients with newly diagnosed glioblastoma treated with enzyme inducing anti-epileptic drugs and standard radiation and temozolomide.
PubMed Identifier: 20821342
author list: Gerstner ER, Eichler AF, Plotkin SR, Drappatz J, Doyle CL, Xu L, Duda DG, Wen PY, Jain RK, Batchelor TT
published in: Journal of neuro-oncology
information resource reference: Phase I trial with biomarker studies of vatalanib (PTK787) in patients with newly diagnosed glioblastoma treated with enzyme inducing anti-epileptic drugs and standard radiation and temozolomide. J Neurooncol. 2011 Jun; 103(2):325-32.
journal title abbreviation: J Neurooncol
publication date: 2010-09-07T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource

Peripheral and cranial nerve sheath tumors.
PubMed Identifier: 16155448
author list: Mrugala MM, Batchelor TT, Plotkin SR
published in: Current opinion in neurology
information resource reference: Peripheral and cranial nerve sheath tumors. Curr Opin Neurol. 2005 Oct; 18(5):604-10.
journal title abbreviation: Curr Opin Neurol
publication date: 2005-10-01T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma.
PubMed Identifier: 20458050
author list: Batchelor TT, Duda DG, di Tomaso E, Ancukiewicz M, Plotkin SR, Gerstner E, Eichler AF, Drappatz J, Hochberg FH, Benner T, Louis DN, Cohen KS, Chea H, Exarhopoulos A, Loeffler JS, Moses MA, Ivy P, Sorensen AG, Wen PY, Jain RK
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma. J Clin Oncol. 2010 Jun 10; 28(17):2817-23.
journal title abbreviation: J Clin Oncol
publication date: 2010-05-10T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource

Ethanol alters the concentration of Met-enkephalin in brain by affecting peptide transport system-1 independent of preproenkephalin mRNA.
PubMed Identifier: 9160250
author list: Plotkin SR, Banks WA, Waguespack PJ, Kastin AJ
published in: Journal of neuroscience research
information resource reference: Ethanol alters the concentration of Met-enkephalin in brain by affecting peptide transport system-1 independent of preproenkephalin mRNA. J Neurosci Res. 1997 May 01; 48(3):273-80.
journal title abbreviation: J Neurosci Res
publication date: 1997-05-01T00:00:00
year: 1997
type: Academic Article
type: Article
type: Document
type: Information Resource

Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis.
PubMed Identifier: 22558206
author list: Plotkin SR, Bredella MA, Cai W, Kassarjian A, Harris GJ, Esparza S, Merker VL, Munn LL, Muzikansky A, Askenazi M, Nguyen R, Wenzel R, Mautner VF
published in: PloS one
information resource reference: Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis. PLoS One. 2012; 7(4):e35711.
journal title abbreviation: PLoS One
publication date: 2012-04-27T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Genomic profiling distinguishes familial multiple and sporadic multiple meningiomas.
PubMed Identifier: 19589153
author list: Shen Y, Nunes F, Stemmer-Rachamimov A, James M, Mohapatra G, Plotkin S, Betensky RA, Engler DA, Roy J, Ramesh V, Gusella JF
published in: BMC medical genomics
information resource reference: Genomic profiling distinguishes familial multiple and sporadic multiple meningiomas. BMC Med Genomics. 2009 Jul 09; 2:42.
journal title abbreviation: BMC Med Genomics
publication date: 2009-07-09T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Phakomatoses: Neurofibromatosis 2
author list: S.R. Plotkin
published in: In Larry R. Squire, Editor-in-Chief, The New Encyclopedia of Neuroscience
information resource reference: Phakomatoses: Neurofibromatosis 2. In Larry R. Squire, Editor-in-Chief, The New Encyclopedia of Neuroscience. 2008.
publication date: 2008-10-15T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Enhancing patient engagement in neurofibromatosis clinical trials
end date: 2018-04-14
principal investigator name: PLOTKIN, SCOTT R
start date: 2015-12-04
type: Grant
sponsor award id: R13TR002095

Principal Investigator
type: Researcher Role
researcher role of: Plotkin, Scott
contributes to: Enhancing patient engagement in neurofibromatosis clinical trials

Facial reanimation of patients with neurofibromatosis type 2.
PubMed Identifier: 21968382
author list: Vakharia KT, Henstrom D, Plotkin SR, Cheney M, Hadlock TA
published in: Neurosurgery
information resource reference: Facial reanimation of patients with neurofibromatosis type 2. Neurosurgery. 2012 Jun; 70(2 Suppl Operative):237-43.
journal title abbreviation: Neurosurgery
publication date: 2012-06-01T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1010457
type: Authorship
author rank in publication: 7
linked author: Plotkin, Scott
linked information resource: Anti-VEGF treatment improves neurological function in tumors of the nervous system.

Anti-VEGF treatment improves neurological function in tumors of the nervous system.
PubMed Identifier: 28911884
author list: Zhang N, Chen J, Ferraro GB, Wu L, Datta M, Jain RK, Plotkin SR, Stemmer-Rachamimov A, Xu L
published in: Experimental neurology
information resource reference: Anti-VEGF treatment improves neurological function in tumors of the nervous system. Exp Neurol. 2018 01; 299(Pt B):326-333.
journal title abbreviation: Exp Neurol
publication date: 2017-09-11T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Withdrawal from alcohol in withdrawal seizure-prone and -resistant mice: evidence for enkephalin resistance.
PubMed Identifier: 11325389
author list: Plotkin SR, Banks WA, Cohn CS, Kastin AJ
published in: Pharmacology, biochemistry, and behavior
information resource reference: Withdrawal from alcohol in withdrawal seizure-prone and -resistant mice: evidence for enkephalin resistance. Pharmacol Biochem Behav. 2001 Mar; 68(3):379-87.
journal title abbreviation: Pharmacol Biochem Behav
publication date: 2001-03-01T00:00:00
year: 2001
type: Academic Article
type: Article
type: Document
type: Information Resource

Traumatic cervical-spine disruption.
PubMed Identifier: 11596603
author list: Plotkin SR, Ning MM
published in: The New England journal of medicine
information resource reference: Traumatic cervical-spine disruption. N Engl J Med. 2001 10 11; 345(15):1134-5.
journal title abbreviation: N Engl J Med
publication date: 2001-10-11T00:00:00
year: 2001
type: Academic Article
type: Article
type: Document
type: Information Resource

Update on primary central nervous system lymphoma.
PubMed Identifier: 16280675
author list: Plotkin SR
published in: Current opinion in neurology
information resource reference: Update on primary central nervous system lymphoma. Curr Opin Neurol. 2005 Dec; 18(6):645-53.
journal title abbreviation: Curr Opin Neurol
publication date: 2005-12-01T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Treatment of relapsed central nervous system lymphoma with high-dose methotrexate.
PubMed Identifier: 15355887
author list: Plotkin SR, Betensky RA, Hochberg FH, Grossman SA, Lesser GJ, Nabors LB, Chon B, Batchelor TT
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Treatment of relapsed central nervous system lymphoma with high-dose methotrexate. Clin Cancer Res. 2004 Sep 01; 10(17):5643-6.
journal title abbreviation: Clin Cancer Res
publication date: 2004-09-01T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Facial numbness in a man with inguinal and retroperitoneal masses.
PubMed Identifier: 16264857
author list: Plotkin SR, Dorfman MV, Loeffler JS
published in: Nature clinical practice. Oncology
information resource reference: Facial numbness in a man with inguinal and retroperitoneal masses. Nat Clin Pract Oncol. 2005 Jan; 2(1):54-8; quiz 1 p following 58.
journal title abbreviation: Nat Clin Pract Oncol
publication date: 2005-01-01T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Audiologic and radiographic response of NF2-related vestibular schwannoma to erlotinib therapy.
PubMed Identifier: 18560388
author list: Plotkin SR, Singh MA, O'Donnell CC, Harris GJ, McClatchey AI, Halpin C
published in: Nature clinical practice. Oncology
information resource reference: Audiologic and radiographic response of NF2-related vestibular schwannoma to erlotinib therapy. Nat Clin Pract Oncol. 2008 Aug; 5(8):487-91.
journal title abbreviation: Nat Clin Pract Oncol
publication date: 2008-06-17T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Identity analysis of schwannomatosis kindreds with recurrent constitutional SMARCB1 (INI1) alterations.
PubMed Identifier: 19320657
author list: Smith MJ, Boyd CD, MacCollin MM, Plotkin SR
published in: Clinical genetics
information resource reference: Identity analysis of schwannomatosis kindreds with recurrent constitutional SMARCB1 (INI1) alterations. Clin Genet. 2009 May; 75(5):501-2.
journal title abbreviation: Clin Genet
publication date: 2009-03-23T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Value of PET in the assessment of patients with neurofibromatosis type 1.
PubMed Identifier: 17885067
author list: Bredella MA, Torriani M, Hornicek F, Ouellette HA, Plamer WE, Williams Z, Fischman AJ, Plotkin SR
published in: AJR. American journal of roentgenology
information resource reference: Value of PET in the assessment of patients with neurofibromatosis type 1. AJR Am J Roentgenol. 2007 Oct; 189(4):928-35.
journal title abbreviation: AJR Am J Roentgenol
publication date: 2007-10-01T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Genetic causes of brain tumors: neurofibromatosis, tuberous sclerosis, von Hippel-Lindau, and other syndromes.
PubMed Identifier: 17964021
author list: Farrell CJ, Plotkin SR
published in: Neurologic clinics
information resource reference: Genetic causes of brain tumors: neurofibromatosis, tuberous sclerosis, von Hippel-Lindau, and other syndromes. Neurol Clin. 2007 Nov; 25(4):925-46, viii.
journal title abbreviation: Neurol Clin
publication date: 2007-11-01T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Clinical reasoning: a case of multiple intracerebral hemorrhages.
PubMed Identifier: 18056573
author list: Wendell LC, Freeman SH, Plotkin SR, Sims JR
published in: Neurology
information resource reference: Clinical reasoning: a case of multiple intracerebral hemorrhages. Neurology. 2007 Dec 04; 69(23):E30-4.
journal title abbreviation: Neurology
publication date: 2007-12-04T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Three-dimensional volumetrics for tracking vestibular schwannoma growth in neurofibromatosis type II.
PubMed Identifier: 18824998
author list: Harris GJ, Plotkin SR, Maccollin M, Bhat S, Urban T, Lev MH, Slattery WH
published in: Neurosurgery
information resource reference: Three-dimensional volumetrics for tracking vestibular schwannoma growth in neurofibromatosis type II. Neurosurgery. 2008 Jun; 62(6):1314-9; discussion 1319-20.
journal title abbreviation: Neurosurgery
publication date: 2008-06-01T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Plasma S100ß is not a useful biomarker for tumor burden in neurofibromatosis.
PubMed Identifier: 23261835
author list: Smith MJ, Esparza S, Merker VL, Muzikansky A, Bredella MA, Harris GJ, Kassarjian A, Cai W, Walker JA, Mautner VF, Plotkin SR
published in: Clinical biochemistry
information resource reference: Plasma S100ß is not a useful biomarker for tumor burden in neurofibromatosis. Clin Biochem. 2013 May; 46(7-8):698-700.
journal title abbreviation: Clin Biochem
publication date: 2012-12-19T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1023833
type: Authorship
author rank in publication: 6
linked author: Plotkin, Scott
linked information resource: Volumetric MRI Analysis of Plexiform Neurofibromas in Neurofibromatosis Type 1: Comparison of Two Methods.

Volumetric MRI Analysis of Plexiform Neurofibromas in Neurofibromatosis Type 1: Comparison of Two Methods.
PubMed Identifier: 29097016
author list: Cai W, Steinberg SM, Bredella MA, Basinsky G, Somarouthu B, Plotkin SR, Solomon J, Widemann BC, Harris GJ, Dombi E
published in: Academic radiology
information resource reference: Volumetric MRI Analysis of Plexiform Neurofibromas in Neurofibromatosis Type 1: Comparison of Two Methods. Acad Radiol. 2018 02; 25(2):144-152.
journal title abbreviation: Acad Radiol
publication date: 2017-10-31T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1024976
type: Authorship
author rank in publication: 7
linked author: Plotkin, Scott
linked information resource: Health literacy assessment in adults with neurofibromatosis: electronic and short-form measurement using FCCHL and Health LiTT.

Health literacy assessment in adults with neurofibromatosis: electronic and short-form measurement using FCCHL and Health LiTT.
PubMed Identifier: 29119424
author list: Merker VL, McDannold S, Riklin E, Talaei-Khoei M, Sheridan MR, Jordan JT, Plotkin SR, Vranceanu AM
published in: Journal of neuro-oncology
information resource reference: Health literacy assessment in adults with neurofibromatosis: electronic and short-form measurement using FCCHL and Health LiTT. J Neurooncol. 2018 Jan; 136(2):335-342.
journal title abbreviation: J Neurooncol
publication date: 2017-11-08T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Chemotherapy: present and future.
PubMed Identifier: 22483828
author list: Terry AR, Plotkin SR
published in: Otolaryngologic clinics of North America
information resource reference: Chemotherapy: present and future. Otolaryngol Clin North Am. 2012 Apr; 45(2):471-86, x.
journal title abbreviation: Otolaryngol Clin North Am
publication date: 2012-04-01T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Neurofibromatoses.
PubMed Identifier: 22411249
author list: Uhlmann EJ, Plotkin SR
published in: Advances in experimental medicine and biology
information resource reference: Neurofibromatoses. Adv Exp Med Biol. 2012; 724:266-77.
journal title abbreviation: Adv Exp Med Biol
publication date: 2012-01-01T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1034531
type: Authorship
author rank in publication: 7
linked author: Plotkin, Scott
linked information resource: Early changes in glioblastoma metabolism measured by MR spectroscopic imaging during combination of anti-angiogenic cediranib and chemoradiation therapy are associated with survival.

Early changes in glioblastoma metabolism measured by MR spectroscopic imaging during combination of anti-angiogenic cediranib and chemoradiation therapy are associated with survival.
PubMed Identifier: 29202103
author list: Andronesi OC, Esmaeili M, Borra RJH, Emblem K, Gerstner ER, Pinho MC, Plotkin SR, Chi AS, Eichler AF, Dietrich J, Ivy SP, Wen PY, Duda DG, Jain R, Rosen BR, Sorensen GA, Batchelor TT
published in: NPJ precision oncology
information resource reference: Early changes in glioblastoma metabolism measured by MR spectroscopic imaging during combination of anti-angiogenic cediranib and chemoradiation therapy are associated with survival. NPJ Precis Oncol. 2017; 1.
journal title abbreviation: NPJ Precis Oncol
publication date: 2017-06-12T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Exacerbation of cerebral radiation necrosis by bevacizumab.
PubMed Identifier: 21149667
author list: Jeyaretna DS, Curry WT, Batchelor TT, Stemmer-Rachamimov A, Plotkin SR
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Exacerbation of cerebral radiation necrosis by bevacizumab. J Clin Oncol. 2011 Mar 01; 29(7):e159-62.
journal title abbreviation: J Clin Oncol
publication date: 2010-12-13T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1036101
type: Authorship
author rank in publication: 49
linked author: Plotkin, Scott
linked information resource: Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844-848.

Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844-848.
PubMed Identifier: 29290338
author list: Koczkowska M, Chen Y, Callens T, Gomes A, Sharp A, Johnson S, Hsiao MC, Chen Z, Balasubramanian M, Barnett CP, Becker TA, Ben-Shachar S, Bertola DR, Blakeley JO, Burkitt-Wright EMM, Callaway A, Crenshaw M, Cunha KS, Cunningham M, D'Agostino MD, Dahan K, De Luca A, Destrée A, Dhamija R, Eoli M, Evans DGR, Galvin-Parton P, George-Abraham JK, Gripp KW, Guevara-Campos J, Hanchard NA, Hernández-Chico C, Immken L, Janssens S, Jones KJ, Keena BA, Kochhar A, Liebelt J, Martir-Negron A, Mahoney MJ, Maystadt I, McDougall C, McEntagart M, Mendelsohn N, Miller DT, Mortier G, Morton J, Pappas J, Plotkin SR, Pond D, Rosenbaum K, Rubin K, Russell L, Rutledge LS, Saletti V, Schonberg R, Schreiber A, Seidel M, Siqveland E, Stockton DW, Trevisson E, Ullrich NJ, Upadhyaya M, van Minkelen R, Verhelst H, Wallace MR, Yap YS, Zackai E, Zonana J, Zurcher V, Claes K, Martin Y, Korf BR, Legius E, Messiaen LM
published in: American journal of human genetics
information resource reference: Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844-848. Am J Hum Genet. 2018 01 04; 102(1):69-87.
journal title abbreviation: Am J Hum Genet
publication date: 2017-12-28T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Spinal ependymomas in neurofibromatosis Type 2: a retrospective analysis of 55 patients.
PubMed Identifier: 21294614
author list: Plotkin SR, O'Donnell CC, Curry WT, Bove CM, MacCollin M, Nunes FP
published in: Journal of neurosurgery. Spine
information resource reference: Spinal ependymomas in neurofibromatosis Type 2: a retrospective analysis of 55 patients. J Neurosurg Spine. 2011 Apr; 14(4):543-7.
journal title abbreviation: J Neurosurg Spine
publication date: 2011-02-04T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Patient and physician attitudes regarding clinical trials in neurofibromatosis 1.
PubMed Identifier: 19170300
author list: McQueen M, MacCollin M, Gusella J, Plotkin SR
published in: The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses
information resource reference: Patient and physician attitudes regarding clinical trials in neurofibromatosis 1. J Neurosci Nurs. 2008 Dec; 40(6):341-5.
journal title abbreviation: J Neurosci Nurs
publication date: 2008-12-01T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients.
PubMed Identifier: 22805104
author list: Plotkin SR, Merker VL, Halpin C, Jennings D, McKenna MJ, Harris GJ, Barker FG
published in: Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
information resource reference: Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients. Otol Neurotol. 2012 Aug; 33(6):1046-52.
journal title abbreviation: Otol Neurotol
publication date: 2012-08-01T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 101933
type: Authorship
author rank in publication: 6
linked author: Plotkin, Scott
linked information resource: Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis.

Authorship 1044085
type: Authorship
author rank in publication: 14
linked author: Plotkin, Scott
linked information resource: Pain correlates with germline mutation in schwannomatosis.

Pain correlates with germline mutation in schwannomatosis.
PubMed Identifier: 29384852
author list: Jordan JT, Smith MJ, Walker JA, Erdin S, Talkowski ME, Merker VL, Ramesh V, Cai W, Harris GJ, Bredella MA, Seijo M, Suuberg A, Gusella JF, Plotkin SR
published in: Medicine
information resource reference: Pain correlates with germline mutation in schwannomatosis. Medicine (Baltimore). 2018 Feb; 97(5):e9717.
journal title abbreviation: Medicine (Baltimore)
publication date: 2018-02-01T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models.
PubMed Identifier: 29440379
author list: Zhao Y, Liu P, Zhang N, Chen J, Landegger LD, Wu L, Zhao F, Zhao Y, Zhang Y, Zhang J, Fujita T, Stemmer-Rachamimov A, Ferraro GB, Liu H, Muzikansky A, Plotkin SR, Stankovic KM, Jain RK, Xu L
published in: Proceedings of the National Academy of Sciences of the United States of America
information resource reference: Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models. Proc Natl Acad Sci U S A. 2018 02 27; 115(9):E2077-E2084.
journal title abbreviation: Proc Natl Acad Sci U S A
publication date: 2018-02-09T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

About Neurofibromatosis 2
author list: Scott Plotkin, M.D., Ph.D.
published in: About Neurofibromatosis 2
information resource reference: About Neurofibromatosis 2. 2007.
publication date: 2007-01-01T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Neurofibromatosis and Schwannomatosis
author list: Miriam J. Smith and Scott R. Plotkin
published in: The MGH Guide to Clinical Cancer Genetics (eds., DC Chung and DA Haber)
information resource reference: Neurofibromatosis and Schwannomatosis. The MGH Guide to Clinical Cancer Genetics (eds., DC Chung and DA Haber). 2010; in press.
publication date: 2010-07-01T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource

Clinical presentation, immunohistochemistry and electron microscopy indicate neurofibromatosis type 2-associated gliomas to be spinal ependymomas.
PubMed Identifier: 22394059
author list: Hagel C, Stemmer-Rachamimov AO, Bornemann A, Schuhmann M, Nagel C, Huson S, Evans DG, Plotkin S, Matthies C, Kluwe L, Mautner VF
published in: Neuropathology : official journal of the Japanese Society of Neuropathology
information resource reference: Clinical presentation, immunohistochemistry and electron microscopy indicate neurofibromatosis type 2-associated gliomas to be spinal ependymomas. Neuropathology. 2012 Dec; 32(6):611-6.
journal title abbreviation: Neuropathology
publication date: 2012-03-07T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Regulation of met-enkephalin in animal models of alcoholism
author list: SR Plotkin
published in: Regulation of met-enkephalin in animal models of alcoholism
information resource reference: Regulation of met-enkephalin in animal models of alcoholism. 1997.
publication date: 1997-01-01T00:00:00
year: 1997
type: Academic Article
type: Article
type: Document
type: Information Resource

Enkephalin, PPE mRNA, and PTS-1 in alcohol withdrawal seizure-prone and -resistant mice.
PubMed Identifier: 9426834
author list: Plotkin SR, Banks WA, Kastin AJ
published in: Alcohol (Fayetteville, N.Y.)
information resource reference: Enkephalin, PPE mRNA, and PTS-1 in alcohol withdrawal seizure-prone and -resistant mice. Alcohol. 1998 Jan; 15(1):25-31.
journal title abbreviation: Alcohol
publication date: 1998-01-01T00:00:00
year: 1998
type: Academic Article
type: Article
type: Document
type: Information Resource

Primary CNS Post-Transplant Lymphoproliferative Disorder: The International PCNSL Collaborative Group Experience
author list: R Cavaliere, B O’Neill, S Plotkin, G van Imhoff, E Neuwelt, K Jahnke, L Abrey, T Batchelor, G Illerhaus, S Horning, G Petroni, B Lopes, and D Schiff
published in: Cancer
information resource reference: Primary CNS Post-Transplant Lymphoproliferative Disorder: The International PCNSL Collaborative Group Experience. Cancer. 2009; in press.
publication date: 2009-12-31T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource